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Thesis Overview 
 
Psychogenic nonepileptic seizures (PNES) can be defined as paroxysmal 
events that resemble epileptic seizures, without being associated with either 
abnormal electrical activity of the brain or primary physiological disturbances 
otherwise. It is estimated that about 10% of new presentations seen in an 
epilepsy clinic, and up to 30% of patients with intractable epilepsy will eventually 
be diagnosed as having PNES (Benbadis & Hauser, 2000).                                     
 
Attributing a specific ‘cause’ to PNES is conceptually and clinically contentious 
but it seems reasonable to say that they represent a physical expression of 
psychological distress involving behaviour that the patient finds difficult or 
impossible to control or disavows as being intentional. 
 
Most patients with PNES are initially thought to have epilepsy and treated with 
antiepileptic drugs (AED), sometimes for many years. Up to 40% of patients are 
inappropriately maintained on AEDs after the diagnosis of PNES has been 
established. As such, rather than being intrinsic to the condition, the widely 
reported poor outcomes associated with PNES may be substantially 
confounded by continued inappropriate medical management and iatrogenic 
harm.   
 
Withdrawing or continuing antiepileptic medication in patients with PNES could 
have important physical and psychological consequences, which may affect the 
prognosis of the attack disorder. If this is the case, manipulating medication 
following the diagnosis of PNES may have a role in the management of this 
disorder. The work contained in this thesis aims to explore some aspects of the 
effects that continuing or withdrawing AED has on the course and outcome of 
PNES.  
 
Following an initial general overview on the subject of PNES (chapter 1), a 
systematic review of the literature is presented in chapter 2; the conclusion 
being a lack of good quality and reliable evidence for the effects of AED 
treatment in patients with PNES and a need for further original research in this 
area.  The rationale and programme of research is presented in chapter 3 
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Chapter 4 presents the results of a large observational study to establish the 
feasibility and safety of supervised AED withdrawal in patients with an 
established diagnosis of PNES. Only 3 of the 78 patients included reported a 
new type of event requiring the reintroduction of AED, and no serious medical 
events were reported. The study therefore shows that, with appropriate 
diagnostic investigations and surveillance during follow-up, withdrawal of AED 
can be achieved safely in patients with PNES. 
 
A randomised controlled trial presented in chapter 5 aims to evaluate the 
potential therapeutic effect of AED withdrawal. Of the 25 subjects recruited, 14 
were randomised to immediate withdrawal (IW) and 11 to delayed withdrawal 
(DW). Patients randomised to IW had a significant reduction in the use of 
emergency treatment for PNES, and a lower proportion was found to be using 
emergency services. The IW group also had a sustained reduction of attacks 
throughout the study and by 18 months post-diagnosis 50% were attack free as 
compared with 27% in the DW group. 
 
The results of this exploratory trial suggested a possible therapeutic effect of 
AED withdrawal, with a sustained reduction of attacks following the withdrawal 
of medication, coupled with a significant reduction in health care utilisation and 
no evidence of any deterioration.  
 
The last original paper presented in chapter 6 investigates the longer term 
psychosocial outcome of PNES with an observational study of the 25 patients 
included in the RCT. This study reports a significant improvement in some 
psychological measures; particularly in illness representations and mood, as 
well as for some measures of social adjustment. 
 
The evidence presented in these three studies (chapter 4, 5 and 6) suggests 
that a clear delivery of the diagnosis of PNES, followed by AED withdrawal, is 
safe and has possible beneficial effects on the clinical and psychosocial 
outcome of PNES.  In particular medication withdrawal in and of itself appears 
to be a helpful concomitant in the successful removal of an inappropriate label 
of label of epilepsy, reduces the potential for iatrogenic harm, may help patients 
to shift towards a more psychologically-based explanation, and is associated 
with positive psychosocial outcomes. 
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Finally, chapter 7 gives a summary of the main findings as well as discussing 
methodological limitations of the current research. The clinical implications of 
the evidence from this body of work are also discussed, as well as possible 
avenues for future research in the field. 
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1.1. Definition 
 
Psychogenic nonepilepstic seizures (PNES) can be defined as paroxysmal 
events that resemble or can be mistaken for epilepsy, without being associated 
with abnormal EEG activity or primary physiological disturbance otherwise.  
 
Different terms have been used to describe this clinical phenomenon, from 
hysterical seizures or pseudo seizures to, dissociative seizures or nonepileptic 
attack disorder.  Up to 15 other terms have been used (Scull, 1997). Some of 
these terms are seen as pejorative and unacceptable by patients and have 
been gradually abandoned (Stone et al, 2003). For the purpose of the paper we 
will use the term, psychogenic nonepileptic seizures (PNES), which is the term 
that has been most consistently used in recent papers by the main researchers 
in the field (Reuber, 2008; Duncan and Oto, 2008; La France et al, 2008). 
 
Although not the specific subject of this thesis the difficulties in finding a 
universally agreed and acceptable term for this disorder is a good illustration of 
the wider problems of “identity” of PNES (Kanner, 2003), with ongoing debate 
on questions as fundamental as whether it is a distinct disorder (Taylor, 2001; 
Wesseley & White , 2004), what is the underlying mechanism (Tojek et al., 
2000; Reuberet et al, 2003a; Goldstein et al., 2004a ; Bowman, 2006), or which 
specialist should manage these patients in the first place (Harden &  Ferrando, 
2001; O’Sullivan et al, 2006).  
 
1.2. Epidemiology of PNES and associated harms  
 
To appreciate the impact of PNES, different aspects other than the absolute 
number have to be considered. It is important to be aware that patients with 
PNES are as disabled by this condition as patients with epilepsy, are high users 
of medical services and, as a consequence, at great risk of iatrogenic harm.  
 
Epidemiological studies of PNES are difficult since most patients are initially 
misdiagnosed as having epilepsy and the eventual diagnosis often depends 
upon the possibility of PNES being considered in the first place. In one 
epidemiological study the authors noted an increase of the incidence of PNES 
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during the course of the study, possibly reflecting an increase level of 
awareness on the part of physicians (Szaflarski et al, 2000).  
 
Specific epidemiological studies of the incidence and prevalence of PNES are 
sparse but a reasonable estimate can be gained from data on the misdiagnosis 
of epilepsy, which remains a significant problem (Chadwick & Smith, 2002). 
Good quality, community-based epidemiological studies have reported rates of 
misdiagnosis of epilepsy ranging from 20 to 26% and PNES has been found to 
be the second most common condition to be mistaken for epilepsy after 
syncope (Scheepers et al, 1998; Smith et al, 1999; Zaidi et al, 2000) 
 
There are two epidemiological studies on the incidence of PNES. The first, from 
Iceland, calculated the incidence of PNES as 1.4 per 100.000, with the highest 
incidence for the 15 to 24 age group. This study also estimated that PNES 
affects 5% of all patients newly presenting with seizures (Sigurdardottir and 
Olafsson, 1998). The second study was based in Hamilton County in Ohio and 
estimated the mean incidence of PNES at around 3.03/100000. This study also 
reported a higher rate of epilepsy than the Icelandic study, which could explain 
difference in incidences of PNES between the two studies (Szaflarski et al, 
2000). 
 
PNES are particularly prevalent in certain settings. Up to 30% of patients with 
intractable epilepsy referred to an epilepsy specialist centre for further 
assessment will eventually be diagnosed as having PNES (as opposed to about 
10% of new presentations seen in an epilepsy clinic (Benbadis & Hauser, 
2004)). Outwith neurology, PNES are not uncommonly seen in patients 
subjected to acute stressors including mild head injury (Westbrook, 1998; 
Hudak, 2003) or after a general anaesthetic (Allen et al, 1992; Lichter et al, 
2004; Reuber et al, 2000). 
 
In marked contrast to former series, there is an emerging consensus that the 
coexistence of epilepsy and PNES is the exception rather than the rule. Recent 
research has consistently reported figures of around 10% (Martin et al, 1998; 
Benbadis et al, 2001; McKenzie et al, 2009). Although earlier studies reported a 
co-morbidity of epilepsy and PNES as high as 50% (DeTimary et al, 2002; 
Reuber et al, 2003b), these numbers are likely to reflect a combination of highly 
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selected samples deriving from tertiary referral centres, and the more liberal 
definition of epilepsy adopted in older work, in particular the practice of 
diagnosing or assuming epilepsy on the basis of non-specific EEG 
abnormalities.  
 
Even in cases where co-morbidity is confirmed, the clinical picture is generally 
of frequent PNES in the context of well controlled epilepsy, with the exception of 
patients with learning difficulties where there tends to be a higher prevalence of 
coexisting active epilepsy (Duncan & Oto, 2008). 
 
Clinical and psychosocial outcomes are poor.  Iatrogenic factors are probably 
widespread and are certainly responsible for potentially serious adverse 
physical in particular in the context of ‘pseudostatus’ (Howell et al, 1989; Brady, 
1997; DeToledo et al, 2005). By analogy with epileptic status, pseudostatus  
refers to prolonged nonepileptic attacks, which can attract an erroneous 
diagnosis of epileptic status and inappropriate and aggressive treatment, often 
in an ITU setting. About 10% of patients with PNES will present in pseudostatus 
at some point and of patients referred to a neurological unit with refractory 
status, 25% will turn out to have PNES (Walker et al, 1996).  Inappropriate use 
of intravenous AED, general anaesthesia and intubation, are the most 
immediate and serious iatrogenic harms in PNES  (Cohen et al, 1988; Howell et 
al, 1989; Pakalnis, 1991; Doretzky et al, 2006), the morbidity and mortality for 
intubated patients being just as high irrespective of whether the diagnosis is 
epileptic status or pseudostatus. 
 
AEDs have important unwanted effects which have a negative impact on 
patient’s quality of life (Morrow et al, 2006; Meador et al, 2007) and acute, 
chronic and cumulative iatrogenic harm results from inappropriate prescription 
of AEDs (Benbadis, 1999; Bode et al, 2007; Duncan & Oto, 2008). The adverse 
effect profile differs greatly between AEDs, however all can produce detrimental 
cognitive side effects (Meador et al, 2007). 
 
Patients with PNES also tend to be treated with multiple rather than single 
AEDs, at higher dosages and with the newer and more expensive AEDs, all 
factors with a clear economic implication. There is evidence that patients with 
PNES report more side effects or allergies as compared with patients with 
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epilepsy. A significant number have been reported to reach toxic drug levels 
(Krumholz & Niedermeyer, 1983; Reeves et al, 1998; Hantke et al, 2007).  
 
Many AEDs are teratogenic and the risk increases with polytherapy, a feature of particular 
importance given that the majority of PNES patients are women of childbearing age on 
more than one AED (Sigurdardottir et al, 1998; Szaflarski et al, 2000). There is now 
concerning evidence that children who have been exposed to AED pre-natally have higher 
rates of developmental delay and that children exposed to Sodium Valproate in utero have 
a significantly lower IQ when compared with controls. This issue is  relevant for patients 
with PNES with an important number treated with Sodium Valporate as the attack disorder 
is often mistaken for primary generalized epilepsy (Meador et al, 2009).. 
 
The economic burden of this disorder is undoubtedly relevant and probably 
substantial but the problems of definition, prevalence and highly selected 
samples again make precise estimates difficult. Direct medical costs for the 
average patient with PNES before diagnosis, has been estimated to be between 
$8000 and $15000 per month (Martin et al, 1989; Binder & Slinsky, 2007). 
Indirect costs and the impact on social and occupational functioning are harder 
to estimate but the cost associated with loss of work on its own is estimated as 
$22000 per patient per year (Binder et al, 2007). 
 
Unfortunately, once established reviewing an erroneous diagnosis of epilepsy is 
expensive and often involves inpatient stays, repetition of imaging and 
prolonged EEG (Smith et al, 1999).  
 
1.3. General characteristics of patients with PNES 
 
Patients with the diagnosis of PNES represent a heterogeneous group in terms 
of the aetiology and the manifestation of the disorder (Leiss et al, 1992; 
Kalogjera-Sackellares, 1997; Cragar et al, 2005; Baslet et al, 2010), however, 
some common characteristics have been consistently reported.  
 
A consistently reported finding is the over-representation of women amongst 
patients with PNES, with most studies reporting figures around 75% 
(Sigurdardottir et al, 1998; Szaflarski at al, 2000; Gates, 2002; DePaola et al, 
2006). The only exceptions to this are rates reported in children under the age 
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of 12, or in older patients (Wyllie et al, 2002; Duncan et al, 2006). However 
when compared directly demographic, clinical and psychpathological 
associations of PNES in males and females are broadly similar apart from the 
higher number of women reporting sexual abuse (Oto et al., 2005). 
 
The reasons for this gender difference are outwith the remit of this thesis but 
have been a subject of study, comment by a variety of disciplines with PNES 
and its various equivalents in various historical and cultural milieu being cited as 
the exemplary socially constructed disease by workers from many theoretical 
backgrounds. No clear conclusions are apparent but Showalter 
comprehensively covers this interesting issue in her book “The Female Malady” 
(Showalter, 1985). 
 
The age of presentation of PNES is frequently reported as between 20 and 40 
years of age. However, it is important to bear in mind that PNES can manifest at 
any age; for example they are not uncommon in children (Wyllie et al, 2002; 
Bhatia & Sapra, 2005) and have also been described in older adults (Behrouz et 
al, 2006; Duncan et al, 2006). A large percentage of children with PNES report 
psychological stressors related to school or relationships with peers (Ercan et 
al, 2003; Vincetiis et al, 2006) and a recent study of older patients with PNES 
found lower reports of abuse, suggesting different aetiologies in different 
demographic groups (Duncan et al, 2006) 
 
High levels of comorbid psychopathology have also been reported in this group 
of patients, particularly depression and anxiety (Bowman & Markand, 1996; 
Kanner et al, 1999; Mokleby, 2002) as well as personality disorders, specifically 
borderline type (Kalogjera-Sackellares & Sackellares, 1997a; Binzer et al, 2004; 
Reuber et al, 2004). The important issue of associated psychopathology is 
discussed in detail later on in this chapter.   
 
In summary, although patients with PNES do not conform to a single stereotype 
it can be said that younger females with high levels of psychopathology and 
past history of abuse are over represented amongst this patient group (Moore & 
Baker, 1997). 
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1.4. Diagnosis 
 
An accurate clinical diagnosis of PNES following thorough history taking and in 
particular a direct observation of the attacks by an epilepsy specialist is possible 
in the great majority of cases. (Roberts, 1998; Reuber & Elger, 2003c). The 
diagnosis of PNES, however, poses specific challenges, since most patients 
come with a previous diagnosis of epilepsy, which may have gone unquestioned 
for many years (Reuber et al, 2002; Bodde et al., 2007; Duncan & Oto, 2008; 
Kuyk et al, 2008). In most cases, therefore, the diagnostic process not only 
involves making the positive diagnosis of PNES but also removing the firmly 
attached label of epilepsy.  
 
Taking into account the above considerations as well as the potential 
consequences of a misdiagnosis, video EEG confirmation of the clinical 
diagnosis is frequently deemed necessary (Leiss et al, 1992; Cragar et al, 
2005).  
 
As well as epilepsy, PNES must also be distinguished from other paroxysmal 
events, which are mediated by physiological or psychological causes (Roberts, 
1998). There are a number of conditions that can present with sudden changes 
of behaviour or level of consciousness; syncope being by far the most common 
but the differential diagnosis is exceptionally wide. This introduction will not 
expand further on the differential diagnosis of blackouts; however for a clear 
and comprehensive overview see reviews by Roberts and Benbadis (Roberts, 
1998; Benbadis, 2009). 
 
1.4.1. Clinical diagnosis 
 
In terms of the clinical diagnosis the ictal semiology or clinical features of the 
attacks, although not attracting their former level of attention, are important 
aspects of the diagnosis. Several studies have investigated this issue and 
reported a range of clinical features that should alert clinicians to the possibility 
of PNES. The most common clinical features that distinguish PNES from 
epileptic attacks are listed in table 1.  It is important to recognise however that 
there is no single semiological feature pathognomonic for PNES, and that no 
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symptom should be considered in isolation when making the clinical diagnosis 
of PNES (Leiss et al, 1992).  
 
Table 1.1: Clinical characteristics of PNES.  
PNES Characteristics
Gradual onset of attacks (Luther, 1992; Meierkord, 1991; Luther, 1992) 
 
Out of phase movements (Gates, 1985)
 
Side-to-side head movements (Gates, 1985; Groppel, 1999)
 
Sustained eye closing (Flugel, 1996; DeToledo, 1996; Sirven & Glosser, 1998)
Undulating motor activity ( Leis, 1992)
Attacks longer than 2-5 min (Gates, 1985, Binder & Salinsky, 2007)
Quick recovery (Krumholz 1989; Leiss, 1992; Ettinger, 1999)
 
As well as the clinical features reported in Table 1, other symptoms less 
commonly seen in PNES can also assist in the differential diagnosis; swooning 
attacks (limp, still and unresponsive), purposeful moments, rhythmic pelvic 
movements, responsiveness, and stuttering or weeping during the attack are all 
more commonly seen in PNES when compared with epileptic attacks (Luther et 
al, 1982; Gates et al, 1985; Meierkord et al, 1991; Bergen & Ristanovic, 1993; 
Walczak et al, 1996; Hoerth et al, 2008). 
 
Conversely, certain clinical features considered typical of epilepsy can aften 
present in PNES.  These include autonomic manifestations like tachycardia, 
flushing and sweating (Goldstein et al, 2007), incontinence and injury, including 
tongue biting (Pegero et al, 1995; Stone & Duncan, 2006) and provocation of 
attacks by specific triggers such as flashing lights (Meierkord et al, 1991). 
Nocturnal attacks have often been thought to be a feature of epilepsy (Roberts, 
1998) but are frequently reported in PNES (Duncan et al, 2004). 
 
As well as behaviour during the attacks, other features of patients’ behaviour 
can provide some clues and alert clinicians to the possibility of PNES. Patients 
with PNES are more likely to have attacks in medical settings (Benbadis, 2005) 
and to take age-inappropriate soft toys into hospital (Burneo, 2003). PNES 
patients also appear to have a particular and distinct way of communicating and 
talking about their attacks that distinguishes them from patients with epilepsy 
(Schwabe et al, 2007; Plug, 2009).   
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As detailed in Table 2 (overleaf) various factors in the history and background of 
patients can often indicate or support a diagnosis of PNES (Reuber & Elger, 
2003c). 
 
Table 1.2: Factors in patient background history that should raise suspicion of PNES (adapted 
from Reuber & Elger, 2003). 
Differential Characteristics PNES Epilepsy 
Attacks started before 10 years of 
age 
Rare Common 
Attacks in medical settings Common Uncommon
Recurrent “status” Common Uncommon 
Multiple operations and invasive 
tests 
Common Uncommon 
Other medically unexplained 
symptoms (pain, fatigue)
Common Uncommon 
History of sexual abuse Common Uncommon 
Psychiatric treatment Common Uncommon 
 
It is important to point out that listing sexual abuse as a common feature of 
PNES (table 2) is an oversimplification. If at one point in the past it was 
assumed that sexual abuse was the causal event which resulted in patients 
developing PNES (Betts & Boden, 1996), it is now more the case thatsexual 
abuse is understood in the context of, and as perhaps merely a particularly 
specific marker of; poor attachment, family dysfunction and emotional and 
physical neglect. As mentioned later in this chapter, it is this neglect that results 
in the person’s vulnerability and the risk of developing PNES (Bowman & 
Markand, 2005). 
 
It is also important to point out yet again that some of the features listed in table 
2 can also be features in the background of patients with epilepsy; for example, 
a traumatic (as distinct from specifically sexually traumatic) past does not 
appear to distinguish between patients with or without epilepsy (Berkhoff et al, 
1998; Fleisher, 2002). 
 
 22 
 
1.4.2. Diagnostic tests 
 
 Video EEG recording of a typical attack remains the gold standard. This 
diagnostic technique has high specificity and sensitivity. It consists of 
simultaneous video and EEG recording of typical attacks (Cragar et al, 2002; 
Cuthill & Espie, 2005). 
 
Unfortunately, Video EEG recording remains an expensive and scarce resource 
(Silva et al, 2001) but less time consuming and resource intensive diagnostic 
techniques have been proposed. Short video EEG is an outpatient test, which 
uses activation or suggestion techniques including photic stimulation and 
hyperventilation aiming to induce a typical attack. This test represents a cost-
effective, as well as an accurate diagnostic technique for PNES, having a 
diagnostic yield of 50% to 60 % (Bhatia et al, 1997; Srikumar et al, 2000; 
McGonigal, 2002a). 
 
The use of provocation techniques that aim to increase the diagnostic yield of 
video EEG remains controversial (Devinsky & Fisher, 1996a). Some authors 
consider these methods as unethical particularly when placebo is used (Gates, 
2001) but others feel that the use of induction techniques is justified in this area 
where making an accurate and prompt diagnosis is crucial (Lancman et al, 
1994; Wasserman et al, 2003; McGonigal et al, 2002b). 
 
The role of other tests such as post-ictal prolactin blood levels, SPECT scan or 
personality profiles as assessed with the MMPI are limited as diagnostic tools 
since none of them has high enough sensitivity or specificity to be used alone. 
Inter-ictal or routine EEG is also of little help and can in fact be misleading since 
non specific abnormalities are common in the general population and their 
misinterpretation has often led to the erroneous diagnosis of epilepsy in the first 
place (DeTimary, 2002; Chadwick & Smith, 2002; Benbadis & Tatum, 2003).  
 
In summary, many studies have been undertaken to identify specific symptoms 
or psychological features that can aid the diagnosis of PNES and although no 
feature is pathognomonic an accurate clinical diagnosis of PNES is possible for 
the majority of patients. Due to the intrinsic complexities of this group of 
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patient’s however, video EEG confirmation is often required for the definitive 
diagnosis of PNES.  
 
1.5. Classification of PNES 
 
Several classifications of PNES have been suggested over the years, which 
variously take as their basis the semiological characteristics of the attacks, 
personality profiles or an underlying psychosocial mechanism (table 1.3).  
PNES are classified according to the main psychiatric classification systems 
ICD-10 (WHO, 1992) and DSM-IV (American Psychiatric Association, 1994) as 
dissociative disorders or somatoform conversion, respectively.  
 
Table 1.3: Criteria for different classification systems for PNES.  
1 . Classification according to main psychiatric classification (DSM-IV & ICD-10)
2 . Classification based on clinical features of PNES 
3 . Classification according to personality profiles (as assessed by MMPI)
4 . Classification according to underlying mechanism of PNES 
 
 
PNES classification, on the basis of clinical manifestation, range from simple 
dichotomous classifications of convulsive versus non-convulsive attacks 
(Meierkord et al, 1991; Gates, 2002) to more complex distinctions of different 
aspects of the semiology (Flugel et al, 1996). Some authors have linked certain 
clinical features with specific aetiologies or outcomes, for example Betts and 
Boden describe “abreactive attacks” in sexually abused females (Betts & 
Boden, 1996) and patients with more dramatic ‘grand mal’-like attacks have 
been found to have a poorer prognosis (Selwa et al,  2000; Reuber et al, 2002). 
 
The classification of PNES on the basis of clinical characteristics has limited use 
and can distract from the main issue of the underlying psychological 
mechanism. Semiological classifications are more or less based on the 
classification of epileptic seizure proposed by the International League Against 
Epilepsy (ILAE) and tend to reduce PNES to a false or ‘pseudo’ version of 
‘genuine’ seizures, rather than a complex and highly heterogeneous 
psychologically driven phenomenon in its own right. As Leiss et al remark in 
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their paper on diagnostic pitfalls ‘this type of classifications may artificially 
produce a focused patient group when none exists’ (Leiss et al, 1992). 
 
Several authors have also attempted to classify PNES according to personality 
profiles, mainly with reference to the Minnesota Multiphasic Personality 
Inventory (MMPI). Although some studies have been able to identify distinct 
groups (Gumint, 1986; Cragar et al, 2005; Reuber et al., 2004) most studies 
emphasise the heterogeneity of personality profiles among PNES patients 
(Kalogjera-Sackellares, 1997a; Cragar et al, 2002). 
 
Finally PNES have also been classified according to the possible underlying 
mechanism. Most of these classifications include broadly similar categories, 
which are summarised in table 1.4. With this type of classification in mind 
LaFrance and Zimmerman have designed a potentially useful semi structured 
clinical interview to categorise patients with PNES according to the underlying 
psychopathology (LaFrance & Zimmerman, 2010). 
 
Table 1.4: Classification of PNES according to suspected aetiology.  
Misinterpretation of physical symptoms Alsaadi & Marquez, 2005.
Reinforced behaviour Ford, 1993; Alsaadi & Marquez, 2005.
Cognitive difficulties Ford, 1993; Lesser, 2003; Alsaadi & Marquez, 2005; LaFrance, 2008.
Stressors and interpersonal difficulties Ford, 1993; Lesser, 2003; Bowman & Markand, 1996; Alsaadi & 
Marquez, 2005.
Personality traits Lesser, 2003.
History of trauma Bowman & Markand, 1996; LaFrance, 2008.
Psychiatric pathology Lesser, 2003; Alsaadi & Markand, 1996; LaFrance, 2008.
 
 
In summary many authors have attempted to classify PNES using different 
criteria.  The individual classification systems remain unvalidated and although 
they contribute towards further understanding and conceptualisation of this 
complex disorder they serve most to illustrate its heterogeneity.  
 
1.6. Aetiology  
 
Major advances in the recognition and diagnosis of PNES have not translated 
into an increase of our understanding of the underlying cause of the disorder, or 
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an effective evidence-based management (Reuber, 2008; Brooks et al, 2007). 
Part of the problem is that patients represent a heterogeneous group (Baslet et 
al, 2010) and PNES seem to be a symptom of different underlying causes rather 
than an illness in itself (LaFrance, 2008). 
 
Diagnosis with reference to the current psychiatric classification systems, DSM-
IV and ICD-10, has not been particularly useful with PNES being classified as a 
dissociative disorder under ICD-10 and a conversion disorder under DSM-IV, let 
alone the fact that many patients also fulfill the criteria for mood and anxiety 
disorders, PTSD, episodic dyscontrol or, in a minority, factitious disorder (Alper 
et al, 1995; Bowman, 2001; Fiszman et al, 2004). 
 
Dissociation refers to a disturbance in the normally integrated functions of 
identity, memory and consciousness, and conversion refers to a loss of function 
presumed to be of psychological origin. The issue of whether PNES are a result 
of conversion or a symptom of dissociation is a subject of controversy in some 
circles (Kuyk et al, 1996; Bowman, 1996; Brown & Trimble, 2000; Goldstein et 
al, 2000; Prueter et al, 2002) whereas yet others consider somatisation as the 
characteristic process (Alper et al, 1997; Devinsky et al, 1998; Tojek et al, 2000; 
Reuber et al, 2003a). Some authors have attempted to resolve these polarities, 
for example Harden argued that PNES are a form of dissociation which involves 
conversion-like triggers (Harden, 1997) and Bodde et al pointed out that 
dissociation has to be seen as one mechanism rather than a cause of PNES 
(Bodde et al, 2009).  
 
Since there does not seem to be a single mechanism that explains the 
underlying cause for all patients, the conceptualisation of this disorder using a 
more general model of predisposing, precipitating and perpetuating factors as 
often applied to other functional or medically unexplained symptoms has been 
proposed as more useful for PNES (Stone et al, 2005; Reuber, 2007). 
 
This model, however, has its limitation and some aspects are difficult to fit in or 
overlap. For example, trauma can be a risk factor or a precipitating factor and 
depression can predispose or perpetuate the problem. In a recent review Bodde 
et al attempted to overcome some of these problems by using a modified 
version which included shaping factors and divided predisposing factors into 
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those indicating a psychological aetiology or conferring a psychological 
vulnerability (Bodde et al, 2009). 
As regards the model adopted for the purpose of this thesis, and as illustrated in 
figure 1.1, PNES are conceptualised as arising and existing within a causal 
matrix with biological, psychological and social aspects. 
 
 
 
Figure 1.1: Bio-psycho-social model of PNES   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Predisposing factors 
• Biological: 
Eg.learning difficulties, minor head injury 
• Psychologycal: 
Eg.personality disorder, traumatic 
experiences 
• Social: 
Eg. family conflict  
 
 Shaping factors 
• Experience of epilepsy 
• Medical management of a 
physiological attack -Panic 
attack or complicated syncope  
Precipitating factors  
• Physical, psychological or social, 
stressful life events. 
“reactivation of past trauma memories”  
  
Maintaining factors  
Secondary gain (sick role, benefits) 
Medical management (treatment as 
epilepsy) 
Attacks become an avoidant coping 
mechanism 
                      Magnifying factors  
   Heath professional’s response and management 
 27 
 
In summary, there are a number of factors in the patients’ background that 
place them at a higher risk of developing PNES in the face of certain stressors, 
a further set of factors then determine the more or less chronic course of the 
disorder.  Very importantly, the model acknowledges that a substantial influence 
on the course is independent of the subject, in particular the response of health 
care providers. 
 
1.6.1. Predisposing factors  
 
Past traumatic experience is one of the most frequently reported associated 
factors; reports of childhood abuse are high amongst PNES patients and may 
be predisposing (Alper et al, 1993). A recent review paper for example found 
rates of reported trauma ranging between 40 -100% and of physical or sexual 
abuse between 23-77% (Fiszman et al, 2004). 
 
Sexual abuse was considered at one point as one of the main cause of PNES. 
However, over the last 10 years there has been a shift towards a more 
nonspecific but possibly more nuanced view of trauma, with sexual abuse 
conceptualized as a marker of more severe emotional and physical neglect, 
rather than a specific toxin in itself.  Emotional and physical neglect and the 
associated failure of attachment seem to be a predisposing feature in  
somatoform disorders in general (Moore & Baker, 1997; Krawetz et al, 2001; 
Bowman & Markand, 2005; Reuber et al, 2007; Bakvist et al, 2009).  
 
In certain subpopulations of patients with PNES, however, reports of abuse are 
much lower and other aetiological factors appear more relevant. Patients with 
learning disabilities for example are likely to develop PNES as a direct response 
to specific stressors, and for the group of patient that develop PNES later in life, 
anxiety related to personal health or that of a close relative is often the main 
trigger (Duncan et al, 2006; Duncan et al, 2008a).  
 
Pathological personality traits are frequently found in patients with PNES, with 
reports of proportions of patients as high as 75% to 90% fulfilling diagnostic 
criteria for personality disorder. Borderline personality disorder appears to be 
the most prominent, although avoidant and dependant personality profiles are 
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also reported (Reuber et al., 2003a; Galimbierti et al., 2003; Bailles et al., 2004; 
Binzer et al., 2004).  
 
There is also evidence that certain pre-morbid personality traits and coping 
styles are associated with PNES. A relationship between PNES and alexithymia 
(inability to express feelings and emotions) as assessed by the Toronto 
Alexithymia scale (TAS-20) has been reported (Bewley et al, 2005) and patients 
with PNES also appear to exhibit disproportionate levels of fear sensitivity 
(Goldstein et al, 2000).  
 
In terms of coping styles, PNES patients tend to perceive their lives as more 
stressful when compared with epilepsy patients, and use avoidant and hostile 
coping mechanisms (Frances et al, 1999). 
 
Associated psychopathology can also been seen as a possible predisposing 
factor, although at times it is difficult to determine whether psychopathology is 
part of the primary cause or a factor contributing to the subjects susceptibility to 
develop PNES. For example, post-traumatic stress disorder (PTSD) is 
frequently diagnosed in patients with PNES and can be seen as a cause or a 
predisposing factor, since clearly not all patients suffering with PTSD develop 
PNES (Bowman and Markand, 1999; Galimberti et al, 2003; Kanner et al, 
1999). Rather than proposing a specific causal role for any particular psychiatric 
diagnosis, psychiatric ‘caseness’ may simply be a marker of a tendency to use 
maladaptive coping strategies such as dissociation or somatisation, these being 
likely to significantly predispose patients to develop PNES (Goldstein et al, 
2000; Prueter et al, 2002; Reuber et al, 2004; Lawton et al, 2009), 
 
Physical illness and disability can also contribute to someone’s vulnerability to 
develop PNES.  Reports of minor head injury are common among PNES 
patients (Westbrook, 1998; Pakalnis, 2000). Although not as prevalent as once 
assumed patients with epilepsy (particularly in the context of learning difficulties) 
have higher rates of PNES (Lesser et al, 1983; Drake et al, 1992; Moore and 
Baker, 1997; Barnhill, 2005).    
 
 
 
 29 
1.6.2. Shaping factors  
 
Many of the factors that appear to predispose patients to develop PNES also 
apply to other functional or somatic symptoms; however, why an individual 
patient happens to develop PNES is not clear.  
 
The modelling theory is based on the fact that patient presentations mimic 
symptoms seen in others (or even themselves) and has been proposed as a 
possible explanation for a subgroup of patients. Bautista et al. found that up to 
60 % of PNES patients reported having witnessed a seizure in the past, and 
there is also evidence that when compared with patients diagnosed with 
epilepsy, people with PNES report higher rates of a family history of epilepsy 
(Bautista et al, 2008; Aldenkamp et al, 1997). 
 
For another group of patients a paroxysmal physiological event, for example 
syncope, or a panic attack, may be the initial event that shapes the ongoing 
attacks.  When going through the history it is not unusual in this group for the 
first event to have been a faint or a prolonged panic attack, the level of distress 
and alarm often being subsequently compounded by involvement of emergency 
services, the administration of powerful sedatives, and transfer to nigh intensity ‘ 
medical environments. The subsequent labelling of the attack as ‘epileptic’ and 
the apparent life saving intervention of powerful medical authority, in concert 
with preexisting vulnerabilities and experience, can potently influences illness 
beliefs and PNES can quickly evolve. This process is referred to as 
pathoplasticity and explains how particular somatic symptoms are shaped 
according to the medical diagnostic label given to the patient (Barsky & Borus, 
1999).  
 
1.6.3. Precipitating factors 
 
Precipitating factors can be divided into stressors or situations that would 
facilitate the attack disorder to emerge at a particular time, and immediate 
stimuli or situations that would predictably trigger attacks in patients with 
established PNES. A variety of factors have been described as immediate 
triggers for PNES: flashing lights, tiredness or as a direct response to stress 
(Lancman et al, 1994; Benbadis, 2005). 
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Stressful or traumatic life events previous to the start of the attack disorder can 
be identified in the majority of patients (Fleisher et al, 2002; Binzer et al, 2004). 
A wide variety of events have been reported as possible triggers for PNES 
including; family conflict, relationship problems, bereavement, abuse, and 
money and work difficulties, amongst others (Gardner, 1982; Pakalinis, 1991; 
Moore & Baker, 1997; Bowman & Markland, 1999; Salomon et al, 2003). 
Bowman clearly distinguished between; immediate, remote and contextual 
precipitating factors, and concluded that the most common mechanism seems 
to be “the reactivation of emotions of past trauma by a variety of precipitants” 
(Bowman & Markland, 1999). 
 
Physical stressors like surgery, pregnancy have also been reported (William & 
Huff, 1997; Reuber et al, 2000; Lichter et al, 2004; Collard, 2010). Toxic levels 
of AED have also been linked to the genesis of PNES (Niedermeyer et al, 
1970).  
 
The problem with most of this research, however, is that the temporal 
relationship of the event and the start of PNES are often not clearly defined and 
remote, ongoing or acute events are often reported together. Another issue is 
that most of these studies are not controlled or compared to patients with 
epilepsy, limiting their relevance. As Bowman points out, it is likely that these 
different triggers have to be been seen in the context of an individual patient’s 
vulnerability and past experiences (Bowman & Markland, 1999; Bowman, 
2001).  
 
1.6.4. Perpetuating factors 
 
Having an illness can excuse patients from certain responsibilities as well as 
entitling them to compensation in the form of financial and practical help.  
Secondary gain, the notion that behaviour is motivated by explicit material 
reward as well as implicit, or unacknowledged psychic conflict, is possibly 
needlessly pejorative and a substantial oversimplification of the plight of patients 
who get stuck in the sick role. However, receipt of enhanced state benefits 
could be a powerful disincentive to recovery and has certainly been reported as 
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a factor for a poor prognosis (Kristensen & Alving, 1992; McKenzie et al, 2009, 
Sharp et al, 2010).  
 
Relatives’ beliefs and their reinforcement of the illness behaviour can also 
perpetuate the symptoms (Sirven & Glosser, 1998; O’Malley et al, 1999). Family 
dynamics can also play an important role; families of patients with PNES have 
been found to be more hostile and less supportive when compared with 
epilepsy patients (Mokleby et al, 2002; Stanhope, 2003; Lacey et al, 2007).  
 
A potentially preventable perpetuating factor is clinical iatrogenesis, since health 
care professionals have an important role in magnifying and perpetuating 
PNES. ‘Medicalisation’ refers to the exclusive and reductive adoption of a model 
that emphasizes passivity in the face of an organic process and reliance and 
dependence upon medical technology.  Medicalisation can have a powerful 
effect on any patient unfortunate enough to attract a diagnosis of epilepsy, 
erroneous or not, but is of particularly relevance in a group of patients who 
already have a tendency to interpret their attacks as unpredictable and out of 
their control and to attribute their symptoms to physical causes in the first place 
(Stone et al, 2004; Goldstein & Mellars, 2006). 
 
Patients often report feelings of anger and uncertainty following a diagnosis of 
PNES (Green et al, 2004; Carton et al, 2007).  These problems are 
considerably compounded by ambiguous management (such as leaving 
patients on AED following the diagnosis), and repetition of speculative, 
redundant or unnecessary medical tests with low diagnostic yield in a fruitless 
attempt to bring about consensus (Martin et al, 1998). 
 
In summary, patient illness perceptions as well as external factors that can 
reinforce their behaviour can influence the course of PNES once established. 
 
1.7. Management and prognosis 
 
Our knowledge of the best management strategies for PNES remains limited 
and although several psychotherapeutic interventions have been described 
there is little evidence for any one in particular (Brooks et al, 2007). This is 
possibly a reflection of the fact that PNES is not a disease entity but a symptom 
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of a variety of underlying psychological and psychiatric problems requiring a 
range of treatments (Leiss et al, 1992; Kalogjera-Sackellares, 1997b; Cragar et 
al, 2005; Baslet et al, 2010). 
 
However, while acknowledging this therapeutic uncertainty the initial 
management of PNES in terms of assessment, diagnosis, communication and 
the withdrawal of iatrogenic harm is a generic intervention independent of 
associated psychopathology (Shen et al, 1990; Farias et al, 2003; Thompson et 
al, 2005; Howlet et al, 2007; Hall-Patch et al, 2010).  Effective communication is 
particularly important in a group of patients who are often hostile and frequently 
report feeling confused and angry after the diagnosis (Green et al, 2004; 
Thompson et al, 2009).  
  
The clinician’s familiarity and confidence with the diagnosis in this context is 
paramount since patients have generally had many contradictory explanations 
for their symptoms and usually challenge the initial diagnosis (Harden et al, 
2003). A better outcome has been associated with patients’ belief in and 
acceptance of the diagnosis of PNES (Ettinger et al, 1999b).  
 
Communicating the diagnosis in a clear and supportive manner is for some 
patients the only intervention required, and even when attacks persist there is 
evidence that following a confident diagnosis of PNES there is a significant 
reduction of health care utilisation by the patients (Buchanan & Snars, 1993; 
Martin et al, 1998; Kanner et al, 1999; Farias et al, 2003).   
 
Standardised ways to communicate the diagnosis have been proposed and a 
recent study from Hall-Patch et al. assessed the acceptability of a 
comprehensive communication protocol supported with written information 
(Hall-Patch et al, 2010).  Subsequent work has this protocol to be an acceptable 
and effective component of efforts to communicate a psychological explanation 
for PNES (Shen et al, 1990; Betts & Boden, 1992). 
 
As most patients with PNES are treated with AED, withdrawing medication is 
the next logical step following the delivery of the diagnosis. Up to 40% of 
patients, however, are left on medication at this point (Benbadis, 1999; Reuber 
& Elger, 2003c; O’Sullivan et al, 2007; Hall-Patch et al, 2010). This not only 
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places them at an increased risk of iatrogenic harm but also contributes to 
feelings of confusion following the diagnosis (Green et al, 2004). 
 
There is some evidence for the effectiveness of psychotropic medication in 
medically unexplained symptoms.  However in the context of PNES, although 
antidepressants, particularly SSRIs, have been recommended and other 
psychotropic medication has been used, the evidence of benefit is anecdotal 
and use of psychotropic medication in PNES is indicated mostly on the basis of 
co-morbid psychopathology (Alper et al, 1997; Reuber & Elger, 2003c; 
LaFrance & Devinsky, 2004).  
 
When the diagnosis of PNES is established most patients are referred on for 
further psychological treatment (LaFrance et al, 2008) although, as already 
mentioned, there is little evidence for any particular psychotherapeutic 
management strategy although a wide variety of psychotherapeutic 
interventions have been proposed.  Behavioural approaches, psychodynamic 
based interventions, hypnosis, psycho education andr family therapy amongst 
others have been all described in small case series (Griffith et al, 1995; Kuyk et 
al, 1995; Aboukasm et al, 1998; Prigatano et al, 2002; Zaroff et al, 2004; 
Kallogjera-Sackellares, 2004; for reviews see Reuber, 2003; LaFrance & 
Devinsky, 2004; Barry et al, 2008; Bodde et al, 2009).  
 
Of all the different interventions, Cognitive Behaviour Therapy (CBT) is the one 
that has been more systematically evaluated. LaFance et al tested the effects of 
their CBT protocol specifically designed for patients with PNES in an open label 
study and reported significant improvement in a range of clinical and 
psychological factors (LaFrance, 2009). Following a pilot study, Goldstein et al. 
published one of the only RCTs on treatment of PNES, they randomised 66 
patients to 12 sessions of weekly CBT or standard medical care and concluded 
that CBT is more effective in reducing attack frequency, however they were 
unable to detect changes in most of their psychosocial outcomes (Goldstein et 
al, 2004; Goldstein et al, 2010).  
 
The only Cochrane review on the treatment of PNES, managed to identify three 
small randomised controlled trials, two comparing the effects of hypnotherapy 
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and a third one comparing paradoxical intention treatment to regular Diazepam 
No overall conclusion could be reached (Brooks et al, 2007).   
 
Another recent review found some evidence of better outcomes for inpatient 
multidisciplinary treatment strategies (LaFrance, 2007; Kuyk et al, 2008), but 
other authors have pointed out the importance of treating patients in their own 
environment as more relevant to addressing precipitating or perpetuating 
stressors and triggers for PNES (Betts & Boden, 1992; Buchanan & Snars, 
1993). 
 
Although intensive interventions appear to result in attack freedom in a high 
proportion of patients in the short-term, gains tend not to be maintained and the 
majority of patients relapsed over subsequent follow-up (Farias et al 2003; 
O’Sullivan et al, 2006) according with the fairly general finding that whatever the 
treatment modality employed only a third to a half of patients are reported to be 
attack free within two years of the diagnosis (Iriarte et al, 2003; Reuber, 2003; 
DePaola et al, 2006). 
 
The usefulness of much of the literature is somewhat diluted by doubts about 
the validity of attack freedom or reduction as an outcome. There is evidence 
that reduction or cessation of attacks, although useful as an objective clinical 
outcome measure, may not correlate with psychosocial recovery and the 
importance of including comprehensive and relevant psychosocial measures of 
outcome has been stressed by a number of authors (Quigg et al, 2002; Reuber 
et al, 2003b; LaFrance et al, 2008).  
 
As shown in table 1.5 (overleaf), several studies have reported prognostic 
factors for the outcome in PNES.  Methodological problems are generally 
apparent (Ettinger et al, 1999b) and all that can be said with confidence is that 
measures reflecting good pre-morbid social adjustment and functioning, as well 
as lower levels of psychopathology, correlate with a better outcome. 
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Table 1.5: Studies reporting prognostic factors for PNES outcome. 
 
Study No. 
subjects
Attack 
free Good prognosis for NES Poor prognosis for NES
1 Aboukasm et al 1998 Therapy +feedback
by epilepsy specialist
2 Arain et al 2007 Higher education
Mostionless spells
Accompanied to clinic
3 Drake et al 1992 20 NA~ Patients with conversion improved when AED 
withdrawn
4 Ettinger et al 1999 Believing the diagnosis
In employment
Perceived good health
5 Kanner et al 1999 Personality disorder
Recurrent depression
6 Lancman  et al 1993
7 Kristensen et al 1992
8 Meierkord et al 1991 Female
Independent life
Formal psychotherapy
No coexisting epilepsy
9 O’Sullivan 2007 Resistant to psychotherapy
Impaired social function
10 Selwa 2000 Less dramatic attacks 
Shorter duration of the disorder 
11 McKenzie et al 2009 History of anxiety & depression
Receiving state benefits
12 Silva et al 2001 Independent life style
Accepting diagnosis
Low IQ
13 Violent behavior
14 Walczak 1995 Shorter duration of NES
No psychiatric disorders
61 53%
48 35%
56 51.80%
45 29%
28 45% Receiving state benefits
96 25.40% None of the factors tested was associated 
with poor outcome
110 40%
38 16%
57 40%
187 38% Male gender
McDade & Brown 1992 18 44.40%
17 38%
51 35%
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1.8. Conclusion 
 
This introduction provides an overview of the main aspects of PNES, and 
although informed as comprehensively as possible by published evidence, it 
must be made clear that this is not a systematic review and reflects to some 
extent the views of the author. The main objective of this chapter was to set the 
scene for the original research of the thesis. 
 
PNES are not uncommon and represent a significance problem to a variety of 
clinicians. Compared with our ability to diagnose PNES, our understanding of 
this disorder, in terms of its underlying mechanisms, and particularly with 
reference to treatment, remains limited.  Beyond diagnosis there is very little 
evidence for any particular therapeutic intervention and as Reuber discusses in 
his review we are left with more answers than questions (Reuber, 2008). 
 
One of the major issues in patients with PNES is the potential for iatrogenic 
harm, largely associated with AED. In this area many questions remain 
unanswered; Is withdrawing the medication necessary in all cases? Is it harmful 
to leave or withdraw patients’ AED? Or is AED withdrawal an intervention in its 
own right? A panel of experts intending to design a treatment trial for PNES also 
discussed all these questions (La France, 2006). The current thesis intends to 
answer these questions with a combination of observational studies and an 
RCT on the effects of AED withdrawal. 
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Chapter 2: 
 
 
Does discontinuation of antiepileptic drugs affect the outcome of nonepileptic 
seizures? A systematic review of the literature.  
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2.1. Abstract 
 
Background: Psychogenic nonepileptic seizures (PNES) are psychologically 
mediated attacks that resemble and are often mistaken for epilepsy. Most 
patients are initially treated with antiepileptic drugs (AED) and a significant 
proportion continue to receive this medication after the diagnosis of PNES has 
been confirmed. Continuing antiepileptic medication in patients with PNES may 
have important physical and psychological consequences and may affect the 
prognosis of this disorder. 
 
Objectives: To review the current literature for any evidence of an effect of 
continuation of AED treatment on the outcome of PNES. 
 
Methods: Search strategy; Ovid MEDLINE (to Aug 2009), EMBASE (Oct 2009), 
PsycINFO (Oct 2009), Cochrane database of systematic reviews. According to 
our selection criteria; English language studies of adults with PNES containing 
data on the impact of AED on the prognosis, were included. 
 
Results: The search identified 3 observational studies, two of which reported the 
continuation of AED as having a negative effect on the outcome and a third no 
effect. All of the selected studies had important methodological limitations. 
 
Conclusions: Because of the limited quality of the selected studies it was not 
possible to conclude that there is a correlation between taking AED and an 
adverse outcome. A randomised controlled trial would be the only way to 
establish if withdrawing AED at diagnosis contributes to a better outcome in 
patients with PNES.  
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2.2. Introduction 
 
Psychogenic non-epileptic seizures (PNES) may be defined as paroxysmal 
events that resemble and/or are treated as epileptic seizures without being 
associated with any measurable alteration in the electrical activity of the brain 
and are thought to have a psychological underlying cause. Outcome is often 
reported as poor but there is little evidence-based knowledge on how best to 
treat this disorder.  
 
Most patients with PNES are diagnosed with epilepsy and therefore treated with 
AED, sometimes for many years (Benbadis, 1999; Bode et al, 2007; Duncan & 
Oto, 2008). As described in chapter 1 (page16), the effect of inappropriate 
prescription in this population has been increasingly recognized, investigated 
and reported.  Specific maladaptive patterns of medication taking, possible 
unrecognised psychotropic effects of AED, and the impact that taking AED may 
have on the patient’s understanding of their disorder have  been described or 
proposed (Reeves et al, 1998; Hantke et al, 2007; LaFrance et al, 2006; Carton 
et al, 2003) . 
 
The role of AED in the diagnosis of PNES has been frequently reported in the 
literature. For example, a lack of response to AED and higher reports of side 
effects support the diagnosis of PNES as opposed to epilepsy (Bowman & 
Coons, 2000; Hantke et al, 2007). There is also some anecdotal evidence to 
suggest that AED can be implicated in the genesis of PNES and possible 
mechanisms have been proposed; from forced normalisation, AED toxicity or 
the consequence of an idiosyncratic side effect (Trimble, 1996; Neidermeyer et 
al, 1970; Weaver, 2004). 
 
Although tapering AED after diagnosis is recommended as being part of 
treatment as usual for PNES (LaFrance, 2008) up to 40% of patients with PNES 
continue to be prescribed AED after the diagnosis is established.  This in itself 
may adversely influence the outcome (Reuber et al, 2003a; O’Sullivan et al, 
2007). 
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Withdrawing or continuing antiepileptic medication in patients with PNES can 
therefore have important physical and psychological consequences, which may 
affect the prognosis of the attack disorder. If this is the case manipulating 
medication following the diagnosis of PNES could have a role in the 
management of the disorder. 
 
Our hypothesis is that withdrawing medication after the diagnosis of PNES is a 
congruent and important therapeutic step in management, with positive effects 
on the outcome. 
 
The purpose of this paper is to review the current literature for evidence about 
the effect of taking AED on the outcome of PNES.  
 
2.3. Methodology 
 
Research question:  
 
Does discontinuation of antiepileptic drugs influence the outcome of 
nonepileptic seizures?  
 
Search strategy: 
 
The electronic search included the following databases Ovid MEDLINE (to Aug 
2009), EMBASE (Oct 2009), PsycINFO (Oct 2009), Cochrane database of 
systematic reviews. 
  
The search terms included [Pseudoseizure$], [Pseudoepilepsy] or 
[Hysteroepilepsy] [Nonepileptic], [dissociative], [hysterical], [conversion] or 
[psychogenic ] combined with [ seizure ] or [attack] combined or not with 
[disorder]. 
 
The above search was linked to the terms [Antiepileptic drug$], [Antiepileptic 
medication] and [Anticonvulsant$]. 
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The references of several review articles identified through the search were also 
examined in order to identify further relevant studies and improve the sensitivity 
of our search. 
 
2.4. Data collection and analysis  
 
Inclusion criteria:  
 
• Papers where the study population had the diagnosis of PNES 
• Studies including data on AED, particularly on its effects on course and 
prognosis of PNES  
• Studies written in English  
• Studies including adult populations only 
 
Assessment of the quality of the studies   
 
To our knowledge there are no rating scales to assess the quality of outcome 
studies on PNES. We have therefore designed a scale based on a suggested 
checklist of items that should be included in reports of observational studies by 
the STROBE statement and suggestions from a Consensus statement on the 
characteristics of a clinical trial on outcome measures for PNES (La France et 
al, 2006).  
 
A study of PNES ideally will include only patients with video EEG confirmation 
of the diagnosis and exclude patients with coexisting epilepsy. The outcome 
measures should include psychosocial outcomes with a follow up time of at 
least 12 months to be sensitive to changes of all outcomes. In terms of sample 
size we considered a sample that at least would be able to detect (or exclude) a 
large effect. 
 
Our 14 point scale (see appendix A) combined generic methodological points as 
well as specific issues for PNES (LaFrance et al, 2006). 
 
The checklist from the STROBE statement (appendix B) was also used as a 
template for the methodological review of the individual papers. 
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2.4.1. Selection of studies 
 
The search yielded 194 citations in total. The author inspected all the citations 
identified from the search and selected 20 relevant studies of patients with 
PNES that reported prognostic factors.  These papers were fully inspected for 
inclusion criteria by the author and a research assistant independently and in 
case of disagreement, a decision was reached by discussion. Of the 20 papers, 
two were reviews and therefore not included and 14 had no data on 
continuation of AED as a prognostic factor.                                                                                                                  
 
No randomised controlled trials were identified. Of the studies containing 
outcome data we found four observational studies that had data correlating 
outcome of PNES with taking AED’s. Two of these studies were based on the 
same sample and methodology therefore we have reported them together. 
 
For the break down of selected papers see the flow chart below. 
 
Figure 2.1: Flow-chart of paper selection for review. 
 
  
 
Initial search 
194 papers identified 
 
 
PNES + prognosis data 
papers 18 
 
 
Excluded: 174/194: 
-84 unrelated to PNES 
-10 pediatric population 
-80 no data on prognosis 
SELECTED PAPERS: 3 
Continuation of AED as a prognostic factor 
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2.5. Results  
 
2.5.1. Summary of the rejected studies  
 
Of the relevant studies, 14/18 were not included since they contained no data 
on continuation of AED as a prognostic factor (see table 2.1).  
 
Table 2.1: Description of rejected studies. 
 
No. Subjects AED At diagnosis AED At follow up Attack Free Good Prognosis for NES Poor Prognosis for NES
Aboukasm et al 1998 61 63.90% 22.90% 53% Therapy +feedback
by epilepsy specialist
Arain et al 2007 48 85% 100% 35% Higher education
Mostionless spells
Accompanied to clinic
Drake et al 1992 20 100% NR NA~
Patients with conversion 
improved when AED withdrawn
Ettinger et al 1999 56 48.20% 32.40% 51.80% Believing the diagnosis
In employment
Perceived good health
Kanner et al 1999 45 NR NR 29% Personality disorder
Recurrent depression
Chronic abuse
Lancman  et al 1993 93 53.80% NR 25.40%
None of the factors tested 
was associated with poor 
outcome
Kristensen et al 1992
Meierkord et al 1991 110 NR NR 40% Female
(majority ) Independent life
Formal psychotherapy
No coexisting epilepsy
O’Sullivan 2007 38 1.5 +/-1.4 35% 16% Resistant to psychotherapy
(mean number ) Impaired social function
McKenzie et al 2009 187 52% 13.2%* 38% Male gender
History of anxiety & 
depression
Receiving state benefits
Silva et al 2001 17 72.70% 36.30% 38% Independent life style
Accepting diagnosis
McDade & Brown 1992 18 1.88 NR* 44.40% Low IQ
(mean number) Violent behavior
Walczak 1995 51 38/51(74.5%) 53% 35% Shorter duration of NES
No psychiatric disorders
Selwa et al 2000 57 NR 32% 40% Shorter duration of the disorder, 
Less dramatic attacks 
*Intent to withdraw AED reported
NR = not reported
Receiving state benefits28 86% 62.50% 45%
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 All these studies were observational and from tertiary referral centres. As 
shown in table 2.1, samples size ranged from 18 to 187 subjects and the follow 
up times varied from days to years, not only between studies but also within 
subjects as individual studies report a wide range of follow-up lengths amongst 
patients. 
 
As is detailed in table 2.1, in terms of prognosis, most papers report measures 
reflecting independent life style and social adjustment of the subjects as positive 
prognostic factors. On the other hand, receiving state benefits, the chronicity of 
the disorder and high level of psychopathology are correlated with poor 
prognosis, with the exception of the two larger studies that found no relationship 
with chronicity and attack freedom.  
 
In terms of the number of patients exposed to AED, most studies report high 
percentage at diagnosis, however not all studies report the number of patients 
continuing on AED at follow up. Only two studies make reference to the number 
of patients who are attack free and not on AED.  Buchanan et al. found that the 
less chronic group, with a high percentage of attack free patients at follow up, 
are less likely to be on AED; and Drake reports an improvement of all patients 
with conversion disorder (n=10) following the withdrawal of medication.  
 
In the study by Arain et al, medication was withdrawn in all patients following the 
explanation of the diagnosis. At follow up (time was not specified), 35% of 
patients were attack free.  
 
The study by O’Sullivan et al also considered the possibility of different 
outcomes between subjects taking AED with, or without, mood stabilising 
effects, and found no significant difference in a range of psychosocial outcome 
measures. The same authors also found that males were more likely to be on 
AED before and after the diagnosis.  
 
2.5.2. Selected studies: Description of selected studies  
Two of the 4 selected papers, presented different outcome data from the same 
study and are therefore described together (see table 2.2 for description of 
studies and table 2.3 for assessment of quality criteria). 
 Table 2.2: Description of selected studies. 
 
 
Sample Follow up
Design Population N
Epilepsy 
included
% Video 
EEG 
diagnosis
Response 
rate Management
Folllow-up: 
Years (sd)
% Attack 
free
AED at 
diagnosis
% ongoing 
AED
Continuation 
of AED effect 
on outcome
Predictors of 
good outcome
Predictors of poor 
outcome
Carton et 
al 2003
Postal 
questionnaire 
Cohort
Specialist 
centre
84 No NR
84/115 
(73%)
No Treatment 
Protocol
4.7(NR)* 28% NR 32% Negative
Employed, 
reaction to 
diagnosis (relief 
of not having 
epilepsy) 
Continuation of 
AED, reaction to 
diagnosis 
(confusion or 
anger)
Bode et al 
2007
Phone 
questionnaire 
cohort
Specialist 
centre
21 No 100%
22/28 
(78.5%)
No Treatment 
Protocol
4.7(1.3) 47.6%* 13.50% NR No effect
Higer education, 
younger onset of 
NES, less 
dramatic attacks
Higer scores on 
dissociation, 
higher scores on 
personality traits 
(inhibitedness, 
emotional 
dysregulation & 
impulsivity)  
Reuber et 
al 2003
Postal 
questionnaire 
cohort
Specialist 
centre
164 Yes 55.40%
164/329 
(49.8%)
No Treatment 
Protocol
4.1 (3) 28.60% 75% 40.70% Negative -
Associated 
psychopathology, 
high scores of self-
avoudant 
behaviour 
*4 to 6 years   NR, not reported 
 
 
 
 
           45 
2.5.3. Paper 1- Non-epileptic seizures: patients' understanding and reaction to 
the diagnosis and impact on outcome. (Carton, S., Thompson, P.J. & Duncan, 
J.S)  
 
This was an open non randomised postal questionnaire study of 84 patients 
with confirmed PNES without coexisting epilepsy, seen at an epilepsy specialist 
centre and reviewed 6 months to 7 years following the diagnosis. 
 
Patients answered a semi structured interview over the phone and demographic 
information was sourced from medical notes. A short questionnaire was also 
sent to their GP’s. 
 
The main outcome of the study was attack freedom, and the prognostic factors 
considered in the paper related to the understanding of, and reaction to, the 
diagnosis of PNES by the patient. The authors also considered prognostic 
factors previously reported in the literature, which they grouped into precipitating 
factors, negative impact of PNES on daily life, and psychological follow up. 
 
The sample was drawn from 115 patients diagnosed with PNES only during an 
inpatient assessment at a tertiary referral centre over a period of 8 years. 
 
The follow up period ranged between 6 month to 7 years and the length of the 
disorder ranged between 1 month to 41 years (no data on standard deviation 
were given). 
 
By the end of the study, 28% of patients were seizure free and a further 48% 
reported a >50% reduction of attacks, almost a third of patients (32%) remained 
on AED. Only a third of the patients had some understanding of the diagnosis of 
PNES and the most common reaction to diagnosis was confusion. 
  
In terms of prognostic factors patients who; continued the AED (p<0.0001), or 
had described confusion (p<0.001), or anger (p<0.002) at the diagnosis of 
PNES, were more likely to continue to have attacks. Conversely, patients who 
reported relief following the diagnosis of PNES (p<0.0001), or were employed 
(p< 0.009), were more likely to be attack free.  
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Methodological quality   
 
The introduction of the paper contained good background information and 
clearly stated the objectives of the study, however did not specify the main 
hypothesis. 
 
For the study design a combination of qualitative and quantitative methods was 
used and this was clearly described. The settings and data collection were also 
well described. 
 
The sample came from the inpatient population of a tertiary referral centre which 
makes it comparable to most of the published studies on PNES; however, the 
population may not be representative of patients selected from the community, 
or a general practice setting. 
 
It is unclear how the 115 patients were selected; whether they were consecutive 
or what percentage of the total number of patients assessed they represented. 
 
The eligibility criteria of the participants appeared clear, patients had an 
unequivocal diagnosis of PNES; however, the percentage of patients with video 
EEG confirmation, which was one of our quality criteria, as shown in table 2.3, 
was not reported. 
 
Another point in our quality criteria scale was the exclusion of patients with 
epilepsy, and although that was the case for this study, the authors did not 
define the criteria for the diagnosis of epilepsy. 
 
The outcome variables were clearly described and steps were taken to ensure 
precise and unbiased measurement. This was achieved by combining self 
report with GP data and by assessing inter-rater reliability for the qualitative 
data. The prognostic factors were also fully defined and appropriate to the 
objectives of the study. 
 
The sample was also well described and the characteristics comparable to 
samples of other similar studies. The rest of the results were also clearly 
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presented and although the outcome data is quantitative, some appropriate 
qualitative data is presented. 
 
Simple and appropriate statistical tests were used; however, multiple testing, 
particularly considering the small sample, was an issue. 
 
One of the main drawbacks of the paper is the lack of definition or 
standardisation of the intervention. It is not clear whether all patients had the 
same type of assessment, or how and by whom the diagnosis was 
communicated. Considering that the main objective of the study was to assess 
the reaction and impact of diagnosis, the above points are particularly relevant 
since there is evidence that the initial intervention of delivering the diagnosis is 
very important and can influence the prognosis (Ettinger et al, 1999b).  
 
Another important factor that can affect prognosis, and was not accounted for in 
this paper, was the chronicity of the disorder, which varied greatly between 
patients from months to years.  
 
The type of psychological intervention that patients received was not clearly 
described, however it appears that there was not a standard approach for all 
subjects and the length of the intervention also varied widely. 
 
The above points were potential sources of bias particularly in this study were 
the outcome of interest was the understanding of, and reaction to, the 
diagnosis.  
 
Another important point when considering the quality of the study is the 
homogeneity of the subjects in terms of follow-up times. The length of follow up 
varied widely from 6 months, which would be considered short term, to 7 years, 
which is obviously long term. There is evidence that short term outcome is more 
favourable and this is also not taken into consideration in the present study. 
 
In terms of the rating of the methodological quality, this paper scored the 
highest (table 2.3); however, as with most studies in the field, important 
interventions are not standardised and although that was only one of our points 
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in our quality checklist, this represents a particularly important point when trying 
to interpret the results. 
  
Table 2.3: Quality criteria for selected studies.  
Carton et al Reuber et al Bodde et al
Representative sample 
Explicit inclusion criteria X X X
Coexisting epilepsy excluded X X
Avoid patient selection bias X X X
Video EEG diagnosis X
Similar disease length 
Sample size > 75 X X
Sufficient length of follow up X X
Similar length of follow up 
Drop out rate <40% X X
Standardized intervention
Valid outcome measures X X
Clearly stated outcome 
measures 
X X
Objective measure of outcome X X X
Final score 8/14(57%) 7/14(50%) 7/14(50%)
 
  
2.5.4. Paper 2-, Factors involved in the long-term prognosis of psychogenic 
nonepileptic seizures. (Bodde,N.M.G., Janssen,A.M.A.J., Theuns, C., 
Vanhoutvin, J.F.G., Boon, P.A.J.M. and Aldenkamp, A.P). 
 
This was a prospective observational study of 22 patients with confirmed PNES 
and no associated epilepsy, assessed at baseline and 4 to 6 years post-
diagnosis with an average of 4.7 years post diagnosis (SD 1.3). 
 
The aim of the study was to investigate factors involved in the long-term 
prognosis of PNES. Improvement was defined as any reduction in attacks from 
baseline.  
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As outcome measures, the authors included self reported attack frequency, and 
psychological rating scales including the Symptom Check List, The Dissociative 
Questionnaire and the MMPI. 
 
Out of the 22 patients included in the study 86.4% were female; the average 
age was 30.4 years (range 15- 49); and there was an average diagnostic delay 
of 7.2 years. At baseline only 13.5% of patients were on AED and 41% reported 
daily attacks. At follow up, 7/22 (31.8%) of the sample had been attack free for 
at least one year. 
 
No relationship was found between attack reduction and any of the 
demographic or clinical data at baseline, including use of AED’s. 
 
Linear regression, used to analyse possible psychological predicting factors, 
showed that higher psychopathology and self-avoidant behaviour predicted poor 
improvement. No association was found between any specific personality profile 
and improvement. 
 
Methodological quality  
 
In the introduction of the paper the reasoning behind the study was explained 
together with clear background information; however, the specific objectives 
were not clearly stated and there was no hypothesis defined. 
 
The study design was not fully described and the ‘settings’ were unclear, 
particularly information on how and by whom the patients were assessed, and 
on how the data was collected. The eligibility criteria for the subjects were clear 
with precisely described diagnostic standards and a good description of the 
instruments used to measure outcomes.  
 
The objective of the study was to investigate possible associations between 
attack reduction and a series of measures. The way the results were presented, 
however, was confusing: it was not clear which were the important or most 
relevant findings and some of the outcome data was reported for the whole 
group rather than comparing the good and poor outcome subjects. 
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For our quality checklist the sample had to be greater than 75 and the sample of 
this study was much smaller (n=22). The small sample size was particularly 
problematic considering the amounts of statistical tests that were performed. 
 
From the point of view of association between AED and outcome, the fact that 
the number of patients on AED was very small, and the majority of patients had 
a reduction of attack frequency, a negative result should be viewed with caution. 
 
As shown in table 2.3, the lack of valid outcome measures was an issue in 
terms of the quality of the study. The author’s definition of a good outcome 
included any reduction of attacks from baseline, which cannot be considered a 
good outcome in itself since most published studies show a reduction of attacks 
following diagnosis, regardless of intervention (Bodde et al, 2007). We can 
argue, therefore, that some of these patients did not in fact have a clinically 
meaningful change, and that a minimum reduction of 50% of attacks, as used in 
many studies, would have been more relevant as an outcome measure of 
improvement. 
 
Another measure with questionable validity is the use of the MMPI to assess 
changes in psychological symptoms. The MMPI is a personality inventory, and 
since personality, by definition, is a set of reasonably stable traits, a different 
scale designed to assess changes particularly in such a short time-frame would 
have been more appropriate. 
 
The discussion of this paper suggests that the good outcome of the study in 
terms of attack freedom may have been a result of the impact of the diagnostic 
process and delivery. The problem is that there is no evidence in the paper that 
there was any standardised or agreed procedure for delivering the diagnosis 
and therefore it does not appear that all subjects had the same intervention. 
From this point of view an association cannot be made. 
      
The main weaknesses of this paper, in terms of methodological quality, were 
the small sample size and the fact that the main outcome measure was not valid 
to assess improvement of PNES.  
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2.5.5. Paper 3(a)- Outcome in psychogenic nonepileptic seizures: 1 to 10-year 
follow-up in 164 patients. (Reuber M., Pukrop R., Bauer  J., Helmstaedter C., 
Tessendorf N., Elgar C.E.)  
 
This study was a postal questionnaire on the long term outcome of PNES with 
or without epilepsy. Of the 329 patients identified from a tertiary referral centre 
database, 164(49.8%) responded. 
 
The aim of the study was to identify clinical and psychological factors that may 
predict the outcome of patients with PNES. Outcome measures included; attack 
freedom, social adjustment, personality traits and level of psychopathology. 
Patients were grouped into good, intermediate or poor outcome according to 
attack freedom and level of social functioning.  
 
Of the 164 responders, 130 (79.3%) were women and only a minority had been 
in higher education. The mean age was 38.6 (sd: 14) and the mean duration of 
follow up was 4.1 (sd: 3) years.   
 
Following the diagnosis, patients were managed by the local referring team. A 
high number were treated as inpatients; 68(41.5%) on a psychiatric ward and 
134(81.9 %) in a neurology ward. 
 
At follow up 43.9% of patients had a “poor” outcome and only 16.2% were 
considered to have a good global outcome which implied being attack free and 
working. The majority of subjects, 116 (71.2%), continued to have attacks and 
66 (40.5%) were still dependant. 
 
In terms of factors predicting outcome; younger age, higher educational 
attainment, less dramatic attacks, few somatoform complaints and low 
dissociation scores had a better prognosis. 
 
Lower levels of psychopathology and low scores on the personality dimensions 
of inhibitedness, emotional dysregulation, and compulsivity, also predicted a 
better outcome. 
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In terms of the effects of AED on outcome, the authors report that in patients 
with PNES only, the continuation of AED is associated with persistence of 
attacks and inability to lead an independent life. 
 
Methodological quality  
  
The background and objectives of this study were clearly explained in the 
introduction; specific research questions, study design and different time lines 
were well described. 
 
In terms of eligibility, the diagnostic criteria for epilepsy and PNES were clear, 
however, only just over half of the subjects had the diagnosis of PNES 
confirmed by video-EEG, although alternative measures were taken to ensure 
patients had as accurate a diagnosis as possible.  
 
A potential source of systematic error in the study was the high percentage of 
patients that had the coexisting diagnosis of epilepsy. From a postal 
questionnaire it would be impossible to determine what kind of attack was being 
reported by the subjects, whether epileptic or not.  
 
The reasons for choosing specific outcome measures were clearly argued and 
the different sources of data well described. There was no evidence, however, 
that there was a system in place to minimise bias when placing subjects into the 
different outcome groups. 
 
The management of a large proportion of subjects as inpatients with PNES is 
unusual and probably reflects the characteristics of the German health service. 
The majority of subjects were treated as in-patients, some under neurologists 
and others in psychiatric units. From a methodological quality point of view there 
was also no evidence that any specific treatment protocol had been used. 
 
The statistical tests used are appropriate and well described and the analysis 
addressed the issue of multiple testing. 
 
The number and characteristics of participants at each stage of the study were 
clearly reported. As shown in table 2.2, one of the main problems of the study 
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was the number of responders, which was lower than 60%. Although, in terms 
of basic clinical and demographic data, responders appear similar to patients 
lost to follow up, the two groups could have been very different in terms of 
outcomes and psychological profile. 
 
Considering the large amount of data presented the results were clear with 
helpful tables illustrating the main findings.  
 
The discussion clearly summarised the main findings as well as acknowledging 
the limitation and potential bias of the paper. 
  
2.5.6. Paper 3(b)- Measuring outcome in psychogenic nonepileptic seizures: 
how relevant is seizure remission? (Reuber M., Mitchell A.J., Howlett S, Elger 
C.E).  
 
This was another study from the postal questionnaire with the same data and 
sample but a different research question. The aim of this second paper was to 
investigate the validity of attack remission as a single outcome measure by 
investigating the correlation between attack freedom and social adjustment. The 
study found that attack freedom could not be used as a comprehensive 
measure of a good outcome. 
 
This study only included patients with PNES only and investigated potential 
differences between patients in remission or not at follow up. It was found that 
patients in remission were as likely as patients that continued to have attacks to 
remain on AED. This was a direct comparison between the relevant groups 
(n=86) using the Chi square, a more robust test than the one used in the original 
paper where the authors looked for significant relationships between many 
factors including persistence of AED and three different outcome categories . 
 
2.6. Discussion  
 
The papers included in the present systematic review are all observational and 
from that point of view none of the studies are protected against bias. As shown 
in table 2.3, all samples were drawn from tertiary referral centres and therefore 
from a highly selected population. 
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None of the studies provided a scientific rationale for the chosen sample size. 
For the purpose of quality assessment, we chose the cut-off of 75 subjects 
which by general convention is sufficient to detect a moderate effect size 
(Cohen, 1992).  However this was only a rule of thumb as there was substantial 
heterogeneity of patients and clinical settings and no study was specifically 
powered to detect changes in outcome between patients who remained on or 
off AED. 
 
In terms of the validity of the studies, factors other than the absolute sample 
size also need to be considered. For our methodological quality criteria, a good 
study would only include patents with video EEG confirmation of PNES and 
exclude patients with co-morbid epilepsy (table 2.3). In the study by Reuber et 
al., only 55% of the sample had the diagnosis confirmed by video EEG, and 
60% had coexisting epilepsy - resulting in a much smaller, valid sample. 
Conversely, the study by Bode et al, has the smallest, though ‘purest’, sample 
from this point of view, since all patients had video EEG confirmation and 
subjects with coexisting epilepsy were excluded. 
 
Response bias is also an issue for the paper by Reuber et al., where the 
response rate was less than 50% compared with the almost 80% from the study 
by Bode et al. 
 
The variability on the length of follow up times, within subjects, varied between 
months to several years in all three papers. There is evidence that outcomes 
are better in the short term (months to two years) and that studies with follow up 
times over 5 years report worse results, particularly for psychosocial outcomes 
(Farias et al, 2003; O’Sullivan et al, 2006). 
 
As shown in table 2.3 another of our quality criteria was whether the length of 
follow up was long enough to detect changes for all the outcomes of interest. 
Changes in mood or attack frequency can be detected at a shorter follow-up, 
compared to vocational status or medical disability, which may take years. The 
paper by Carton et al included patients from 6 months after the diagnosis, which 
is probably too short and, although the other two studies assessed patients at 
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least a year after the diagnosis, there was large variability in the length of follow 
up within samples. 
 
A common problem and one of the main weaknesses of the three papers is the 
lack of definition and standardisation of the intervention. There was no 
management protocol in any of the studies, with high variability in how subjects 
were managed within and between studies. Considering that these were 
outcome studies, the fact that only some patients may have had potentially 
effective interventions makes the interpretation of results difficult. 
 
When evaluating and weighing up the different studies, the issue of outcome in 
patients with PNES is complicated by the fact that there is no clear definition of 
what constitutes a good outcome. There is increasing evidence that attack 
reduction or even attack freedom is not valid as the only measure of a good 
outcome; and that more comprehensive measures, taking into account social 
adjustment and psychological status, have more validity when assessing the 
outcome of patients with PNES (Reuber et al, 2005; Quigg et al, 2002; 
LaFrance et al, 2006).  
  
Reuber et al’s definition of a good outcome was clear and comprehensive, 
including measures of social adjustment. In contrast, Bode et al. defined a good 
outcome as any reduction in attacks, which cannot be considered a valid 
measure since most outcome studies report reduction of attack frequency 
following the diagnosis. Most patients with a good outcome in this latter paper 
would be classified as having a poor outcome in the other two studies.  
 
Another factor that will affect the validity of the selected studies is the 
percentage of patients on AED, since this is our outcome of interest. From this 
point of view, the selected sample by Bodde et al. had only 3/22 (15%) patients 
on medication, which clearly affects the power to detect any significant 
differences in terms of outcome of patients on or off AED.  
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2.7. Summary  
 
Of the three selected papers for the present systematic review, the two largest 
studies report an association between continuing AED and a poor outcome of 
PNES; whereas the smallest and least powered study reported no association. 
 
The results of the present review appear to support our hypothesis however, 
because of the described methodological limitations of all the studies we can’t 
conclude that any correlation between taking AED and an adverse outcome was 
free from confound or bias. 
 
The quality of most of the research on PNES is limited, partly reflecting the 
practical and methodological difficulties when studying this group of patients. 
Carrying out outcome studies in this area has particular challenges due to the 
relatively small incidence of the disorder, the heterogeneity of the group and the 
absence of a universal treatment approach (LaFrance et al, 2006). 
  
The current published studies on outcome of PNES (including our selected 
papers) are difficult to compare and interpret since there is great variability 
amongst the selected populations, as well as a lack of consensus on what is a 
good outcome or a reasonable follow up period (Bowman & Markand, 2005; 
LaFrance et al, 2007).  
 
These studies, however, recognised the potential effect that taking AED may 
have on the outcome of PNES. The Carton et al study presents some qualitative 
data where continuation of AED reflects patients’ and GP’s views on the cause 
of the disorder, in this case “epilepsy” rather than PNES (Carton et al, 2007). 
 
Following this systematic review we are unable to conclude whether failing to 
withdraw AED has an effect on the outcome of PNES, however the data does 
suggest that a substantial number of patients with PNES continue to take AED 
and that these subjects have a poorer outcome. A randomised controlled trial 
would be the only way to establish if withdrawing AED at diagnosis contributes 
to a better outcome in patients with PNES.  
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Chapter 3:  
 
Going forward: Prologue to the original thesis research 
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3.1. Aims and objectives of the thesis portfolio  
 
In the overview in chapter one, evidence was presented to show that PNES, 
within certain settings, is not an uncommon disorder entailing a major impact on 
patients’ mental, physical health and social functioning (Breuer et al, 1998; 
Bowman & Markand, 2005). Since the majority of these patients are wrongly 
diagnosed as having epilepsy, most are treated with AEDs often for many 
years. As described in chapter 1 (page 16), the routine use of AED in this group 
of patients has important and overwhelmingly negative consequences.  
 
There is a lack of evidence for an effective treatment in the current literature 
(Brooks et al, 2002). The scarce evidence for the management of PNES is not 
surprising considering that PNES is a symptom of a variety of underlying 
causes, making the formulation of a single theoretical framework upon which to 
base any particular management strategy very difficult. The wide range of 
treatments described in small observational studies, possibly reflects the 
heterogeneity of the patient group.  
 
Although a definitive, universal psychotherapeutic intervention cannot be 
recommended this does not belie the fact that PNES is a condition associated 
with substantial harm that has to be recognized and diagnosed. There is reason 
to believe that if performed confidently and sympathetically the delivery of the 
diagnosis in association with a clear ‘undiagnosis’ of epilepsy can constitute an 
effective intervention in itself. Reuber in particular has questioned the likelihood 
or appropriateness of elaborating a single management strategy and proposes 
a stepped care approach with the essential initial generic step including the 
presentation of the diagnosis (Reuber, 2008). 
 
The present thesis aims to focus on the component parts of this initial 
intervention. Since most patients with PNES are initially thought to have 
epilepsy and treated inappropriately with AED, the withdrawal of medication 
should be part of this initial process, but is sometimes delayed because of a 
variety of background factors and concerns outlined below. The primary 
hypothesis of this thesis is that withdrawing AED following the diagnosis of 
PNES is in itself a therapeutic step and enhances the positive effects of a clear 
delivery of the diagnosis. 
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Although the effect of diagnosis and medication withdrawal was elucidated to an 
extent by the systematic review in chapter 2, this was not the specific focus of 
any of the papers and the role of a clear diagnosis and medication withdrawal 
was obscured by methodological and clinical heterogeneity, a lack of 
explicitness or standardistion of the intervention, loss to follow up and 
differences in reported outcomes.  Overall, although continuing inappropriate 
prescription of AED was associated with a poor outcome this could not be 
shown at a level that would endorse the specific efficacy and safety of 
medication withdrawal as an intervention in patients with PNES.  
 
There is some evidence to suggest that the intervention of withdrawing AED in 
this group of patients is perceived as unsafe by clinicians (O’Sullivan et al, 
2006), which would partly explain why such high numbers of patients with PNES 
are left on AED. Concerns exist regarding the accuracy of the diagnosis and the 
recurrence of possible epilepsy following the withdrawal of medication, in 
particular the precipitation of potentially fatal status epilepticus. These concerns 
together with the perception that leaving patients with PNES on AED is not 
harmful would naturally incline physicians to err on the side of caution and not 
withdraw medication following the diagnosis of PNES (Reuber & Elger, 2003c). 
 
The issue regarding the accuracy of the diagnosis has been extensively 
researched and there is good evidence that an accurate diagnosis is possible 
with the right expertise and diagnostic tests. For the purposes of the current 
thesis all subjects were diagnosed as suffering from PNES on the basis of the 
current gold standard; video EEG confirmation of a clinical diagnosis by a 
clinician experienced in the diagnosis and treatment of both epilepsy and PNES.   
 
The safety of AED withdrawal is another issue and in this case there is no 
evidence on the absence of harm of this intervention. Establishing the safety of 
AED withdrawal in this patient group has to precede any study on the possible 
therapeutic effects of withdrawing medication.  
 
The first study therefore aims to answer the question of whether withdrawing 
AED in patients with PNES is a safe intervention. For this purpose an 
observational study was conducted, consisting of a case series of a group of 
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patients with NES followed up over a period of twelve months after AED 
withdrawal. 
 
The first study can be conceptualised as a Phase one trial preliminary study 
directed toward demonstrating the safety and tolerability of an intervention with 
regard to the risk of untoward health related events.  The intervention in this 
case would be the diagnosis of PNES and subsequent AED withdrawal, the 
untoward event would be either the misdiagnosis of epilepsy as PNES or the 
‘induction ‘of epilepsy by withdrawal of AED. 
 
In this context an observational study was considered adequate and   
methodological rigour was maintained by ensuring that the design included the 
points below: 
 
• The study was based on a clinic population of the only regional service 
assessing patients with PNES from primary and secondary care 
• Standardised intervention 
• Clear protocols for diagnosis and drug withdrawal  
• Clear inclusion criteria and well defined outcomes 
 
As well as determining the safety of the intervention the observational study was 
an opportunity to show that for the purpose of generalisability and replication a 
reliable and valid diagnosis of PNES could be made and withdrawal of 
medication undertaken with the resources available to other tertiary centres. 
 
Once there was evidence that withdrawing AED in patients with PNES was a 
safe intervention it was possible to proceed to addressing the next research 
question of whether withdrawing AED has a positive therapeutic effect. 
   
As outlined above the systematic review of the literature (chapter 2) revealed 
that the only evidence for the possible effects of discontinuation of AED 
following the diagnosis of PNES, comes from three observational studies of 
limited quality and with conflicting results. Further observational work along the 
same lines would replicate the flaws identified in the review and only an 
experimental design would be likely to further investigate the effect of AED 
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withdrawal in a way that would be free from confounding and bias as far as 
possible. 
 
The specific choice of a randomized controlled design with groups randomized 
to delayed and immediate withdrawal was justified as follows: 
 
• The natural history of PNES is not so clearly defined that a before and 
after methodology would be adequate as the possibility of spontaneous 
recovery could not be discounted or anticipated in a predictable way. 
 
• Only randomization to parallel groups could address the known and 
probable unknown confounders in this heterogeneous disorder.    
 
• In terms of the basics of study design and anticipating likely 
methodological and practical issues most of the current evidence on AED 
withdrawal had to be extrapolated from epilepsy research.  Although 
most of this evidence is irrelevant to PNES, design and methodological 
issues are similar and in particular gives clear guidance on the timing, 
dosage schedules and monitoring of drug withdrawal. A randomised 
controlled trial comparing the effects of withdrawing AED immediately 
following the delivery of the diagnosis versus a delayed withdrawal 
appeared the most appropriate study design and had clear and relevant 
precedents in the epilepsy literature. 
 
• Blinding of patients to their status as regards delayed or immediate 
discontinuation was not possible, or desirable.  The aim of the study was 
to ascertain the efficacy of two plausible alternatives.  However, although 
subjects had to be aware of their status, neither arm was aware which 
intervention was the control and which the intervention. 
 
The study was designed to include a replication phase on the effect of AED 
withdrawal.   
 
There is evidence that reduction or absence of attacks is not valid as the sole 
measure of a good outcome in patients with PNES (Reuber et al, 2005). 
Psychological and particularly social outcome measures are frequently reported 
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as poor even in patients where attacks are controlled or significantly reduced.  
Hence, although the trial took attack freedom and frequency as its primary 
outcome, a comprehensive range of psychosocial measures were included to 
allow a more detailed exploration of the psychosocial aspects of PNES.  Care 
was taken to include measures along the lines used and reported by other 
workers in the field to allow comparison between our relatively prescriptive and 
behavioural paradigm and the approach of other workers.  
 
The systematic review of the literature also highlighted the methodological flaws 
of many of the outcome studies on PNES; in particular the inclusion of epilepsy 
patients, the absence of a standardised intervention, and the variable length of 
follow up amongst subjects. By the end of the replication phase of the RCT data 
was available for a group of prospectively collected patients, subject to the 
same assessment and intervention and followed up for the same length of time. 
 
In summary, this thesis will attempt to answer the main research question of 
whether AED withdrawal has a therapeutic effect on patients, utilizing a 
combination of study designs, in three stages.  
 
Overall the research portfolio can be conceptualized in the following way: an 
initial phase one trial to investigate safety aspects of the AED withdrawal 
intervention; a phase 3 trial aiming to establish potential therapeutic effects of 
AED withdrawal; and a third paper which can be seen as an open label 
surveillance study aiming to obtain a detailed and comprehensive picture of 
outcome.  
 
The thesis portfolio includes the following papers: 
 
- A systematic review of the literature on evidence of the effects of AED on the 
prognosis of PNES.  
 
- An observational study on the safety of AED withdrawal of 78 patients with 
psychogenic nonepileptic seizures. 
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- A Randomised Controlled Trial comparing the effects of immediate versus     
delayed withdrawal of Antiepileptic drugs withdrawal in patients with 
psychogenic nonepileptic seizures. 
 
- The psychosocial outcomes of 24 patients with psychogenic nonepileptic 
seizures 18 months after the diagnosis.  
 
The main objectives of the thesis are:  
 
- To establish the clinical safety of antiepileptic drug withdrawal in patients with 
PNES. 
 
- To investigate the potential therapeutic effects of antiepileptic drug withdrawal, 
in patients with PNES.  
 
- To explore short-term psychosocial outcomes of patients with PNES following 
a management strategy which includes AED withdrawal. 
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Chapter 4: 
 
Can we safely withdraw antiepileptic medication in patients with psychogenic 
non-epileptic seizures? Descriptive analysis of outcome data on patients with 
PNES treated with antiepileptic drugs. 
 
An abbreviate version of the contents of this chapter are published as follows: 
 
Oto, M., Espie, C., Pelosi A., Selkirk, M. Duncan, R. (2005). The safety of 
antiepileptic drug withdrawal in patients with non-epileptic seizures. Journal of 
Neurology ,Neurosurgery and Psychiatry, 2005 ,76(12);1682-1685. 
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4.1. Abstract 
 
Background: Psychogenic nonepileptic seizures (PNES) or pseudoseizures are 
psychologically mediated attacks that resemble and are often mistaken for 
epilepsy. Most patients are initially misdiagnosed as having epilepsy and 
inappropriately treated with AED. A significant percentage continues to receive 
AED even after the diagnosis of PNES has been confirmed, partly reflecting 
reluctance from the clinicians that perceive the withdrawal of AED as potentially 
unsafe. 
 
Objective: To determine whether withdrawal of anticonvulsant medication (AED) 
can be carried out safely in patients with psychogenic non-epileptic seizures. 
 
Methods: Prospective evaluation of safety and outcome in 78 patients with 
PNES who satisfied a standardised set of criteria for the diagnosis of ‘no 
epilepsy’. 
 
Findings: The patients were taking from 1-3 AED. Sixty four patients were 
withdrawn as outpatients, 14 as inpatients. Five patients stopped their 
medication abruptly, and two had AED inappropriately restarted and had to be 
withdrawn again. Otherwise all patients adhered to withdrawal schedules.  A 
new type of attack was seen in 3 patients, in all 3 cases complex partial 
seizures. In two of these cases the existence of controlled epilepsy was 
unsuspected. PNES frequency declined in the group as a whole over the period 
of the study (follow up 6-18 months), in all individuals except for 8 patients in 
whom there was a transient increase. Fourteen patients produced new physical 
symptoms during withdrawal.  
 
Interpretation: With appropriate diagnostic investigation and surveillance during 
follow up withdrawal of AED can be achieved safely in patients with PNES. 
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4.2. Introduction 
 
Psychogenic nonepileptic seizures (PNES) are psychologically mediated 
attacks that resemble and are often mistaken for epilepsy Diagnosis and 
management of PNES represents a significant clinical problem, since patients 
may present to a variety of doctors with attacks that are mistaken for and 
treated as epileptic seizures or status epilepticus (Howell et al, 1989; DeToledo 
et al, 2000; Reuber et al, 2002). 
 
Most patients with PNES do not have epilepsy, however up to 80% are exposed 
to at least one antiepileptic drug (AED) leading to morbidity and mortality 
(Benbadis, 1999). Even after the diagnosis of PNES is confirmed and no 
evidence of epilepsy has been found, 20-44% patients remain on a single or 
multiple AEDs (Reuber & Elger, 2003c; O’Sullivan et al, 2007; Hall-Patch et al, 
2010). 
 
There is also evidence that this paradoxical prescribing practice is not an 
exclusive phenomenon of PNES but also applies to other medically unexplained 
symptoms where patients are left on medication despite no evidence of a 
physical problem (Barsky & Borus, 1999; Mayou et al, 2000).              
 
Little attention has been given to the reasons for this group of patients 
remaining on medication despite a clear diagnosis of PNES, or the possible 
adverse consequences of drug withdrawal should it take place. 
 
There is a substantial literature however, looking at AED withdrawal in the 
context of patients with proven epilepsy. The consensus amongst experts in the 
field is that AED withdrawal should be considered for all patients with epilepsy 
who have been seizure free for more than two years, even though we have 
evidence that the average risk of recurrence of epilepsy is between 40 and 60 
% within 2 years (Chadwick & Scherokman, 1991). 
  
If a clinician treating a patient with epilepsy is willing to accept a risk of this 
order, why is there an apparent reluctance to withdraw AED in patients who did 
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not have epilepsy in the first place? It seems that the risks and benefits of AED 
withdrawal in patients with PNES are appraised in a very different way. 
 
There are various good reasons why patients with PNES in whom there is no 
evidence of epilepsy, should not be prescribed AED’s.  For example, avoiding 
iatrogenic harm, particularly teratogenicity, in a population with a majority of 
women of childbearing age (Sigurdardottir & Olafsson, 1998; Szaflarski et al, 
2000, DeToledo et al, 2005). There is also some evidence that medication may 
exacerbate PNES (Damaschke et al, 1988; Niedermayer et al, 1970) and that 
continuation of AED after diagnosis may be associated with a poor prognosis 
(Reuber et al, 2003b).  There are also obvious cost implications of giving 
unnecessary expensive medicines (Martin et al, 1998) and in the longer term 
potential medico legal consequences. 
 
Despite all of the above, the reality is that many patients with PNES are 
maintained on AED long after the diagnosis. Although there is little published 
research in this area, some factors may explain the reasons behind the 
reluctance to withdraw medication in this group of patients as summarised in 
table 4.1. One important factor to clinicians may be a lack of confidence in the 
diagnosis and concerns about missing possible underlying epilepsy, with 
consequent perception that AED withdrawal is associated with significant risk of 
serious adverse outcomes such as status epilpticus. Even when this is not the 
case, drug withdrawal does entail a non medical explanation for the attacks 
leading to a potential collision with patients expectations (Doust & DelMar, 
2004).  
 
In order to determine whether it can be safe to withdraw AED in patients who 
have PNES only, we conducted an observational study investigating the 
outcomes of a group of patients with video-EEG confirmed diagnosis of PNES 
and no evidence of epilepsy who were withdrawn form AED’s.   
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Table 4.1: Clinician concerns of AED withdrawal.  
 
Possible clinician concerns of AED withdrawl
1 Accuracy of the diagnosis of PNES or unrecognised underlying epilepsy
2  Morbidity and mortality associated to AED withdrawal if patient has 
unrecognised epilepsy
3 AED withdrawal producing an exacerbation of psychological symptoms if AED were acting as psychotropic drugs 
4 Exacerbation of PNES or symptom substitution in patients who somatise 
when removing the diagnosis of epilepsy and AED
 
 
 
4.3. Methods  
 
The current study was based at the Southern General Hospital PNES clinic, 
which is part of the West of Scotland Epilepsy regional unit.  
 
As part of routine clinical practice, all patients had an extensive clinical 
assessment including detailed description of the events by patients and 
eyewitness. All subjects had video EEG confirmation of the diagnosis by 
recording all typical events. Once the clinical diagnosis of PNES was confirmed, 
a concomitant diagnosis of epilepsy was regarded as excluded if the following 
criteria were satisfied:  
 
• All current types of events described were recorded and identified as 
PNES  
• No description of past events rising suspicion of epilepsy  
• No evidence of events during childhood  
• No inter-ictal epileptiform abnormalities on EEG 
. 
Initially all subjects were investigated as out-patients with “Short Video EEG” 
with suggestion (McGonigal et al, 2004a) and if this investigation was not 
conclusive patients were then admitted to the ward for video EEG.  
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The final diagnosis was always reached by consensus of at least three 
clinicians (including a neurophysiologist). The more complicated cases were 
formally discussed in a team clinical meeting.    
 
Once a firm diagnosis of PNES was made, patients were seen at the clinic 
where the diagnosis was delivered in a non-judgmental and supportive manner.  
 
We developed a written information leaflet on PNES  which was given to the patients and 
relatives at this point (appendix C). In terms of this written information, our intention was to 
ensure that it was relevant and meaningful to the patient group.   
Going by clinical experience we were aware of a specific range of  questions frequently 
asked by patients and relatives at the clinic These questions were used as the basis of the 
leaflet..   
 
The author also recorded all questions asked by 20 new patients and their relatives 
attending the PNES clinic and these were reviewed and thematically grouped to establish 
any dominant themes.  The themes that emerged were:  
 The nature and causes of the disorder;  
 Diagnostic tests;  
 Treatment. 
 
Answers to these questions, combined with ourclinical experience and current research 
evidence were then drafted as the information leaflet   
 
To assess the validity of the questions and responses, the information sheet was passed 
for comment to the epilepsy multi-disciplinary team and 10 consecutive patients at the 
clinic.  The amended information sheet was then piloted at the PNES clinic with further 
patient feedback taken into consideration. 
 
Comments, including the use of terminology, the clarity and relevance of information and 
presentation style, were incorporated into a final version.   
 
 AED medication was withdrawn in all patients with a final diagnosis of PNES-
only and the drugs tapered sequentially following a standard withdrawal protocol 
created by the authors based on clinical experience of AED withdrawal in 
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epilepsy patients during neurosurgical assessment (appendix D). During the 
medication withdrawal patients were reviewed at a minimum interval of 3 
months by the epilepsy specialist. In difficult cases, in particular when coexistent 
epilepsy could not be confidently excluded, medication was withdrawn in an in-
patient setting. 
 
Information on all patients seen at the PNES clinic was prospectively and 
systematically collected in a comprehensive database. Follow up information 
was collected at 6 and 12 months of the completion of the AED withdrawal. 
 
The main outcomes of interest were the potential risks in terms of morbidity and 
mortality associated with AED withdrawal as presented in table 4.1. Other 
outcomes recorded were reduction of attacks and AED status at follow up.   
 
Data were entered prospectively into an Access database on a dedicated PC 
and were regularly checked for completeness and accuracy.  For the current 
descriptive study the information was taken from this Access database and for 
the purpose of analysis the data was transferred to SPSS. 
 
4.4. Sample 
 
Of the total cohort of 235 consecutive patients referred at the clinic between Jan 
2000 and Jan 2003, 184/235(78.2%) had a video EEG confirmed diagnosis of 
PNES and satisfied criteria for “no epilepsy”. The reminder were still either 
awaiting video EEG (25/235, 10, 6%) at the end of the study, or had coexisting 
epilepsy (26/235, 11.1%).   
 
Of the 184 subjects with confirmed diagnosis of PNES alone, 99 (53.8 %) were 
taking AED. The remaining 38(20.6%) had never been on AED or their drugs 
had been withdrawn before clinic attendance (47/184, 25.5%). 
 
Of the 99/235 patients with the diagnosis of PNES-only that were taking AED, 
78/99 were eligible for the study. The remaining 21/99 (21.2%) patients were 
excluded for the following reasons; 12/99 (12%) patients were lost to follow up, 
2/99 (2%) patients refused to come off medication, and 7/99 (7%) were still 
reducing AED at the time of the analysis (Table 4.2). 
 72 
 
Table 4.2: Reasons for participant exclusion. 
 
Lost after diagnosis 12 12
Still reducing medication 7 7
Patient refused to withdraw 2 2
Withdrawal completed
(Study population)
Patients on AED N=99 %
78 78
 
 
4.5. Results  
 
4.5.1. Antiepileptic drug status 
 
Over half of the patients had been started on AED by a neurologist or general 
physician and we were unable to ascertain who had commenced prescription in 
25% of patients. At the time of referral, patients were taking a median of 2 AED 
(range 1-3); 28/78 (36%) were on more than two AED and 20/78 (28%) reported 
side effects on their medication.  
 
When questioned about the impact of AED on their attacks, 4/78 (5%) patients 
felt worse on starting AED but others reported feeling better on the medication 
6/78 (8%) or a temporary improvement when the drugs were started 27/78 
(35%). The rest 36/78 (46%) did not report any change. 
 
4.5.2. Antiepileptic drug withdrawal 
 
All study patients were instructed to come off medication. In the majority of 
cases this was done as an out-patient by giving clear instructions to the patients 
and their GP, with regular review at the clinic. Only 14/78 (18%) patients were 
admitted for drug withdrawal, the reason for admission were as outlined below.  
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• Patients with a possible underlying well controlled epilepsy (4/14). All 
these patients had current or past pathology that could be associated 
with epilepsy (e.g. severe head injury, brain tumour, meningitis). 
• Patients in whom standard diagnostic procedures had failed to confirm 
the diagnosis (5/14). In all these patients medication was withdrawn 
during admission as part of the diagnostic process.  
• Patients with mild learning disability (5/14). This group had difficulties 
understanding the diagnosis of PNES and the withdrawal schedule. In 
addition, patients and their carers also expressed anxiety about coming 
off medication. Three of these patients had failed to complete previous 
attempts of withdrawal as out-patients and all were regular users of the 
emergency services. 
   
The remainder of the cohort (64/78), were able to successfully complete AED 
withdrawal as an out-patient: Of the patients coming off medication at home, 
57/64 (89%) were able to follow the slow titration protocol as planned. Five 
patients (5/64, 7.8%) stopped medication as soon as the diagnosis was given 
and in two patients (2/64, 3%) the medication was suddenly stopped by their 
GP. None of the patients who stopped medication suddenly (7/64, 10.9%) 
reported any adverse effect. There was no evidence of withdrawal seizures 
(although none were taking barbiturates or benzodiazepines). 
 
4.5.3. Demographic and clinical characteristics 
  
Fifty-seven out of 78 (73%) were female, 34/78 of whom were of child bearing 
age, the mean age at the time of presentation at the clinic was 39.6 years 
(sd14.3) and the mean age of onset of events was 32.4 year (sd15.4). Nine out 
of 78 (11.5%) patients had a mild learning disability. Patients had been referred 
to the clinic mainly by epilepsy specialists or neurologists 60/78 (77%). As 
shown in table 4.3 the above figures were comparable with the rest of the PNES 
clinic population. 
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Table 4.3: Characteristics of the study population. 
Study population n=78 Clinic population n=219,                                      Confirmed diagnosis of PNES-only
Gender distribution
FEMALE 57 (73%) 166(76%)
MALE 21(27%) 53(24%)
Source of referral
NEUROLOGY/EPILEPSY 60 (77%) 145 (66%)
GP 8 (10%) 42 (19%)
GEN PHYSICIAN 7 (9%) 19 (8.6%)
PSYCHIATRIST 3 (3.8%) 10 (4.5%)
Missing data 0 3   (1.3%)
Mean age first event 
(years) 32.4 (15.4) 33 (14.4)
18(8%)
Mean age at referral 
(years) 39.6 (14.3) 40 (14.1)
Learning disability 9 (11.5%)
 
At the time of referral this represented a complex group of patients.  There was 
a high prevalence of morbidity of all types; as a result of the direct physical 
consequence of the ‘seizures’, associated psychopathology, as well as a very 
high prevalence of  coexistence of other medically unexplained symptoms (table 
4.4) 
 
Table 4.4: Patients overall characteristics at baseline. 
PATIENTS CHARACTERISTICS AT 
REFERRAL N=78 %
Psychopathology:
CONTACT WITH 
PSYCHOLOGY/PSYCHIATRY 44/78 56.00%
DEPRESSION 44/78 56%
SUICIDE ATTEMPTS 15/78 19%
SELF-HARM 7/78 9%
MEDICALLY UNEXPLAINED SYMPTOMS
56/78 71.70%
Impact of PNES 
INJURY THROUGH ATTACKS 26/78 33%
ATTACK FREE FOR >1 MONTH 23/78 29%
PSEUDOSTATUS 23/78 29%
VISIT TO A&E 43/78 55%
Social impact:
BENEFITS 53/78 68%
EMPLOYED 9/78 11.50%
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4.5.4. Outcome after AED withdrawal 
 
At follow up we had data up to 6 months in all patients. In 56/78 (78%) patients 
we had data up to 12 months and for 28/78 (36%) we had follow up information 
at 18 months after AED withdrawal. 
 
As outlined above we looked at the following end points: evidence of emergent 
epilepsy, AED restarted, frequency of PNES, newly reported symptoms and 
morbidity as a result of AED withdrawal 
 
4.5.4.1. Evidence of coexisting epilepsy after drug withdrawal: 
 
Three patients 3/78 (3.8%) presented with a new type of attack, that turned out 
to be epileptic, in all cases conforming to complex partial seizures.  
 
The coexistence of ES as well as PNES was promptly recognised in these three 
patients and AED medication re-started, bringing epileptic seizures quickly 
under control in all cases. 
 
In one case we had high suspicion of coexistence of underlying ES, therefore 
diagnosis and AED withdrawal was done during a prolonged in-patient 
admission. The patient did not present with the new attacks until a year after 
AED withdrawal. .We had not suspected coexisting epilepsy in either of the 
other two cases; neither had predisposing factors or a childhood history of 
epilepsy and the only events reported by patients and witness were the ones 
recorded during video EEG. 
 
In terms of outcome, ES was controlled in all patients after restarting AED. In 
two cases this represented a reduction to mono-therapy from the two AED they 
were taking at referral. All three patients accepted the dual diagnosis, two 
remain free of PNES and the third had a substantial reduction. 
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4.5.4.2. AED restarted: 
 
Two patients had been restarted on AED, in one case by the GP in view of 
persistence of events and for the other patient as a result of attendance at A&E. 
In both cases medication was withdrawn again successfully. 
 
In one patient, at the first follow up visit (6 weeks), we noticed that the GP had 
continued to issue repeat prescriptions of AED. Contacting the GP over the 
phone as well as through a letter rectified this. 
 
4.5.4.3. Frequency of PNES after drug withdrawal: 
 
There was a significant and sustained reduction of attacks over time, whether 
attack frequency data was analysed by changes between groups, within 
individual subjects, or by the total number of patients attack free (see table 4.5). 
 
Table 4.5: Changes in attack frequency from baseline. 
Attack frequency per 
month
mean                SD median RANGE N
AT REFERRAL 22.23 30.78 15 0.5-180 N=78
 6 MONTHS FOLLOW UP 13.01 38.46 2
0-300 N=78
AT 12 MONTHS FOLLOW 
UP
10.66 36.4 0
0-250 N=56
AT 18 MONTHS FOLLOW 
UP
3.96 11.05 0.75
0-60 N=28
 
  
A Wilcoxon signed rank test showed that there was a significant difference in 
attack frequency between referral and six month follow up (p<0.001). Fifty-six 
patients were followed up at 12 months. These patients had significantly less 
attacks than at referral (p<0.001) or at 6 month follow up (p<0.001).  Twenty-
eight patients were followed up at 18 months. Attack frequency was less than at 
referral (p<0.001) and at 6 months (p=0.001).  
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At 12 months after AED withdrawal, 35 of 71 patients (49%) had been free of 
attacks for more than two months. 
 
An increase of frequency of their usual events 6 months after AED withdrawal 
was reported by 8/78(10%) patients. In most patients (7/8) this represented an 
increase of over 50% with a median of 15 attacks per month at referral versus 
30 at 6 months. This was a transitory effect in all cases and no particular action 
was required for any of these patients.  
 
4.5.4.4. Morbidity and mortality after AED withdrawal: 
 
As shown in table 4.6, no serious adverse events, including admissions to 
intensive care (ITU) or death, were reported. 
 
Table 4.6: Morbidity and mortality after AED withdrawal. 
 
Morbidity and mortality after
AED withdrawal N=78 %
Pseudostatus
(prolonged attack treated with
benzodiazepines)
Status epilepticus 0/78 0%
Reporting injuries for the first
time 
0/78 0%
Continue to sustain minor injury
10/78 12.80%
Admissions to ITU 0/78 0%
Death 0/78 0%
4/78 5%
 
Our definition of pseudostatus was a prolonged PNES thought to be epileptic 
and treated by administering AED medication. Twenty three patients (29%) had 
episodes of pseudostatus before withdrawal, but only four had episodes 
afterwards (all had previous episodes). Ten patients (13%) continued to report 
minor injury (bruises and grazes) after withdrawal.  
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4.5.4.5. Newly reported medical and psychological symptoms: 
 
Fourteen patients (18%) reported new symptoms, while three (3.8%) reported 
an exacerbation of previous symptoms, and nine (11.5%) had investigations for 
new complaints. In two patients the new complaint (chest pain and fatigue) 
represented the main source of disability and health care utilisation at follow up. 
Ten patients (13%) were started on new drugs, in most cases (6/10) an 
antidepressant drug (see table 4.7).  
 
Table 4.7: Report of new clinical events after AED withdrawal. 
New physical complaints 
after withdrawal
N=78 %
New physical symptoms 14/78 18%
Exacerbation of long 
standing symptoms
3/78 3.80%
New medication started 10/78 12.80%
Undergoing new 
investigations
9/78 11.50%
 
As shown in table 4.8, five patients (6.4%) reported new psychological 
symptoms: low mood (three patients), irritability, and anxiety however, none 
required psychiatric intervention. One patient with a past psychiatric history self 
harmed transiently after AED withdrawal.  
 
Table 4.8: New reports of psychological complaints following AED withdrawal.  
New psychological complaints 
following AED withdrawal
N=78 %
New symptoms 5/78 6.40%
Self harm 1/78 1.20%
Suicide attempts 0/78 0%
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4.6. Discussion 
 
To our knowledge this study is the largest observational study of the outcome of 
AED withdrawal in this complex population. Although the study population 
represents a selected sample, the general characteristics of the group were 
comparable with the rest of our clinic patients and with those described in most 
reports on PNES (Moore & Baker, 1997; Reuber & Elger, 2003c; O’Sullivan et 
al, 2007) although the mean age of onset of events of our group was at the 
upper end of the range of most studies.  
 
Despite our selected  sample,  we do feel that with this study we have been able 
to present data that might address the concerns that arise in the care of patients 
with PNES, in particular the safety or otherwise of withdrawing AED. 
 
As well as data on the safety aspects of AED withdrawal, the current study 
provides some interesting information on other aspects of AED prescription in 
patients with PNES. In terms of the effect that prescribing AED had on these 
subjects, it is interesting to point out that almost half of the patients reported 
some benefit at least initially from the AED and only a minority reported an 
exacerbation of attacks. Transient response to AED in terms of a reduction of 
PNES frequency has been described by some authors (Bowman & Markand, 
1996; Sirven & Glosser, 1998) but an exacerabtion of attacks with AED is more 
often reported in the literature, being cited as a distinguishing factor between ES 
and PNES.  However this was not the case in our group.  
 
In terms of patient safety, the main outcome of the study, two factors are critical 
in our view: the confidence with which possible underlying epilepsy is excluded, 
and the quality of monitoring of the patients during and after AED withdrawal. 
 
The best indicator of the accuracy of criteria for excluding epilepsy is whether or 
not epileptic seizures occur on withdrawal of AED. Interestingly, relapse 
occurred soon after withdrawal in the two patients, in whom it occurred 
unexpectedly, indicating that these patients had controlled epilepsy rather than 
epilepsy in remission. In the third patient, who had a history of resected frontal 
low grade glioma, complex partial seizures occurred just over a year after AED 
withdrawal. This suggests that either a pre-existing epilepsy was in remission or 
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that a new epilepsy had arisen (not inconceivable given the past history), and 
suggests the need to monitor patients over an extended period.  
 
Our study ended in January 2003 and no other patients have since had epileptic 
seizures. This is compatible with the results of studies of relapse rate in patients 
with epilepsy following AED withdrawal, which shows that the majority of 
relapses occur within six months after withdrawal (Chadwick & Scherokman, 
1991).  
 
Our criteria for excluding epilepsy are straightforward, and are applied with care, 
particularly in the matter of being sure that descriptions of all events are as 
accurate as they can be, and that they are carefully compared with the events 
that have been recorded. Nonetheless, when a patient has controlled epilepsy 
and has not had an epileptic seizure for some years, it may be unrealistic to 
expect accurate descriptions of early events in all cases. This may particularly 
be the case if the original events were complex partial seizures that were 
promptly controlled, and when the present PNES are much more frightening 
and dramatic in the eyes of relatives.  
 
Despite the absence of recurrent major seizures in our series, it is clear that close 
supervision of the withdrawal process is an important safety measure, not only to ensure 
that the occurrence of epileptic seizures is rapidly detected and communicated to the 
PNES team, but also to ensure that patients (and doctors) comply with withdrawal 
schedules. There is evidence that re-introduction of AED in this group of patients is not 
uncommon, presumably in association with a lack of acceptability of the diagnosis by 
patients, carers and GP’s (Lempert et al, 1990; Walczak et al, 1995; Jongsma, 1999; 
O’Malley, 2000). In the current study great effort and time was devoted to promote the 
acceptance of the diagnosis as intrinsic to the success of the intervention . 
 
We ensured that; patients, relatives and General Practitioners received clear and 
consistent information in terms of the diagnosis and the importance of coming off 
medication. Extra appointments were offered if concerns arose from the patients or the 
relatives regarding the diagnosis or medication withdrawal.  Clear and detailed letters 
were sent to the GP’s and for a few patients letters were also sent to their local Accident 
and Emergency to forestall inappropriate treatment of apparent status epilepticus. 
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For example, one of the patients included in the study was re-started on AED by his GP 
after he reported an increase of nonepileptic attacks as the medication was withdrawn. 
Because of the frequency of follow up contacts, we were able to quickly identifiy and 
address the problem. After establishing that there was no evidence of emerging epilepsy, 
clear explanation and reassurance were given to the patient together with further 
instruction to withdraw AED. To ensure the success of the second attempt at drug 
withdrawal the patent’s GP was contacted by phone to clarify any concerns and this was 
followed by a letter. 
 
Over-treatment of epileptic seizures is common in patients who also have PNES 
(Blumer et al, 2006). For the small number of our patients in whom epileptic 
seizures appeared after AED withdrawal we were able to re-introduce AED 
treatment sensibly, resulting in mono-therapy and lower doses.  
 
The level of reporting of new physical or psychological complaints following 
AED withdrawal was low in our patients, particularly considering the high rates 
of reported psychopathology and physical symptoms at presentation. In those 
who reported new medically unexplained symptoms, it was unclear whether this 
was associated with the removal of the diagnosis of epilepsy, with withdrawal 
itself, or with the reduction in PNES frequency that took place at the same time. 
Medically unexplained symptoms are common in patients with PNES (Lempert 
& Schmidt, 1990; Ettinger et al, 1999; Reuber et al, 2003) and it is perhaps 
unsurprising that the removal of one psychogenic symptom might sometimes 
provoke the appearance of another.  
 
Overall our patients had a generally good outcome with a significant reduction in 
frequency of PNES after drug withdrawal and only a minority of patients 
reporting an increase. Similar rates of reduction of attack frequency following 
diagnosis of PNES have been reported in other follow up studies using different 
methods  of diagnosis and management (Ettinger et al ,1999; Selwa et al, 2000; 
Reuber et al, 2003, Goldstein et al, 2004) which suggests that the reduction is 
probably a result of multiple factors, of which AED withdrawal is only one. It 
would require a randomised controlled trial of drug withdrawal to establish the 
extent to which there is a causal relation between AED withdrawal and a good 
outcome of PNES and we are in the process of carrying out such a trial. 
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The MRC AED withdrawal study indicates that a patient who has had tonic-
clonic convulsions but has been seizure-free on a single AED for two years has 
a 60% risk of seizures in the first year after drug withdrawal (Chadwick & 
Scherokman, 1991). While the number of patients in our study is relatively 
small, our data suggest a much lesser risk in appropriately selected and 
monitored patients with PNES, yet patients often remain on AED. We cited 
some potential adverse consequences of AED in the introduction; it may be 
worth adding that of the 34 of our patients who were women of childbearing age 
nine had had pregnancies while on AED.  
 
 
4.7. Conclusion  
 
Overall, from the point of view of safety, which was the main objective of the 
study, the outcome of patients after medication withdrawal was positive, with 
minimal and not serious adverse events. Even for the three patients in whom 
the diagnosis of epilepsy emerged after drug withdrawal AED withdrawal 
allowed clarification of diagnosis and rationalisation of treatment.  
 
We conclude that in appropriately selected patients with PNES, and where 
suitable expertise and monitoring are available, AED withdrawal can be safe. 
Patients who are thought to have PNES should therefore be referred to 
appropriate centers.  
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Chapter 5: 
 
Clinical outcome of a Randomised Controlled Trial comparing the effects of 
immediate versus delayed withdrawal of Antiepileptic drugs in patients with 
nonepileptic seizures. 
 
An abbreviated version of the contents of this chapter are published as follows: 
Oto. M, Espie CA, Duncan R. (2010) An exploratory randomised controlled trial 
of immediate versus delayed withdrawal of antiepileptic drug in patients with 
psychogenic nonepileptic seizures(PNEAs). Epilepsia. 
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5.1. Abstract 
 
Background: Psychogenic nonepileptic seizures (PNES) are psychologically 
mediated attacks that resemble and are often mistaken for epilepsy. Most 
patients with PNES are treated with AED and continue to receive medication 
even after the diagnosis is confirmed. A failure to withdraw AED’s may 
undermine the diagnosis of PNES and hinder adjustment to the removal of the 
diagnosis of epilepsy and negatively affect outcome. 
  
Main hypothesis: Withdrawing AED following the diagnosis of PNES is in itself a 
therapeutic step and enhances the positive effects of a clear delivery of the 
diagnosis. 
.  
Methods: A Randomized controlled trial of AED withdrawal in patients with 
PNES. Patients were randomized to immediate or delayed (9 months) 
withdrawal of AED. We recorded attack frequency, changes of the use of 
emergency medical services and a variety of psychosocial measures at 
baseline, 9 months and 18 months.  
 
Result: Of 193 patients screened, 38 fulfilled entry criteria, 13 declined 
participation and 25 were randomised. Fourteen patients were randomized to 
immediate withdrawal (IW), 11 patients to delayed withdrawal (DW). There was 
a significant reduction in spell frequency from baseline to 9 months in the IW 
group but not in the DW group (p=0.028). There was a significantly greater 
reduction in use of rescue medication in the IW group compared to the DW 
group between baseline and 9 months (p=0.002). Emergency healthcare 
utilization dropped to zero in both groups by the end of the study. Psychological 
measures reflecting internal locus of control increased significantly more in the 
IW group (p=0.005). 
 
Conclusion: The present study may be regarded as an exploratory exercise and 
as such has provided a suggestion that withdrawing AED enhances the effect of 
a clear delivery of the diagnosis. This effect is reflected in a persistent reduction 
in attack frequency and a cessation of the use of emergency services and 
medication following AED withdrawal. Importantly none of our data show any 
negative effects.  
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5.2. Introduction 
 
Psychogenic nonepileptic seizures (PNES) may be defined as paroxysmal 
events that resemble and could be mistaken for epileptic seizures, without being  
associated with any measurable alteration in brain electrical activity. The 
underlying cause for PNES could be plausibly attributed to psychological 
processes as opposed to alternative physiological processes such as faints. 
PNES present to virtually all health care professionals, account for 
approximately 18% of patients presenting with blackouts and represent a 
significant management problem to epilepsy specialists (Kotsopoulos et al, 
2003). 
 
A variety of psychological interpretative paradigms have been proposed to 
explain or understand PNES. These range across the traditionally 
psychodynamic, the strictly behavioural and the eclectically psychosocial, and 
allude to a variety of psychological mechanisms including dissociation, 
hysterical re-enactment, learned behaviour and frank malingering (Bowman & 
Markand, 1996; Gates, 2002; Salomon et al, 2003; Marchetti et al, 2008).  As 
such, the difficulties of assessment of the various treatments, of an already 
heterogeneous disorder (Lesser et al, 2003; Cragar et al, 2005; Baslet et al, 
2010), are compounded by the breadth of approaches adopted. Unsurprisingly, 
a recent Cochrane review on the behavioural treatment of PNES concluded that 
there is no reliable evidence to support the use of any one specific treatment 
(Brooks et al, 2007). 
 
Nevertheless, elements of management indicated by clinical consensus are 
beginning to receive some support from published research. In particular, there 
is increasing evidence that an initial clear and unambiguous communication of 
the diagnosis of PNES and the removal of an erroneous diagnosis of epilepsy is 
an integral part of management. In itself this may constitute the decisive and 
only necessary intervention for a minority of patients. (Shen et al, 1990; Farias 
et al, 2003; Hall-Patch et al, 2010).  
 
Almost 80% of patients with PNES are exposed to Antiepileptic drugs (AED) 
and about 40% remain on AED after the diagnosis of PNES has been 
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established (Benbadis, 1999: Reuber et al, 2003; O’sullivan et al, 2007). 
Consequently, despite the emphasis placed on delivering a clear (un)diagnosis, 
insufficient attention has been placed on the potential impact that continuing 
AEDs may have on the prognosis, course or outcome of PNES thereafter. 
 
Studies across a range of physical and psychological disorders have confirmed 
that such inconsistency between diagnosis and management undermines 
compliance and outcome (Barski & Borus, 1999). Thus it seems at least 
plausible that a failure to withdraw AEDs may undermine the diagnosis of PNES 
and hinder adjustment to the removal of the diagnosis of epilepsy. 
 
Our working hypothesis is that an immediate withdrawal of AEDs following the 
diagnosis of PNES would enhance the therapeutic effect of a clear delivery of 
the diagnosis. 
 
In a previous study we showed that AED withdrawal in the context of PNES is 
safe (Chapter 4). The next step and the aim of the present study was to 
investigate the potential therapeutic benefit of a planned withdrawal of AEDs 
following the diagnosis of PNES. We designed a randomised controlled trial 
comparing changes in attack frequency in patients following differing AED 
withdrawal regimes. In one group medication was withdrawn immediately after 
the presentation of the diagnosis of PNES. In a second group, withdrawal of 
AED was delayed until 9 months after the delivery of the diagnosis. The 
rationale for this comparison was to observe any possible differences in 
outcome between the group who had the intervention (AED withdrawal at time 
of diagnosis) and the control group which continued to take the medication. 
 
5.3. Methods  
 
5.3.1. Aim 
   
The study aim was to investigate the therapeutic effect of a planned withdrawal 
of antiepileptic drugs in patients with PNES. More specifically, to consider 
potential benefits of immediate relative to delayed withdrawal, as measured by; 
reduction in the number of attacks, number of patients that become attack free, 
changes in physical and psychological health status and healthcare utilisation. 
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5.3.2. Study design 
 
Pragmatic randomised controlled trial comparing two groups (immediate AED 
withdrawal (IW) vs. delayed AED withdrawal (DW)) with repeated measures. 
The study therefore comprises a controlled comparison phase, followed by a 
replication of the drug withdrawal effect. The design of the study is illustrated in 
appendix E. The study design adhered to the CONSORT guidelines (Moher et 
al, 2001; appendix F). 
 
5.3.3. Participants 
  
The trial was based at the Glasgow PNES regional clinic in the Institute of 
Neurological Sciences at the Southern General Hospital. Patients are referred 
from a wide variety of sources throughout the West of Scotland, including 
primary and secondary care (total population 2.7 million). 
 
All patients referred to the clinic between April 2001 and January 2004 were 
screened as potential eligible subjects. Patients were eligible if they had video 
EEG confirmed diagnosis of PNES, without coexisting epilepsy, and taking at 
least one AED. Inclusion criteria are shown in table 5.1 and the flow-chart of 
recruitment is presented in figure 5.1. 
 
 
Table 5.1: Inclusion criteria for the study.  
1 Taking at least one Antiepileptic drug
2 Active NES (> 1 event per month) 
3 Diagnosis of NES confirmed by video EEG
4 No evidence of coexisting epilepsy
5 Patient able to give informed consent.
6
Female, if of childbearing age, must not be 
pregnant and must be using a medically acceptable 
form of contraception
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Figure 5.1: Flow-chart of RCT design. 
 
 
 
 
  
 
 
Assessment for eligibility 
                 n=219  
       Eligible for trial: diagnosis of PNES   
                                  n=193 
          Fulfill entry criteria: n=38 
       Randomised: n=25 
Delayed AED withdrawal  
                 n=11 
Immediate AED withdrawal  
                 n=14 
 
Completed study n=11 
Analysed n=11 
Completed study n=13 
Analysed n=14 
Declined to participate 
             n=13  
Excluded: N=155 
 
 Not on AED n=75 
 
 Awaiting video EEG n=37 
 
 Coexisting epilepsy n=19 
 
 Other n=21 
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Emphasis was placed on accurate diagnosis with a strict protocol and a 
minimum of three clinicians (two epilepsy specialists and a neurophysiologist) 
were involved, each one assessing the case independently. Details of the 
diagnostic criteria are shown in appendix G. 
 
5.3.4. Interventions  
 
Subjects were randomly allocated to immediate withdrawal (IW) of antiepileptic 
drugs or delayed withdrawal (DW). As shown in figure 5.1, patients randomised 
to IW were asked to immediately start a gradual withdrawal of their AED at the 
time when the diagnosis of PNES was given. Patients randomised to DW 
continued to take their medication for a further nine months at which point their 
medication was slowly withdrawn. The full protocol with details of the 
intervention is attached in appendix H along with participant consent form 
(appendix I). 
 
In order to standardize the information given to patients, the research fellow 
followed the script of a purposely designed semi-structured interview which can 
be viewed in appendix J. This was based on pilot work described in chapter 4, 
to elucidate the most frequently asked questions by patients at the clinic 
following the diagnosis of PNES.  
 
All patients with the confirmed diagnosis of PNES were also given an 
information leaflet in the form of questions and answers which had also been 
designed by the author. Further information on the purposely designed patient 
information sheet can be found in appendix K. 
   
Assessment and data collection took place pre-randomisation (baseline data) 
and at 9 months post randomisation with subsequent data collection 18 months 
later at the end of the replication phase. The period of 9 months from the 
randomisation point was chosen to ensure that all subjects had been off all 
AEDs for at least two months by the end of the controlled phase. 
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5.3.5. Drug withdrawal 
 
Medication was gradually withdrawn in weekly decrements following our 
standard protocol, which had been used regularly at the PNES clinic for a year 
before the start of the research trial. For patients taking more than one AED, 
drugs were withdrawn sequentially following our own protocol (appendix D).  
 
5.3.6. Outcomes and data collection 
 
The primary outcome measure was change in self reported attack frequency 
from baseline to 9 months and at the end of replication phase at 18 months. As 
well as comparing the absolute reduction of attacks we also analysed data in 
terms of clinically significant change. Clinical response was defined as reduction 
of attacks grater than 50%, and remission as being attack free. As secondary 
outcomes we also measured any changes between and within groups in illness 
attribution and health care utilisation, as well as differences in physical and 
psychological health status from baseline to 9 and 18 months. 
 
Patients reported attack frequency retrospectively at each visit since self 
reporting of attacks in these patients has been shown to be reliable (Quigg et al, 
2002). Most patients also used the diary we offered to record the attacks. For 
secondary outcomes, at all visits, patients completed the same set of 
questionnaires. All information was recorded in the clinical notes. 
 
The Hospital Anxiety and Depression Scale (HADS) (Zigmond & Snaith, 1983; 
appendix L) was used to assess changes in mood over time. To assess 
changes related to AED side effects, in particular tiredness (a frequently 
reported side effect), we used the Side Effects and Life Satisfaction Inventory 
(SEALS) (Brown & Tomlinson, 1982; Gillham et al, 2000 – see appendix M). 
Finally the Illness Perception Questionnaire IPQ (Weinman et al, 1996; 
appendix N) which assesses patients’ illness representation was employed. We 
were particularly interested in assessing changes when on or off medication in 
their perceived control over their condition. 
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We recorded basic demographic data for all patients screened for the trial. 
Progress data for all participants were collected three monthly at the clinic or 
otherwise through a telephone consultation. 
 
5.3.7. Sample size and power considerations 
 
The only available data on which to base our power calculation were from 
descriptive retrospective cohort studies. These data suggest that, after 
diagnosis of PNES, up to one third of the patients become attack free or 
demonstrate a substantial reduction of attack frequency regardless of 
management.  
 
Based on the above a power calculation based on an alpha of 0.05 estimated 
that the sample size required to detect an effect of medium size with 80% power 
would be 87, reducing to 26 for a large effect (Cohen 1992).  Various 
constraints made it impossible to aspire to anything approaching a sample size 
of greater that 30 but other steps were taken to maximize power via reducing 
variance such as imposition of strict entry criteria, the choice of clear and 
unambiguous end points and maximising treatment fidelity. Despite these 
manouevres the possibility of inadequate power persisted but it was felt ethically 
appropriate to proceed with an exploratory trial since there had been no 
previous controlled trials on management of PNES.  
 
5.3.8. Blinding 
  
Blinding of participants or the clinician was not possible. Due to the nature of the 
intervention (coming off or remaining on AED), patients had to know in which 
group they had been allocated. It was the impact of coming off medication or 
remaining on it, after the diagnosis, that we were interested in assessing, rather 
than the effects of any AEDs. 
 
The clinician, however, was blinded to adherence with the withdrawing regime 
which was tested by measuring drug levels in blood. These results were sent to 
an independent clinician who kept the results confidential until the end of the 
trial. 
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Furthermore, the research assistant who administered rating scales at baseline 
was blind to participant allocation. At the 9 and 18 months visit, patients self-
rated the same scales in an attempt to minimise bias and to increase reliability 
of measures. The scales were scored by the research assistant and results 
made available to the investigator upon completion of the trial.   
  
5.3.9. Randomisation 
 
A random number list was generated using Excel by an independent clinician 
who was not involved with the trial. The random list was given to a secretary 
from another department who again had no knowledge or involvement of the 
trial. Each time a patient agreed to participate, the nominated secretary was 
contacted by telephone to obtain a random number. A simple random allocation 
method was used with patients who were allocated an even number 
randomised to IW and patients with an allocated odd number randomised to the 
DW group. 
 
5.3.10. Statistical methods 
 
The evaluation of the data was performed with the computer program SPSS 
version 14. A descriptive analysis of all data showed that the primary outcome 
variable (attack frequency) was not normally distributed. Thus within and 
between group comparisons were made using the appropriate non parametric 
tests (Wilcoxon Paired Rank Test and Wilcoxon Two Sample respectively).  
Similarly dichotomous outcomes were compared within and between groups on 
the appropriate measures (McNemar’s test and Fisher’s exact test respectively) 
All analyses were intention to treat, with last observation carried forward used 
for missing values.  A p value < .05 was considered statistically significant.  
 
5.4. Results 
  
5.4.1. Sample characteristics at baseline  
 
From April 2001 to Jan 2004 we screened 219 patients of whom 25/219 (11%) 
were ultimately randomised. Of the excluded patients, 26/219 (11.8 %) had 
epilepsy only, 79/219 (36%) were not on AED at the time of the study and 
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13/219 (6%) declined to participate. The remaining 76/219 (35%) of the 
excluded patients had a clinical diagnosis of PNES and were taking AED, but 
were excluded because: they did not have video EEG confirmation of diagnosis 
within the recruitment period (37), had coexisting epilepsy (19) or for other 
reasons, including pregnancy, inability to consent or history of childhood 
epilepsy (total 21).  
 
At baseline we had data on the 168/194 patients with PNES who were not 
included in the study and were able to compare them with the randomised 
patients as shown in table 5.2 (26/194 of the excluded did not have PNES). 
 
Table 5.2: Comparison at baseline, between randomised patients and the rest of patients with 
NES not included in the study. 
 
Excluded n=168 Randomised n=25  
 
Female 126/168 (75 %) 20/25 (80 %)
Married 98/168 (58 %) 17/25 (68 %)
Employed or students 38/168 (22 %) 4/25 (16 %)
State benefits 96/168 (57 %) 16/25 (64%)
Reported sexual abuse 43/168 (25.5 %) 8/25 (32 %)
Age at presentation at clinic, Mean 37.6 (sd 14.4) 41 (sd 14.4)
Duration of  NES (months), Mean 70.8 (sd 50.8) 57.4 (sd 48.6)
Convulsive attack 114/168 (67 %) 13/25 (52 %)
 
Following randomisation, the groups assigned to immediate or delayed 
withdrawal were compared on demographic and clinical characteristics as well 
as well as factors reported as being of prognostic significance in PNES (Reuber 
& Elger, 2003). We also rated items identified from our semi structured interview 
that reflected the impact of PNES in support needs and daily activities (Table 
5.3). We found no statistically significant differences between groups. 
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Table 5.3: Baseline between-groups comparison of possible prognostic factors. 
Immediate withdrawal Delayed withdrawal
N=14 N=11
Age in years 40.7 sd14.1 41.4 sd 15.5
(mean) (16-62) (19-65)
Duration NES in months 59.3 (sd 51.2) 59 (sd 47.4)
(mean, range) (3-144 ) (9-129)  
Taking >1 AED 5/14 (35.7%) 6/11(54%)
Attack frequency 
(median, range)
None Compliant with AED 1/14 (7 %) 1/11 (9%)
Daily activity limited by NES 8/14 (57.1%) 5/11 (45.5%)
 20(5-720)   12(6-120)
Female(n) 12/14 (85.7%) 8/11(72.7%)
 
For the randomised patients, there was no difference in input from a clinical 
psychologist; four patients (two in each group) declined referral, and the rest 
were seen by one of the psychologists a mean number of 4 times (IW range 0 to 
7 and DW range 0 to 8). Only one patient from the IW group dropped out at four 
months after initial visit however she was included in the study using the method 
of last observation carried forward. At the end of the study, one subject from 
each group (2/25, 8%) was found to have none detectable serum levels of AED 
suggesting that the group as a whole were concordant with the medication. 
 
5.4.2. Outcome  
 
5.4.2.1. Primary outcome: changes in attack frequency   
 
Our primary outcome was the effect of our intervention (medication withdrawal) 
on attack frequency at the end of the controlled phase of the study at 9 months 
from the start of the trial.  The control group was in turn exposed to the same 
intervention at 9 months in a subsequent replication phase with patients being 
followed up for 18 months in all.  
 
At baseline all patients (n=25) reported monthly attacks ranging between 10 and 
295; the data were not normally distributed. As a result, and considering the 
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small size of our sample, we used the median values to compare groups as a 
more stable way to illustrate the group central tendency. 
 
At baseline the median of attacks of the IW group was 20(range 5-720) 
compared with a median of 12 (range 6-120) for the DW group, this difference 
was not statistically significant (p=.700). 
 
As can be seen in figure 5.2, median number of attacks declined across the 
study in both groups. At the end of the controlled phase the IW group reported a 
median attack frequency of 2(0-295) compared with 6 (0-100) for the DW which, 
when compared, was not a statistically significant. By the end of the replication 
phase the medians had reduced further in both groups to a median of 1(0-6) in 
the IW group and of 4(0-32) in the DW group, which again when compared was 
not statistically significant. It is noteworthy that in both groups of theses values 
had reduced considerably. 
 
Figure 5.2: Changes in median number of attacks between IW and DW groups at main end 
points.  
 
 
 
 
 
 
 
 
 
 
 
 
Visual inspection of figure 5.2 suggests that subjects in the IW group had a 
greater reduction from baseline than the DW group at the end of the controlled 
phase. Using within group change scores for comparison of median values the 
reduction for the IW group was statistically significant (p=.028) and that was not 
the case for the DW group.  
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5.4.2.2. Clinically significant changes between groups 
 
To assess the clinical impact of our intervention we compared both groups for 
the proportion of patients attack free and the proportion with >50% reduction of 
attacks as well as differences in health care utilisation as shown in table 5.4.  
 
Table 5.4: Clinical and social outcomes between groups from baseline to end of the study 
(*P<.05) 
Baseline  9 months 18 months  
IW IW IW
DW DW DW
 
Attack frequency (median and 
range)
  20  (5-720)                                 
12 (6-12)
 2 (0-295)                                   
6 (0-100)
1  (0-60)               
4 (0-32)
Attack free  0/14                                 
0/11
3/14(21%)                      
3/11(23%)
7/14(50%)               
3/11(27%)
Use of emergency medication 6/14(43%)                    
4/11(36%)
0/14*                             
4/11(36%)
0/14                      
0/11
Use of emergency services for NES 3/14(21%)                    
5/11(45%)
1/14(7%)                       
3/11(23%)
0/14                           
0/11
Use of emergency services for 
other than NES 
10/14 (71%)                  
8/11(2%)
4/14(28%)                    
4/11(36%)
0/14                          
0/11
Working 2/14(14%)                       
0/11       
2/14(12%)                      
0/11                         
4/14*(28%)                  
0/11         
Receiving  state benefits 11/14(78%)                  
10/11(91%)
11/14(78%)                
10/11(91%)
9/14 (64%)              
8/11 (72%)
 
Inspection of the data in figure 5.3 (below) shows a sustained increase in the 
number of patients achieving >50% reduction of attacks throughout the study. 
This improvement continues beyond the controlled phase, and is particularly 
noticeable in the IW group by the end of the study, although this difference is 
not statistically significant (p=.700). As shown in figure 5.4 at the end of the 
controlled phase (9months) both groups had a similar proportion (IW 21% vs 
DW 27%) of patients who had achieved full remission status for at least two 
months. Interestingly, at the end of the extension phase, the number participant 
numbers had doubled under IW (50%), suggesting some enhanced effect in the 
longer term that was not evident in DW (27%) at that time point. Formal 
analysis, however, did not support this visual impression (p= .076).  
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Figure 5.3: Changes in percentage of patients with > 50% reduction of attacks between IW and 
DW group at main end points.  
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Figure 5.4: Changes in percentage of attack free patients between IW and DW group at main 
end points.   
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In terms of health care utilisation, at baseline a similar proportion of patients in 
both groups received antiepileptic emergency medication to control their 
attacks, at 9 months however no patients from the IW group were using 
emergency medication compared with 4/11(36%) patients in the DW group, 
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representing a statistically significant difference (p=0.026). This effect 
disappeared by the end of the replication phase when all patients were off AEDs 
and no patient in either group was receiving antiepileptic emergency 
medication.   
 
A similar pattern of improvement was observed in the use of emergency 
services due to PNES related symptoms, although in this case the difference 
between groups at 9 months was not statistically significant. By the end of the 
replication phase again no patients were using emergency services because of 
their attacks.   
 
The use of health care services for other chronic symptoms remained stable 
throughout the study in both groups. Only a small percentage of patients (IW: 
3/14 -21%, DW; 2/11-18%) presented to medical services with new symptoms 
arising since the start of the trial at 9 months, by the end of the study, however, 
no use of medical services for new symptoms were reported in either group. 
 
5.4.2.3. Psychosocial outcomes  
 
In terms of social outcomes, little change was noted in either group by the end 
of the controlled phase. At the end of the replication phase, the number of 
subjects receiving state benefits and the reported level of disability due to PNES 
were reduced in both groups. We observed a change in working status for the 
IW group (4/14, 28%) at the end of the study, which was significantly greater 
than the DW group where no patients were employed.  
  
From the psychological rating scales, the HADS mean scores for anxiety were 
at the lower end of mild (>10) in both groups at baseline and remained at the 
same level throughout the study (see table 5.5)  
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Table 5.5: HADS scores over the three assessment points, between groups.  
       Baseline      9 months     18 months 
IW                DW IW          DW IW          DW
Anxiety 
Mean -SD 10.9              9.9 8.7          8.1 10.0           9.5
(6.4)            (3.4) (4.4)      (4.3) (3.2)       (3.4)
Depression 
Mean –SD 9.0                 6.2 6.2          7.5 6.9            7.0
(5.5)            (4.0) (4.8)      (3.5) (3.5)       (3.8)
 
 The mean scores for depression appear to improve for the IW group by the end 
of the control phase as opposed of the DW group were the score increased 
slightly, however this was not statistically significant. 
 
As shown in table 5.6, the only statistically significant difference detected on the 
SEALS questionnaire, was the significantly higher number of patients from the 
DW at the end of the controlled phase (who were still on medication) 
complaining of tiredness. By the end of the replication phase (18 months), when 
all patients were off AEDs, the scores in the DW group were lower and not 
significantly different from the IW group. For the rest of the domains there were 
no significant differences between the two groups throughout the study. 
 
Table 5.6: SEALS scores for the three assessment points, between groups. 
  Baseline   9 months 18 months 
  IW         DW IW          DW IW         DW
Worry   8          7.9 7.7              6.3 8             7.6
(Mean-SD) (2.8)     (4.9) (2.4)         (3.5) (2.5)      (2.6)
Cognition  25.8       24.9 24.2         31.2 26.3       26.8
(Mean-SD) (12.6)      (11) (12.1)      ( 7.6) (12)      (12.9)
Temper   7             6 7.2            6.4 6.6         6.2
(Mean-SD) (3.7)       (3.1) (3 )          (3.3) (3.5)     (3.2)
Tiredness  7.6           9.2 7.1 *         10.6 9.2         8.2
(Mean-SD) (3.9)       (4.7) (4.1)        (3.8) (3.5)      (4.7)
Dysphoria 9.5         10.9 8.7            9.4 11.3       11.4
(Mean-SD) (5.2)       (3.3) (4.7)         ( 4) (3.8)     (3.2)
*P<0.05
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As illustrated in Table 5.7, the domains from the IPQ that reflected an internal 
locus of control (attacks caused by; stress, state of mind, own behaviour) 
increased in both groups throughout the study, this increase was statistically 
significant for the IW group by the end of the replication phase, where more 
subjects were attributing their attacks to their mental state (p=0.005). At that, 
point, a higher proportion of subjects in the IW group which had been off 
medication for 18 months were also attack free. For the remaining domains of 
the IPQ there were no statistically significant differences between groups.  
 
Table 5.7: IPQ scores for the three assessment points, between groups. 
 Baseline   9 months 18 months         
IW                    DW                 IW                   DW                   IW                     DW                
Number of symptoms 8.3(2.2)          7.3(2.5) 7.4(4.3)             8(2.4) 6.6(4.2)           5.2(3.5)
External locus of control 14.6(5.6)       16.3(4.7) 14.4(4.5)        14.7(4.4) 14,3(4.9)        14.4(3.6)
Internal locus of control 8(3.4)              8(2.6) 10(2.4)               9(3.4) 11.2(1.8)         8.3(2.8)
Control cure 3(0.4)              3(0.2) 3.1(0.7)          3.2(0.6) 2.5(0.8)           2.7(0.3)
Consequence 3.8(0.7)          3.3(0.8) 3.4(6.5)          3.4(6.0) 3.3(0.7)             3.2(1)
Time line 3.1(0.4)            3(0.5) 2.7(0.5)            3(0.3) 3.4(0.8)            3.2(0.7)
 
 
 
 
5.5. Discussion 
 
This is the first controlled trial aimed at determining the possible therapeutic 
effect of scheduled AED withdrawal at the time of diagnosis of PNES (Bodde et 
al, 2009). Our hypothesis was that immediate AED withdrawal would enhance 
the therapeutic benefit of clear and unambiguous delivery of the diagnosis.  
 
Our hypothesis was partially confirmed by statistical differences between the 
pattern and extent of reduction in attack frequency in the IW group relative to 
the control group. These effects however, have to be seen in the context of 
overall benefit in giving the diagnosis clearly in the first place. 
 
A tentative suggestion could be made that the co-delivery of the diagnosis and 
medication withdrawal resulted in a statistically significant and persistent fall in 
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attack frequency manifested over the course of the study as compared to the 
group where the interventions were delivered separately. 
 
Clinical improvement throughout the study was observed and by 18 months all 
but one of the patients in the IW group had a >50% reduction and half were 
attack free which represents a good outcome when compared with current 
literature (29%-52%) including a pilot study evaluating the impact of Cognitive 
Behaviour Therapy as a treatment for PNES (Ettinger et al, 1999b; Reuber et al, 
2003a; Goldstein et al, 2004) 
 
Our other clinical outcome measures provide some clearer suggestion of an 
effect of AED withdrawal following the delivery of the diagnosis of PNES. The 
use of emergency services for PNES dropped to zero in the IW and DW group, 
as did the use of emergency AEDs; this change was noted earlier in the IW 
group and in the case of use of emergency AED, the difference between groups 
was significant. This is consistent with our previous study which also showed a 
drop in use of emergency services following the diagnosis and AED withdrawal 
which was also independent of continuation of the attack disorder (McKenzie et 
al, 2009). 
 
This reduction in demand for emergency healthcare suggests a change in 
attitude of the attacks themselves, on the part of carers if not patients. A 
possible explanation could be that the withdrawal of medication has the effect of 
discouraging ‘medicalisation’ of symptoms. Another important point is the 
potentially detrimental effect of health care contacts in this group of patients 
(Barsky & Borus, 1999). A reduction of contacts may therefore be beneficial in 
the long term; however this issue requires further study. 
 
There exists a concern that patients who cease have will go on to develop new 
somatic complaints. Our data are reassuring in this regard since only a minority 
of patients in each group presented with new symptoms, all of which had 
resolved buy the end of the study. 
 
Occupational status is poor in patients with PNES, and existing evidence 
suggests it remains so even in patients whose attacks cease to be dependent 
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(Quigg et al, 2002; Reuber et al, 2003a) and our relatively short-term data is 
consistent with this. 
 
At the start of the study all our patients were taking AEDs which are known to 
have mood stabilising effects and are routinely used to treat emotional 
dysregulation and affective disorders (LaFrance, 2007). One possible outcome 
of the AED withdrawal would therefore be exacerbation of anxiety and 
depression. The HADS scores however remained stable for both groups 
throughout the study.  
 
As might be expected the SEALS tiredness scores at 9 months were 
significantly higher for the DW patients who were still on medication. This 
finding is an example of the negative impact that medication has in these 
patients. 
 
One of the hypotheses behind the study was that removing medication would 
enhance the message that PNES are not a result of a neurological condition 
and change patients illness attributions. Patients’ perception that the cause of 
their attacks was due to stress increased steadily in the IW group becoming 
significantly higher at the end of the study, reflecting a greater internal locus of 
control. For the rest of the IPQ results, it is difficult to draw conclusions because 
of the potential for multiple testing effects. Importantly none of the small 
changes in scores throughout the study reflected deterioration.   
 
5.5.1. Methodological considerations 
 
This study was conceived as an exploratory trial which could inform future 
research in a field lacking in evidenced-based treatments and we are therefore 
aware of the limitations of the study, particularly our small sample size (n=25). 
This was on the other hand a pragmatic trial conducted within a busy regional 
epilepsy service which potentially makes our experience and results relevant to 
other epilepsy units. 
 
Despite a high patient through-put, our difficulty in recruiting participants can be 
partly explained by the fact that our inclusion criteria were very strict; however 
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we deemed the robustness of the diagnosis of PNES essential in terms of the 
validity of the study.  
 
Retention was on the other hand very high, possibly reflecting the effort of the 
investigators to keep as many patients as possible by using a proactive and 
flexible approach regarding appointments. There is no doubt that from that point 
of view all our subjects received a great deal of attention which may have 
influenced the outcome, particularly in a group of patients that often feels 
rejected and misunderstood by physicians (Mokleby et al, 2002; Carton et al, 
2007) 
 
The fact that the groups were small was problematic, particularly considering 
that we were testing the effect of a single intervention in a group of complex and 
heterogeneous patients (Lesser et al, 2003; Cragar et al, 2005; Baslet et al, 
2010). We tried to minimize this variability by comparing our groups at baseline 
not only on demographic data but also other factors which had shown to 
influence the outcome of patients with PNES in previous observational studies 
and in all these aspects both groups were very similar. 
 
An important factor to consider in terms of the effect of our main intervention is 
that in our daily practice, we positively emphasise and explain the importance of 
withdrawing medication to all patients as a crucial step to a complete recovery. 
In order to assess the impact of this intervention and to randomise and consent 
patients we had to be neutral when discussing the effects of medication 
withdrawal, therefore diluting the message of the importance of coming off AED 
and possibly reducing impact of the intervention. 
 
Recruitment and retention, the heterogeneity of the patients, controlling for 
Hawthorne effects and choice of adequate outcome measures were all 
methodological issues we encountered. Reassuringly, La France et al., in their 
report of their pilot study for a treatment trial of PNES, describe very similar 
difficulties and make some recommendations for the success of future research 
(LaFrance et al, 2007). 
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5.5.2. Ethical considerations 
 
The ethical implications of leaving subjects with NES on AEDs for 9 months 
after the diagnosis, was discussed extensively by the team. We were clear in 
the fact that our study was designed to compare two pragmatic management 
alternatives and although it is our feeling that patients with PNES should not be 
maintained on AEDs, in practice they often are to the point that it constitutes 
treatment as usual for many physicians (Reuber et al, 2003b; O’sullivan et al, 
2007; Hall-Patch et al, 2010).  
 
 
5.6. Conclusions 
 
Our research represents a methodologically rigorous attempt to evaluate an 
intervention on the management of these very complex patients and represents 
an important contribution to the very few studies designed to test a specific 
management strategy for PNES. 
 
The present study may be regarded as an exploratory exercise and as such has 
provided a suggestion that withdrawing AED enhances the effect of a clear 
delivery of the diagnosis. This effect is reflected in a persistent reduction in 
attack frequency and a cessation of the use of emergency services and 
medication following AED withdrawal. Importantly, none of our data show any 
negative effects.  
 
. 
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Chapter 6: 
 
 
Psychosocial outcomes of patients with psychogenic nonepileptic seizures 18 
months after diagnosis  
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6.1. Abstract  
 
Background: Psychogenic nonepileptic seizures (PNES) are psychologically 
mediated attacks that resemble and are often mistaken for epilepsy. The 
evidence base regarding the management of PNES is limited; however, clinical 
consensus increasingly supports a clear communication of the diagnosis 
followed by medication withdrawal as the first management step. 
 
Aims: To assess the longer term psychosocial outcomes of AED’s withdrawal in 
a group of patients with PNES. 
 
Methods: The current study is an observational extension of a pragmatic 
randomised trial comparing the clinical outcomes of PNES patients randomised 
to immediate (IW) versus delayed withdrawal (DW) of AED following the 
diagnosis. Comprehensive psychosocial data for the whole sample was 
collected at baseline and 18 months latter when all subjects were off AED’S  
 
Results: We found significant changes in illness perception with a reduction in 
reported symptoms, a shift towards a more internal locus of control and fewer 
patients reporting a chronic view of PNES. Patients’ mood also improved with 
significantly lower depression scores at the end of the study. For the social 
outcomes we detected a significant improvement in self reported level of 
functioning as well as an almost significant reduction of patients receiving state 
benefits because of PNES only. Employment status did not change from 
baseline. 
 
Conclusion: A clear delivery of the diagnosis of PNES followed by AED 
withdrawal is successful in removing the label of epilepsy, helping patients to 
shift towards a more psychologically based explanation without negative effects 
on their psychosocial status. 
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6.2. Introduction 
 
Psychogenic non epileptic seizures (PNES) are paroxysmal events that 
resemble or are mistakenly ascribed to epilepsy, without being associated with 
epileptiform discharges in the brain. Non epileptic attacks are relatively common 
and represent a significant part of the workload of epilepsy specialists and other 
physicians (Martin et al., 1998). An underlying psychological process is often 
assumed but whether causal or not, patients presenting with PNES certainly do 
describe high levels of associated psychopathology, with depression and 
anxiety being most frequently reported (Bowman & Markand, 1996; Moore & 
Baker, 1997; Mokleby et al., 2002; Bailles et al, 2004; D’Alessio et al, 2006). 
Their experience of disability, unemployment and receipt of benefits is just as 
high as in patients with epilepsy (Szaflarski et al, 2003; Hixson et al, 2006).   
 
The purpose of this study is to present the 18 month outcome of a consecutively 
and prospectively recruited series of patients with a video EEG confirmed 
diagnosis of PNES, and who underwent a planned withdrawal of medication and 
subsequent brief psychological therapy. 
 
6.2.1. Background and rationale for this paper 
 
Increasing awareness of the diagnosis of PNES and the introduction and 
subsequent wide availability of simultaneous video EEG has substantially 
improved the accuracy of diagnosis and the differentiation between PNES and 
epilepsy (Cragar et al, 2002). The same cannot be said for prognosis and 
management (LaFrance & Devinsky, 2004). Most available treatment studies 
are methodologically poor, and difficult to interpret, and give little support to a 
single overarching rationale or approach. However, one area of growing 
consensus within the literature is the acceptance that the initial step of 
communicating the diagnosis effectively can in and of itself have substantial 
therapeutic efficacy.  Communicating the diagnosis in a clear and unambiguous 
way has been shown to help patients understand and ultimately accept the 
diagnosis, an essential prerequisite of future engagement with any potential 
therapeutic intervention, whatever its form and rationale (Shen et al, 1990; 
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Farias et al, 2003; Hall-Patch et al, 2010).. 
 
Most patients with PNES are originally diagnosed as having epilepsy and 
treated with AED. AEDs have deleterious effects on physical health and 
psychological well-being and their inappropriate prescription courts substantial 
iatrogenic harm (Niedermeyer et al., 1970; Howell et al., 1989; DeToledo et al., 
2000; Peruca & Meador, 2005). Over and above this, however, the fact of being 
prescribed AED may amplify and reinforce illness perceptions towards 
‘organicity’ and attenuate and undermine the message that NES is a ‘non-
organic’ disorder, perhaps militating against the patient’s engagement with 
behavioural or cognitive treatments designed to help them gain insight into or 
control their attacks (Jacoby et al., 1992; Carton et al., 2003).  Observational 
work (Reuber & Elger, 2003c) suggested an association between remaining on 
anticonvulsants post diagnosis of PNES and a poor prognosis and the RCT 
described in the previous chapter confirms the specific efficacy of diagnosis and 
medication and medication withdrawal as an intervention in PNES. 
 
Although attack reduction or cessation is the goal of treatment, there is a lack of 
consensus as to what might constitute a good outcome. Although reduction or 
cessation of attacks has obvious face validity and is easily and reliably rated as 
a measure of the ’disorder’, it may not translate into or correlate with broader 
psychosocial recovery (Quigg et al, 2002; Reuber et al, 2005).   
 
Studies of PNES have been criticised for their over narrow concentration on 
seizure frequency as an endpoint (Reuber et al., 2005; LaFrance et al., 2008). 
There is also evidence from studies looking at recovery beyond reduced seizure 
frequency that report ongoing psychological morbidity and poor social 
functioning even when a significant proportion of patients report a reduction or 
cessation of attacks. (Quigg et al, 2002; Reuber & Elger, 2003c; McKenzie et al, 
2009). 
 
In summary, the evidence-base regarding the management and outcome of 
PNES is limited, but the converging imperatives of good practice and clinical 
consensus regarding the clear communication of the diagnosis and early 
withdrawal of medication, are beginning to find a level of support in 
observational studies (Shen, 1990; Farias, 2003; Thompson, 2005; Hall-Patch 
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et al., 2010) as well as the experimental work described elsewhere in this 
thesis.  
Following on from the RCT described in chapter 5 the purpose of this paper is to 
present the longer term psychosocial outcomes in 24 prospectively recruited 
patients with PNES following their exposure to a consistent and thorough 
diagnostic assessment and management strategy. 
 
6.2.2. Aims of the study  
 
To assess the longer term psychosocial outcomes of AED’s withdrawal in a 
group of patients with PNES. 
 
6.2.3. Research questions 
 
Are there any significant changes in patient’s mood following AED withdrawal? 
 
Are there any significant changes in patients well-being following AED 
withdrawal? 
 
Are there any significant changes in patient’s attribution and representation of 
PNES following the withdrawal of AED’s? 
    
6.3. Methodology 
 
The current study is an observational extension of a pragmatic randomised trial 
comparing the clinical outcomes of PNES patients randomised to immediate 
(IW) versus delayed withdrawal (DW) of AED following the diagnosis of PNES. 
Delayed withdrawal took place at 9 months following diagnosis. The current 
study presents a cohort comprising the subjects from both arms when all 
patients had been off medication for at least 6 months following the gradual 
withdrawal of AED’s. 
 
The trial was based at the Glasgow PNES clinic in the Institute of Neurological 
Sciences at the Southern General Hospital between April 2001 and December 
2003. Patients are referred from a wide variety of sources throughout the West 
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of Scotland (total population 2.7 million). Full details of the research protocol 
can be found in appendix H. 
 
6.3.1. Management (intervention) 
 
The diagnosis of PNES was confirmed by video EEG and explained in a clear 
and supportive manner, this was backed up with written information to ensure 
that all the same points were covered (see appendix J for scripts of the visits 
and patient information).  
 
As detailed in chapter 5, all patients were seen 3 monthly to monitor medication 
withdrawal and assess progress. In terms of psychological intervention, 
following the diagnosis, all subjects were given the option to attend a clinical 
psychologist for up to 6 sessions of a Cognitive Behaviour Therapy based 
intervention. 
 
All participants were offered an appointment with one of the two psychologists 
of our service; the referrals were allocated alternatively to psychologist A or B. 
All subjects were seen within four weeks of referral and had at least two visits 
during the first 9 months of the study. 
 
The team psychologists delivered a cognitive behaviour therapy (CBT) based 
treatment, with an initial session focusing on the acceptance and understanding 
of the diagnosis, subsequent sessions dedicated to identifying triggers for the 
attacks, possible stressors and relaxation training with a final session to review 
the therapeutic intervention and discuss relapse prevention techniques. 
Because of the limited availability of clinical psychologists subjects were offered 
a minimum of 2 fortnightly sessions and a maximum of 6.     
 
At the start of the study all patients were on AED medication since this was one 
of the inclusion criteria and by 18 months all participants had been gradually 
withdrawn as part of the management plan. 
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6.3.2. Measures 
 
This paper focused on; psychological and general health outcomes as 
measured by the IPQ, HADS and SEALS, and social and occupational status 
and adjustment as indicated by proxy measures such as employment, receipt of 
benefits and perceived functional status. Because of time and personnel 
constraints all scales were self reported.    
 
Clinical outcomes as attack frequency, as measured by a diary and health care 
utilisation are reported in detail in Chapter 5.  
 
All scales were completed at baseline, 3 monthly follow up and upon study 
completion, scored by a research assistant and the results concealed from the 
primary researcher and those involved in administering psychological treatment 
until the end of the study.   
 
The scales were as follows:   
 
6.3.2.1. Seizure diary  
To record attack frequency subjects were given a standardised diary designed 
specifically for the study. The reason for creating our own attack diary was to 
ensure that it contained no reference to epilepsy or epileptic seizures which 
could potentially send mixed messages and affect patient’s view of the attack 
disorder. The diary was completed based on self report and carer and relative 
comment (see appendix O). 
 
6.3.2.2. National Adult Reading Test (NART-2nd edition) 
 
A list of 50 irregularly spelled words is read aloud by participants, and scored for 
pronunciation errors to determine a predicted full scale IQ. Subjects with a score 
lower than 70 were not included. 
 
An IQ within the normal limits was one of the inclusion criteria for the trial. As 
well as ensuring that all subjects had the capacity to understand there is also 
evidence that patients with a low IQ have a distinct underlying mechanism for 
PNES (Duncan et al, 2008). 
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6.3.2.3. Side Effects and life satisfaction inventory (SEALS; Brown & Tomlinson, 
1982) 
 
This inventory is a 50 item self reported questionnaire derived from, designed 
for, and validated in subjects with epilepsy which is sensitive to change over 
time. In general terms it corresponds to a measure of well being and physical 
and psychological health with particular reference to the day to day problems 
and drug side effects reported by patients with epilepsy. The scale was derived 
from symptoms and side effects reported by patients, with principal component 
analysis identifing five main areas of difficulty; “cognition” ,”dysphoria” ,”temper”, 
“tiredness” and “worry”. Each subscale contains a series of positively and 
negatively phrased items with a four point response matrix between 0 and 3 
with 0 being “never” and 3 “many times”. 
 
The SEALS inventory has been found to have the qualities of validity, reliability 
and responsiveness to be used in research and clinical settings. The scale has 
a good internal consistency with a Cronbach’s coefficient >0.7 for all subscales. 
It is a valid tool to investigate and monitor the effect of AED therapy on quality of 
life and to measure changes in patient’s well-being in response to changes in 
management (Gillham et al, 2000). 
 
This scale, although originally designed for patients with epilepsy, seemed the 
most appropriate tool to assess potential changes following the withdrawal of 
AED as part of the management of PNES. 
 
6.3.2.4. Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 
1983). 
 
The HADS was developed to identify possible cases of anxiety and depression 
amongst patients in non-psychiatric hospital clinics and to monitor mood 
changes over time. To avoid confounding by physical illness, the symptoms of 
anxiety and depression relating to physical illness were excluded from the 
questionnaire. The HADS is a self-report scale comprising of 14 items that 
probe aspects of depression and anxiety in the past 7 days. The scale can be 
divided into two subscales (anxiety and depression), with higher sum scores 
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indicating more anxiety and depression. Scores <8 indicate the normal range, 
scores between 8 and 10 reflect mild symptoms and scores >11 indicate 
clinically relevant symptoms. The scale has a sensitivity of 83.3% and specificity 
of 61.5% for identification of psychiatric cases. The HADS has similar screening 
properties when compared with more comprehensive instruments used to 
identify anxiety and depression (Bjelland,   2002). 
 
6.3.2.5. Illness Perception Questionnaire (Weinman et al 1996) 
 
This provides a quantitative assessment of the five components of illness 
representation derived from Leventahl’s Self-Regulatory Model. The model 
proposes that symptoms generate and are interpreted and acted upon via an 
overarching cognitive and emotional representation of the illness. The scale is 
divided into 5 subscales:  
 
• Identity: the label the person uses to describe the illness and symptoms 
they view as being part of the disease.  
• Consequences: the expected effects and outcome of the illness. 
• Cause: the patient’s idea about the cause of their illness.  
• Time-line: patient perception of how long the illness will last. 
• Control: the extent to which the person will recover or control the illness. 
  
The first subscale is Illness identity and comprises 12 core symptoms that 
patients rate for frequency on a four point scale, ranging from all the time to 
never. The cause subscale can be subdivided into attribution to external factors 
(germ or virus, pollution, hereditary factors, poor medical care and chance) and 
internal factors (stress, my state of mind, own behaviour, other people had a 
role).The other three subscales included a series of statements related to time 
line, consequences or control. The individual items are scored on a 1-5 scale 
indicating the strength of the agreement with the individual statement with 
higher scores indicating stronger agreement. An average score of the individual 
items is obtained. 
 
For the time-line subscale, higher scores represent beliefs that the illness will 
last a long time, higher scores on the consequence subscale reflect a belief of 
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greater consequences and, finally, higher scores for the control-cure subscale 
reflects patients’ impression of lack of control. 
 
This early version of the IPQ has been found to have a good re-test reliability 
and internal consistency (Cronbach’s Alpha >0.7) as well as discriminant and 
predictive validity (Weinman & Petrie, 1997). 
 
6.3.3. Statistical analysis 
 
The evaluation of the data was performed with the computer program SPSS for 
Windows version 14.  
 
A descriptive analysis of the data for continuous variables (i.e. IPQ, HADS and 
SEALS) showed that the results were essentially normally distributed (as 
assessed by kurtosis and skewedness, with both metrics lying between -1 and 
+1), paired t-tests were therefore used throughout. Sensitivity analysis via 
equivalent non parametric tests did not significantly alter the results. To 
maximise ecological validity social functioning data was captured as a series of 
real world dichotomous outcomes such as employed vs. unemployed, analysed 
using McNemar’s test. Finally a post hoc analysis was conducted for all 
outcomes for the grouping / predictor variable of attack freedom, using 
independent t tests or Fishers test as appropriate to assess for any difference in 
baseline or outcome for those subjects demonstrating attack freedom.  
 
For all statistical analyses a p value <.05 was considered statistically significant. 
Outcome data were also presented after correcting for multiple testing using the 
Bonferroni correction.  
 
One of the patients (1/25, 4%) randomised to immediate withdrawal was lost to 
follow up after the second control visit; all their data has been excluded from 
analysis subsequent to this point. 
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6.4. Results 
  
6.4.1. Demographics and baseline characteristics 
 
The mean age of the subjects at presentation to the clinic was 41 years (sd 
14.4), ranging from 16 to 65. The majority of patients were female (20/25, 80%) 
and 17 /25 (68%) had a partner or were married. All patients were on 
medication as it was one of the entry criteria with a median number of AED of 1 
ranging between 1 and a maximum of 3.  
 
The mean IQ as estimated by the NART was 99.6(sd 8.4), ranging between 80 
and 115. At baseline, 14/25(56%) patients had previous contact with psychiatric 
services and 8/25(32%) were prescribed an antidepressant. Five out of the 
twenty five patients (20%) had previously attracted a diagnosis of personality 
disorder, 7/25 (28%) reported other chronic physical symptoms, and 8/25(32%) 
disclosed a history of sexual abuse.  
 
In terms of the psychotherapeutic intervention, 4/25(16%) subjects declined to 
see a psychologist and the rest had a median of 3.8 sessions (range 1-8). At the 
end of the study 4/10 of the attack-free patients and 5/14 had managed to 
complete the 6 sessions, this was not statistically significant (McNemar test 
p=0.26).   
 
At baseline the median attack frequency was 20 per month (range 5- 700); as 
compared to 2 per month (range 0- 60) at the end by which time 10/24 (41.6%) 
patients had been attack free for at least 2 months. Following drug withdrawal 
no patient was in contact with the emergency services or had received acute 
anticonvulsant treatment, a significant reduction of healthcare utilisation 
compared with baseline (p< 0.002). 
 
One of the patients (1/25, 4%) randomised to immediate withdrawal was lost to 
follow up after the second control visit, all their data has been excluded from 
analysis subsequent to this point. 
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6.4.2. Psychological outcomes 
 
As shown in Table 6.1, the mean scores for anxiety and depression at baseline 
were within the mild range. There were no significant differences between the 
HADS scores of the 8 patients on Antidepressants and the rest of the sample at 
baseline. By the end of the study the mean score for depression had decreased 
significantly (p=0.05) with a mean within the normal range. 
 
Table 6.1: Comparison of the mean(sd) scores on psychological outcome measures between 
baseline and end of the study at 18 months.   
At presentation At 18 months 
Mean (sd) Mean (sd)
HADS
SEALS
Worry 7.7 (3.9) 6.7 (2.5) 0.89
Temper 6.6 (3.4) 6.8 (3.1) 0.67
Cognition 24.9 (11.7) 26.5 (3.5) 0.68
Tiredness 8.3 (4.09) 8.6  (4.3) 0.66
Dysphoria 10.1 (4.5) 9 (4.3) 0.25
IPQ
7.8 (2.4) 5.9 (3.9) 0.03*
External locus of 
control 15.4 (5.2) 14.4 (4.3) 0.4
Internal locus of 
control 8 (3) 10 (2.7) 0.01*
Paired T test ,* P< 0.05
0.14
Control 3 (0.5) 3.3 (0.8) 0.15
Consequences 3.5 (0.8) 3.2 (0.8)
0.05
Number of reported 
symptoms
Time line 3 (0.3) 2.6 (0.6) 0.01*
Depression 8.5 (4.9) 6.7 (3.5)
p - value
Anxiety 10.5 (5.3) 9.8 (3.2) 0.5
 
  
 
Despite withdrawal of medication we did not detect any significant changes in 
the SEALS scores between baseline and the end of the study. 
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As shown in Table 6.1, the IPQ scores significantly decreased from baseline for 
several domains; at 18 months there was a significant reduction in number of 
symptoms reported, measures reflecting a higher internal locus of control had 
improved and patients were less likely to perceive their disorder as chronic. 
 
6.4.3. Social outcomes 
 
At baseline 3/25 (8%) subjects were working or in full time education and 
22/25(88%) were unemployed and on disability benefits (see table 6.2). 
 
Table 6.2: Comparison of social functioning outcome data from baseline to end of the study at 
18 months.  
At baseline At follow up p
Employment status: Working 2/25(8%) 4/24(16%) 0.50
On social security benefit
No 4/25(16%) 8/24 (33%) 0.25
Yes for NES 7/25(28%) 2/24 (8%) 0.06
Yes for other 14/25(56%) 15/24 (56%) 0.22
Able to attend clinic alone 5/25 (20%) 10/24 (40%) 0.18
Level of activity
Premorbid level 0/25 8/24 (32%) 0.008*#
Limited by NES 13/25(52%) 7/24 (28%) 0.22
Limited by other 12/25 (48%) 10/24 (40%) 0.62
McNemar test ,* P<0.05
# remained sig. after Bonferroni correction
 
In terms of previous occupation, most patients had unskilled jobs (14/25, 56%) 
and 3 patients had never worked. Interestingly 5/25 (20%) patients had jobs in 
social care, four as care assistants and one as a nursery nurse. At 18 months, 
three patients moved on to further education; one subject started a psychology 
degree and the other two a nursing a degree. One patient had stopped working; 
however, 3 had managed to get back to employment by the end of the study. 
  
Seven patients in the study were awarded benefits only because of the attacks 
and based on an initial diagnosis of epilepsy. At the end of the study, only two of 
these 7 patients were still receiving benefits, this reduction showing a trend 
towards significance (p = 0.06). As shown in table 6.2, measures of dependence 
also improved with twice as many people able to attend the clinic alone and a 
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significant higher number of subjects reporting levels of daily activity back to a 
pre morbid level.   
 
6.4.4. Post-hoc analysis of attack free patients 
 
At outcome, and as presented in table 6.3, subjects who were attack free were 
compared with the remainder on psychosocial outcome to investigate any 
relationship between attack freedom and broader measures of recovery. 
 
Table 6.3: Post-hoc analyses comparing attack or not attack free patients with all outcomes 
which significantly changed from baseline .    
Attack Free patients Non-Attack Free p-value
Depression scores (HADS), Mean (sd) 4.9(2.9) 5.6(2.1) 0.01*
Number of reported symptoms (IPQ), Mean 
(sd)
4.2(4.1) 7.2(3.4) 0.05*
NES seen as chronic, Mean (sd) 2.2(0.6) 2.9(0.4) 0.03*
Internal locus of control (IPQ), Mean (sd) 9.4(2.8) 10.8(2.4) 0.23
Attribution to stress, Mean (sd) 2.4(1) 2.9(1.1) 0.35
Pre-morbid level of activity 1/24(%) 7/24(%) 0.01*
On benefits because of NES only 2/24(%) 0/24(%) 0.58
 
 
Patients in the attack free group had lower scores of depression as assessed by 
the HADS questionnaire; were reporting lower number of symptoms; and were 
less likely to regard their condition as chronic. There were no differences 
between groups in terms of locus of control. 
 
In terms of the social outcomes, attack free patients were more likely to report 
activity at a pre-morbid level but there were no significant changes for receiving 
benefits because of PNES. Only a small number of patients had been on 
benefits purely because of PNES, and although this number clearly fell in 
absolute terms there was insufficient power to demonstrate this statistically.   
 
6.5. Discussion 
 
These results are encouraging because they show a significant improvement 
from baseline on a number of psychological and social functioning measures. 
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However, when looking at these results, in the context of the 40% of attack free 
patients 18 months after the diagnosis, these changes appear modest. 
 
Our results are in line with other outcome studies reporting limited improvement 
of  social functioning variables at follow-up (Quigg et al, 2001; Reuber et al, 
2005; Kuyk et al, 2008). Poor social outcomes have also been reported in other 
medically unexplained symptoms (Stone et al, 2003; Sharp et al, 2010).  
     
We found significant changes in illness perception with a reduction in reported 
symptoms, and a shift towards a more internal locus of control as well as 
significantly lower depression scores at the end of the study. For the social 
outcomes we found a significant improvement on a self reported level of 
functioning, as well as an almost significant reduction of patient receiving state 
benefits because of NES only. Employment status on the other hand did not 
change significantly from baseline. 
 
Considering the nature of our intervention, an important outcome of this paper is 
the fact that by the end of the study none of our patients had been restarted on 
AED. Re-introduction of AED in this group of patients is not uncommonly 
reported and has been linked with a lack of acceptability of the diagnosis by 
patients, carers and GP’s (Lempert et al, 1990; Walczak et al, 1995; Jongsma, 
1999; O’Malley, 2000). Accepting the diagnosis of PNES is in itself important for 
engagement with future treatment (Sirven & Glosser, 1998; O’Malley et al, 
2000) and also has been associated with good prognosis (Ettinger et al, 1999). 
Our management appears therefore to have been successful in removing the 
label of “epilepsy” and helped patients to accept the diagnosis of PNES. 
 
6.5.1. Psychosocial outcomes  
 
At the end of the study the anxiety scores of the HADS had remained stable 
however the depression scores had significantly improved. Although a 
statistically significant change the clinical impact of the reduction of depression 
scores is modest if compared with the effect size expected in trials of 
antidepressants. 
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Interestingly the post hoc analysis showed that attack free patients were more 
likely to have lower scores of depression; it can be argued that the reported 
improvement of mood is a reflection of clinical improvement. This raises the 
question discussed by other authors of whether the attack disorder in itself is 
the cause or at least a significant factor contributing to the frequently reported 
depressed mood of patients with PNES (Bodde et al, 2008; Fiszman & Kanner, 
2010). 
 
We also need to consider the fact that the improvement in mood could also 
been a result of the attention given to the subjects as part of the study. As 
previously discussed by LaFrance, this effect may be a particular issue in this 
group of patients that frequently feel rejected or accused of pretending by health 
professionals (Green et al, 2004; LaFrance, 2007; Thompson et al, 2009).  
 
As part of our intervention, medication was withdrawn in all patients; 
continuation of AED however has been justified by some authors on the basis of 
the potential mood stabilising and impulse control effects of AED’s (Ettinger et 
al, 1999; LaFrance, 2008). Our results, however, show no deterioration in mood 
or behaviour following the withdrawal of AED. O’Sullivan et al. also found no 
differences when comparing outcomes between patients on AED with mood 
stabilising effects or not. Our view is that the benefits of withdrawing AED in 
patients with PNES outweigh any hypothetical benefits from continuing a 
medication originally prescribed for suspected epilepsy.  
 
In summary, we detected a significant improvement of the depression scores 
which may be a result of our intervention or other factors. The fact that 
withdrawal of medication did not result on a deterioration of mood is possibly 
more relevant in the context of our intervention and would support our 
management strategy. 
 
In terms of illness representation, we know that patients with PNES are likely to 
have a more external locus of control and are less likely to see stress as a 
relevant factor (Goldstein et al., 2000; Stone et al., 2004). Our study showed 
that by 18 months subjects, had a greater internal locus of control were more 
likely to attribute their condition to psychological causes and were less likely to 
see their condition as chronic. 
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The changes in locus of control and attribution however did not seem to 
translate into clinical improvement, since by the end of the study attack free 
patients did not have a higher internal locus of control when compared with non-
attack free patients. This finding was surprising since higher internal locus of 
control and reattribution to stress is an important objective of psychosocial 
interventions for PNES and used as markers of improvement (Goldstein et al, 
2004; LaFrance et al, 2009). Since all the patients from our study, were 
constantly advised that PNES were caused by stress, there is a possibility that 
the observed shift toward a psychological explanation partly reflects a response 
bias rather than a true change of insight. 
 
It is also interesting that the external locus of control did not change 
significantly; in fact the scores were low at baseline and remained low. It does 
not appear that the attribution changed for external causes to psychologically-
based ones. This scale’s validity was originally established in patients with 
chronic fatigue syndrome leading to items attributing illness to germs and 
pollution.  As such it is possible that this particular scale (IPQ) did not cover 
external factors of specific relevance to our group who would might be expected 
to attribute their condition to, for example, a neurological disorder (Weinman, 
1996).  
 
For a future longer term outcome study an important issue would be to 
determine weather reattribution to stress or mental state correlated with a real 
shift in locus of control and insight in patients with PNES. 
 
Finally, by the end of the study patients were less likely to see their condition as 
chronic, particularly for attack-free patients, which is intuitively appealing. 
Interestingly, a pilot study of CBT treatment with a similar number of attack-free 
patients showed no changes on the perception of chronicity (Goldstain et al., 
2004).  
 
A wider number of physical symptoms has been associated with poor prognosis 
of PNES (Reuber et al., 2004) and our results seem to corroborate this finding 
since by the end of our study, patients in the attack free group were reporting 
less symptoms when compared with patients that were still having attacks. 
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As part of our comprehensive psychological outcome measures, we were 
interested in the potential impact of AED. The negative impact of antiepileptic 
medication on the quality of life of patients with epilepsy is well documented 
(Jacoby et al., 1992; Perucca & Meador, 2005) and from that point of view 
patients with PNES treated with AED are exposed to the same potential side 
effects if not more.  
 
We used the SEALS questionnaire which is sensitive to medication changes; 
however, we found no significant differences. It is possible that the SEALS 
questionnaire which was designed for epilepsy patients was unable to detect 
any differences in a distinctly different group of patients with high levels of 
psychopathology, including disorders of personality and other somatic 
symptoms as chronic pain and fatigue (Devinsky, 1996b; Galimberi, 2003; 
Benbadis, 2005) 
 
 6.5.2. Social outcomes  
 
As reported by other authors the overall social outcomes of the study were poor 
(Reuber, 2003; O’Sullivan, 2007; Duncan & Oto, 2008; Kuyk, 2008). Some of 
the results, however, were encouraging, particularly the reduction of patients 
receiving state benefits because of PNES.  
 
A high proportion of patients with PNES receive benefits and this has been 
consistently reported as factor of poor prognosis. (Kristensen, 1992; Lempert, 
1999; Reuber et al., 2003b; McKenzie et al., 2009). Most outcome papers report 
the percentage of patients on social security benefits without any further details; 
however the reason for receiving benefits may have nothing to do with PNES. In 
this paper we distinguished between patients on social security because of the 
attacks only, or due to other reasons. 
  
One of the most interesting findings from the present study is the fact that Social 
security benefits were stopped for most of the patients reporting PNES as the 
only disability. Since all these patients were initially diagnosed with epilepsy and 
treated accordingly with AED, a firm diagnosis of PNES followed by the 
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withdrawal of AED appears to have removed the epilepsy label and the need for 
benefits.  
 
A significant number of patients also reported a return to the level of activity of 
before PNES, and these subjects were significantly more likely to be attack free. 
This improvement, however, has to be viewed with caution since the reported 
level of activity of many of our subjects had been very limited even before they 
developed PNES. 
 
6.5.3. Methodological considerations  
 
The current study has some methodological limitations and our findings need to 
be viewed with caution. The sample size was small, particularly considering the 
amount of statistical tests performed; we acknowledged this limitation and also 
presented the results correcting for multiple testing. However, given the 
exploratory and observational nature of the study, the aim was to detect 
potentially important differences in the first place by protecting against Type 2 
error. The results of the current research therefore require confirmation by an 
appropriately powered study.  
 
In terms of the characteristics of the sample, a potential confounder was the 
variation in chronicity amongst patients; there is evidence that the length of the 
disorder has an impact on outcome (Lempert, 1990; Buchanan, 1993; Walczak, 
1995) although this has also been disputed (McKenzie, 2010). It can also be 
argued that eighteen months may be too short a period to detect certain 
changes, particularly employment and benefit status (LaFrance et al., 2006). 
 
As part of our treatment protocol, all our subjects were offered up to 6 sessions 
with clinical psychologists, not all patients attended and only less than half 
completed the course. Although this was our TAU, when presenting the results 
of the whole group, the fact that not all patients had the same input in terms of 
psychotherapeutic intervention, was a potential confounder. 
 
We also acknowledge the fact that this paper is based on an original 
Randomised Controlled Trial investigating the effects of withdrawing AED in 
patients with PNES. 
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The main strengths of the present study on the other hand include; the accuracy 
of the diagnosis and the homogeneity of the sample in terms of management 
and length of follow up, which is a recognised problem for most outcome and 
prognosis studies on PNES (Bowman, 1998; LaFrance, 2007; Bodde et al, 
2008). Our sample represents a purer group of patients when compared with 
other larger studies (Reuber et al, 2003) since all patients had the diagnosis of 
PNES confirmed by video EEG and none had coexisting epilepsy. 
 
6.6. Conclusion 
 
With this paper we present psychosocial outcome data for a group of patients 
with PNES following a study design that overcomes some of the methodological 
problems encountered in other published studies, in terms of diagnostic rigour 
and sample homogeneity.  
 
Despite the methodological limitations, the results of this observational study 
are encouraging; including an improvement of depression scores, a shift 
towards a more internal locus of control, less restricted levels of activity and a 
significant reduction of the number of patients receiving Social Security benefits 
because of PNES only.  
 
Our main management strategy was based on the idea of diagnostic clarity and 
from this point of view we were successful in removing the label of epilepsy and 
shifting the focus to a more psychologically based explanation without 
destabilising the patients. 
 
Further research, with purposely designed studies, larger samples and longer 
follow up periods is still needed in this area. 
 
 
 
 
 
 
 
 125 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 7: 
 
 
Discussion 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 126 
7.1. Thesis findings: Summary 
 
The subject of AED in the context of PNES is increasingly recognised as an 
important issue and although discussed in many review and opinion papers, 
there is very little original research to confirm clinical opinion. The current thesis 
intends to investigate the effects of the continuation or withdrawal of AED in 
patients with PNES. The main findings are presented in table 7.1.  
 
Table 7.1: Key findings from current thesis.  
Chapter   Key Findings 
   
2  
A systematic review of the literature found three observational studies reporting the continuation 
of AED as a prognostic factor.  
  
Two papers reported association between continuation of AED and a poor prognosis and a third 
paper reported no effect. 
  
Due to important methodological problems in all three studies, we were unable to reach a 
conclusion. 
   
4  An observational outcome study on the safety of AED withdrawal in  patients PNES, showed: 
  
- 3/78 patients presented with new attacks (complex partial seizures) during withdrawal, but were 
fully controlled by the end of the study   
  - 4/78 were medically treated for prolonged attacks (significantly lower number) 
  - 14/78 reported new symptoms after AED withdrawal. 
  - No serious medical complications were reported  
  - At the end of the study there was a significant reduction of attack frequency 
   
5  
An exploratory Randomised Controlled Trial evaluating the possible therapeutic effects of  AED 
withdrawal: 
  - 25 subjects were recruited ,14 randomised to IW and 11 to DW 
  
- The IW group had a significant reduction of the use of emergency treatment for PNES, and a 
lower proportion was using emergency services when compared with the DW group. The IW group 
was less likely to report tiredness as assessed by the IPQ. 
  
- The IW had a sustained reduction of attacks throughout the study; by the end of the study 50% 
were attack free as compared with 27% in the DW group (NS). 
  - There was no evidence of clinical deterioration in the IW group or the DW group after   
   
6  
An observational study assessing the longer terms outcomes of  patients with PNES showed the 
following significant findings: 
  - Improvement of the depression scores of the HADS   
  
- Increase of internal locus of control and less patients reporting their condition as chronic as 
assessed by the IPQ  
  
- Less restricted levels of activity as well as a reduction in the number of patients receiving benefits 
because of PNES  
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Chapter 1 comprises the introduction of the thesis, which gives an overview and 
background to PNES. The introduction also starts to set the scene, with 
particular reference to the iatrogenic harm associated with the use of AED and 
the inappropriate medicalisation of PNES that may perpetuate symptoms and 
worsen prognosis. 
 
In chapter 2, a systematic review of the literature concludes that there is a lack 
of good quality research and, therefore, of any reliable evidence on the effects 
of AED treatment in patients with PNES, justifying the need for further original 
research in this area.  
 
Chapter 4 presents the results of a large observational study to establish the 
feasibility and safety of supervised AED withdrawal in patients with an 
established diagnosis of PNES. The conclusion of this study is that the 
withdrawal of AED is a safe intervention in terms of mortality and morbidity.  
 
To evaluate the potential therapeutic effect of AED withdrawal we next designed 
a randomised controlled trial which is presented in chapter 5. The results of this 
exploratory trial suggested a possible therapeutic effect of AED withdrawal, with 
a sustained reduction of attacks following the withdrawal of medication and a 
significant reduction in health-care utilisation.  
 
The last original paper, presented in chapter 6, investigates the longer term 
psychosocial outcome data on the whole group. The study reports significant 
improvement in some psychosocial measures and at the same time highlights 
some of the difficulties in assessing outcomes with current available measures 
in this heterogeneous group of patients. 
 
This last study also presents the results of a sample of patients subject to a 
rigorous diagnostic procedure, a standardized management, and with equal 
length of follow up time. These are unusual methodological features, and indeed 
strengths, over most of the currently published observational studies (Kanner et 
al, 1999; Carton et al, 2003; Reuber at al, 2003b; O’Sullivan et al, 2006). 
 
In conclusion, the research presented in this thesis has provided evidence that 
taking patients with PNES off AED, following diagnosis, is as safe as a clinical 
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intervention, and has potentially beneficial effects as a therapeutic intervention 
in the shorter and longer term for a variety of clinical and psychosocial 
dimensions. The RCT (chapter 5) also represents an important contribution 
adding to the very few methodologically sound studies in the field of PNES. 
  
7.2. Methodological considerations 
 
Above all, the original research presented in this thesis represents a rigorous 
attempt to investigate this complex and heterogeneous group of patients. Only 
patients diagnosed with the gold standard test were included, patients were 
recruited prospectively, and great emphasis was placed on ensuring the 
standardisation of the intervention.  
 
Research with this group of patients however is complicated by several factors:  
 
• A relatively low incidence, often resulting in highly selected or 
opportunistic samples. 
• The limited availability of the main diagnostic test (Video EEG).  
• The heterogeneity of the group in terms of associated psychopathology 
and underlying aetiology for PNES. 
• The paroxysmal nature and variable course of the disorder. 
• No evidence for any particular management strategy and, therefore, no 
gold standard. 
 
The research presented in this thesis attempted to address some of these 
difficulties; however individual chapters do, admittedly, have some 
methodological problems which need to be discussed. 
 
Our subjects were recruited from the only epilepsy service in the West of 
Scotland, most patients being referred directly by the GPs rather than tertiary 
referral centres and from that point of view we feel the sample population is 
representative of the wider PNES population. However, for the RCT only, a 
relatively small proportion of the patients screened were eligible for the study. 
Although we detected no significant differences between the two groups, it is 
possible that this minority of selected patients had unknown confounders.  
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To limit heterogeneity, only patients with video EEG confirmation of the 
diagnosis were included and all patients with coexisting epilepsy were excluded. 
Despite our efficient protocol for video EEG monitoring, this entry criteria limited 
our recruitment, particularly for the RCT (chapter 5). 
 
If our entry criteria for the diagnosis of PNES had been less restrictive, we could 
have recruited a further 37 patients who had the clinical diagnosis of PNES but 
were awaiting video EEG (chapter 5). A recent RCT on CBT treatment for 
patients with PNES achieved the required number of subjects by sacrificing a 
degree of diagnostic accuracy (Goldstein et al, 2010). 
 
The issue of differences in co-morbid psychopathology or underlying causes for 
PNES, was possibly less relevant for the first study (chapter 4) since we were 
testing the clinical safety of an intervention, and in the second study (Chapter 5) 
the randomisation ensured that at least both groups were similarly 
heterogeneous. The last study, however, represents a heterogeneous sample 
from that point of view. 
 
None of the studies in this thesis were blinded in that subjects were aware of 
the intervention.  However the observational study reported in chapter 4 had to 
take place with explicit consent and the pragmatic nature of the RCT and its 
subsequent extension entailed the presentation to patients of real world 
alternatives with the foreknowledge that patient expectation would be a part of 
the effect both in the experimental setting and beyond.  In terms of other 
safeguards against bias all evaluations could have been independent of the 
principal researcher.  
 
In terms of the psychotherapeutic interventions offered to our subjects we 
acknowledge that although delivered by very experienced neuro-psychologists 
who followed a basic agreed structure, their input was not completely 
standardised. This is not ideal from a scientific point of view; however in the 
context of the studies presented in this thesis it is possibly less relevant since 
our aim was to assess the initial steps of management within a neurology clinic 
setting focusing on a shift in medical explanation and management. 
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For a study looking at the further management of PNES beyond the diagnosis a 
strict protocol of any intervention would be essential to evaluate its effectiveness 
as in the case of the studies presented by LaFrance et al and Goldstein et al 
which we see as complementary to our studies (LaFrance et al, 2009; Goldstein 
et al , 2010).  
 
To ensure treatment fidelity we agreed on a series of scripts for all patients’ 
contacts, it proved however impossible to perform an analysis of its delivery. 
 
Finally, since recruitment for the RCT was so difficult, strenuous efforts to 
ensure retention were undertaken to ensure the viability of the study and the 
results may be a reflection of a Hawthorne effect deriving from this added 
attention and effort.  Other authors have recognised this problem (LaFrance et 
al, 2009; Goldstein et al, 2010). 
 
7.2.1. Outcome measures 
 
Choosing relevant and valid outcome measure for this group of patients is 
complicated. As discussed by other authors, the choice of measures has to 
balance comprehensiveness with practicality (Quigg et al, 2002; Reuber et al, 
2005; LaFrance et al, 2006). 
 
Seizure freedom and to a lesser extent attack reduction are recognised as 
objective and valid measures of improvement, however, as already discussed in 
this thesis they are not comprehensive enough as isolated outcomes. Broader 
psychosocial outcomes are necessary to evaluate improvement and outcome of 
patients with PNES (La France et al, 2006). 
 
On the one hand, adding a wide range of outcome measure would ensure a 
more comprehensive assessment of outcome and avoid missing potentially 
important changes due to the intervention. On the other hand, a large number of 
measures can compromise statistical power, a particularly relevant point in this 
field, where prospective recruitment of large number of patients is difficult. 
 
A consensus statement form a group of experts following a workshop on the 
development of treatment for PNES suggested a list of measures which are 
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listed in table 7.2. The use of standardised measures, with solid psychometric 
properties and sensitivity to the intended treatment change, was also 
recommended. 
 
Table 7.2: Potential outcome variables for treatment studies of PNES.  
 
1 Attack frequency 
2 Individual concerns
3 Employment status 
4 Psychiatric symptoms and personality characteristics 
5 Health related quality of life 
6 Psychophysiologycal variables (e.g., arousal)
7 Family/psychosocial factors 
8 Healthcare utilisation 
9 Illness cognition /representation 
 
 
For the three studies included in this thesis our choice of measures aimed to be 
comprehensive, combining attack frequency with a variety of psychosocial 
outcome measures, and covered most of the domains suggested in table 7.2. 
We chose a number of standardised scales as well as relying on self reports for 
some domains.  
 
In terms of standardised questionnaires, we had to use available measures from 
other areas since there are no scales specifically designed to assess PNES. 
The IPQ had been validated for other somatisation disorders (e.g. ME); the 
SEALS was designed to evaluate quality of life in patients with epilepsy, taking 
into account the side effects of AED; and the HADS had been previously used 
for patients with PNES to assess mood changes. 
 
Using scales designed for patients with epilepsy has some logic, since epilepsy 
is also a paroxysmal disorder which has an important impact on patient’s quality 
of life (Jacoby et al, 2009). Patients with PNES, however, have different 
characteristics when compared with patients with epilepsy, with a higher 
proportion with personality disorders, higher levels of somatisation as well as 
distinct ways of perceiving and expressing their distress (Frances et al, 1999; 
Reuber, 2003; Galimberti et al, 2003; Binzer et al, 2004). The SEALS 
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questionnaire was an appropriate choice for our research, particularly since we 
were interested in outcomes associated with AED, although it is possible that 
with so much ‘background noise’ from the study population, this questionnaire 
was not sensitive enough to detect changes. 
 
The IPQ on the other hand was designed to assess illness beliefs for a wide 
variety of illnesses and is validated for a somatoform disorder (ME). There is no 
doubt that assessing illness beliefs in PNES patients is important, particularly 
since our hypothesis was based on how continuation of AED affects patients’ 
understanding of their disorder, however there are some considerations that 
need to be made. 
 
The version of the IPQ which we used had some problems that have since been 
addressed in a revised version, but this was unavailable at the time. 
(MossMorris et al, 2002). As well as strengthening the psychometric properties 
of the scale, a cyclical time line subscale was included for paroxysmal disorders 
which would obviously have been of particular relevance to PNES. 
 
However, for all versions of the IPQ, researchers are encouraged to adapt the 
scale to their particular subject. In retrospect it would have been interesting to 
add symptoms in the ‘identity subscale’ relevant to the attack disorder, and a 
question in the ‘cause subscale’ referring to epilepsy as a possible cause.  
 
For the social outcomes measures we relied on patient self reports, 
corroborated by relatives, as well as including more objective measures like 
employment status and ability to attend the clinic alone. Other authors have 
used validated scales to assess social adjustment and disability like the Work 
and Social Adjustment Scale (Mundt, 2002) or the SF- 36 (Ware & Sherbourne, 
1992) which are validated instruments, are relatively short and easy to use 
(Goldstein et al,  2004). Using one of these scales could have added more 
rigour to our studies. 
 
We felt that health care utilisation was another important outcome to measure 
and, for the sake of clarity, we concentrated mainly on emergency contacts. The 
use of a scale however would have allowed an estimation of the costs and more 
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important the savings resulting of our intervention, relative to say other 
interventions for standardised comparisons. 
 
A difficulty in choosing specific standardised measures to assess outcomes in 
the studies presented in this thesis is the fact that some of the potentially 
relevant factors may be difficult to measure using an existing scale. In this 
context, the use of qualitative methods would have allowed a more 
comprehensive exploration of the impact that giving the diagnosis of PNES and 
withdrawing medication has in this group of patients. 
 
Our assessments were all quantitative and as such we perhaps lacked the 
ability to conduct a more fine grained enquiry into patients’ views. It would have 
been useful to elicit patients views of their condition and the impact of our 
intervention (AED withdrawal) and relate this to their outcome in the study.  
   
In early discussions around the design of the study it was proposed that at 
recruitment qualitative methodology be employed to explore patient perceptions 
of the role of AED prescription and withdrawal.  Unfortunately resources were 
not available to conduct interviews and subsequent analysis along the lines of 
classical qualitative research. A more modest qualitative approach could 
perhaps have been adopted by eliciting the views of patients as the study 
progressed and then using these views as a basis for items in the baseline or 
follow up assessments of subsequent patients.  However it was felt that this 
approach, which would effectively have meant that the nature of the 
assessment evolved as the study progressed, would have compromised the 
reliability and validity of our assessments.  
 
In summary, the quality of studies presented in this thesis could have been 
enhanced by the use of; the IPQ-R version, a validated scale to measure social 
adjustment, and a more comprehensive measure of health-care utilisation.  The 
use of qualitative measures would have also allowed a more fine grained and 
evocative account of the patient experience. 
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7.3. Clinical implications  
 
The findings of the body of work presented in this thesis are relevant to clinical 
practice, since this research was conducted in a real life clinical setting 
comparable to most regional epilepsy services, where most patients with PNES 
are assessed and treated. 
 
Overall, it is hoped that this research raises awareness of the very serious issue 
of iatrogenic harm. Our three studies have shown that a clear diagnosis and 
consistent management of PNES results in a reduction of health-care utilisation, 
specifically a reduction of emergency services and treatment of pseudo status. 
It is important to stress that our intervention was relatively simple and 
achievable and that these positive results were maintained at follow up. 
 
The study presented in chapter 4 demonstrates that AED withdrawal in patients 
with PNES is a safe clinical intervention. This paper, published by the JJNP and 
was the editor’s choice at the time, has already proved to have influenced 
scientific opinion, and continues to be referenced in many papers as the main 
evidence to guide physicians who wish to withdraw AED in a safe manner. It will 
take some time however to determine if indeed clinicians are more likely to take 
patients off AED. 
 
The results of the exploratory randomised control trial (chapter 5) also show the 
importance of withdrawing medication to limit iatrogenic harm, in this case, 
when compared with delayed withdrawal, a pragmatic alternative. The impact of 
the intervention can be illustrated by the experience of one of the participants; 
patient X was randomised to delayed withdrawal, she had three admissions to 
ITU in the past and had been repeatedly treated for prolonged PNES in hospital. 
For the first 9 months after the diagnosis she continued to use emergency 
medication for prolonged attacks and was treated on two occasions in Accident 
and Emergency despite showing a letter with a clear explanation of her 
diagnosis of not epilepsy. From 9 months onwards however as she came off her 
medication there was no contact for emergency services or use of 
Benzodiazepines to treat prolonged events although she continued to have 
attacks.  
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The above anecdotal illustration encapsulates the idea behind much of this 
thesis research. Underpinning our research is the idea that, the use of 
medication as a treatment for a disorder has powerful effects, not just at a 
physiological level but affecting patient’s behaviour and their understanding of 
their disorder.  
 
Finally, with the last paper (chapter 6), we can reassure clinicians that 
withdrawal of AED after the diagnosis is not only safe as a clinical intervention, 
but also does not result in a negative psychological impact. This last study also 
gives an interesting insight into the potential pitfalls of illness reattribution. As 
one of the objectives of therapy, the reattribution of PNES to stress has only 
value if it reflects a real change in locus of control and commitment to recovery. 
 
In summary the work presented in this thesis has helped to establish AED 
withdrawal as an intervention in its own right. AED withdrawal should therefore 
be included in current and future protocols of the initial management and taken 
into consideration in future treatment studies. 
 
7.3.1. PNES in the context of other medically unexplained symptoms (MUS) 
 
Medically unexplained symptoms (MUS) are common in neurology clinics and 
the overall outcome is also poor (Carson et al, 2003; Sharp et al,  2010). 
  
As pointed out by other authors, knowledge from current studies on other MUS 
could be a good source of information for the development of effective 
treatments for PNES. Conversely, knowledge of PNES can also contribute to 
our understanding of other somatisation disorders. 
 
PNES have the distinct characteristic of having a sensitive and specific 
diagnostic test which other disorders, like pain or fatigue, do not have. The 
diagnostic certainty of PNES makes research on iatrogenic harm or on the 
effects of over treatment much easier; the results however can also be applied 
to other MUS.  
  
Lessons could be learned then from the research presented in this thesis, since 
iatrogenic harm is a universal problem in medically unexplained symptoms with 
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a majority of patients treated with multiple drugs or surgery, and, as in PNES, 
the evidence for an effective treatment is sparse (Barsky & Borus, 1999; Mayou 
et al, 2000). 
 
The research presented in this thesis shows that, a clear explanation and a 
removal of a treatment intended for an erroneously diagnosed physical illness, 
greatly reduces iatrogenic harm and has a positive effect on psychological 
outcomes as well as reducing symptoms. 
 
If nothing else this thesis should inform physicians of what not to do. Treating 
patients for something they do not have potentially does more physical and 
psychological harm than no treatment at all.  
 
7.4. Future directions  
 
There is no doubt that further research on the management of PNES is 
required, however, it is unlikely that any single intervention beyond the 
presentation of the diagnosis and removal of AED would be suitable for all 
patients. 
 
As a result of a workshop to discuss the development of treatment for patients 
with PNES, a three arm trial comparing regular review by neurology with CBT or 
antidepressants was proposed (LaFrance et al, 2006). To achieve the power 
necessary to detect changes in such a varied population, this would have to be 
a multi-centre trial. 
 
For a multi centre trial, however, the diagnostic accuracy of PNES would be an 
issue; to ensure the quality of the diagnosis the gold standard technique of 
video EEG would be required. As shown in this thesis, the use of video EEG is 
a factor that limits recruitment. 
 
Targeting or excluding specific subgroups of patients (for example people with a 
personality disorder, multiple other MUS, chronic symptoms) would make future 
studies easier to achieve in terms of retention and sample variance, however 
this would limit their relevance. 
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A multi-centre pragmatic trial with a study design reflecting the stepped care 
model approach seems the only way forward to conduct further research on 
management of PNES with sufficient power.  
 
Following video EEG confirmation of the diagnosis of PNES, all patients would 
be initially randomised to a comprehensive protocol for the delivery of the 
diagnosis of PNES (clear and supportive explanation, basic psycho education 
and written information) or to a clear however basic explanation accompanied 
by written information, offered by the treating neurologist within the constrains of 
a general neurology clinic. For patients on AED the withdrawal of the medication 
would be immediate or delayed.. 
 
Following this first phase patients whose attacks continued would be re-
randomised to a course of CBT or treatment with an SSRI. The group of attack 
free patients would remain as a control group and reviewed at the end of phase 
two. 
 
Power to detect a moderate effect would be substantially diluted by the third of 
patients who seem to respond regardless of the intervention.  
 
Follow up of all patients should be at least two years long because of the often 
reported longer term deterioration of some early responders. 
 
Clinical outcomes should be attack freedom, health care utilisation drug and 
AED use and evidence of new physical symptom. Psychosocial outcome should 
include measures of; social functioning, anxiety and depression as well as 
measures reflection insight into the diagnosis of PNES and shifts of locus of 
control. Ideally an initial psychiatric screening would be also useful. 
 
The above study as well as researching the effectiveness of the different 
management interventions would also allow an initial exploration of possible 
predictors of outcome and identification of subgroups of patient which are more 
likely to respond to particular management strategies  
 
The above represents a gold standard and may not be practically achievable.  
However, there are still many unanswered questions that could be addressed 
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through more modest studies, further research on; patients illness beliefs as 
well as doctors beliefs; cultural bound differences; the influence of underlying 
psychopathology or the natural course of PNES amongst others. All of these 
have been only minimally explored and could increase our understanding of 
PNES and help towards the design of a larger study on the management of 
PNES.  
 
Alternatively there may be some value in a complete paradigm shift and 
consider PNES as one of the phenotypical expressions of somatisation as some 
authors have argued (Wessely, 2004). If we conceptualise PNES as one more 
of the functional somatic symptoms, generic research including all medically 
unexplained symptoms could be the way forward. 
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Appendices 
 
Appendix A: Checklist for the assessment of quality of observational studies on 
the outcome of psychogenic nonepileptic seizures.  
 
1-Is the study based on a representative sample selected from a relevant 
population of patients with NES 
Yes  
No   
 
2-Are the criteria for inclusion explicit  
Yes  
No  
 
3-Were patients with co-existing epilepsy excluded 
Yes  
No 
 
4-Was there an established reliable system for selecting all the cases 
Yes  
No 
 
5-Was the diagnosis of NES confirmed by video-EEG Case definition 
Yes 
No  
 
6-Did all individual entered the survey at a similar point on time in the diseases 
progression  
Yes  
No 
 
7-Was the sample size >75    
Yes  
No  
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8-Was the follow up sufficiently long to assess improvement of NES 
Yes  
No   
 
9-Were cases assessed at a similar point after the diagnosis?  
 
Yes  
No  
 
10-Was the proportion of the sample followed up >60% 
Yes  
No 
 
11-Were all subjects exposed to the same intervention or standardised 
management  
  
Yes  
No 
12-Were the outcome measures valid and comprehensive (including other than 
attack reduction) 
Yes  
No 
 
13 Were tall the outcome measures clearly stated? 
Yes  
No 
 
14-Did the authors used objective measures of outcome (attack diary, rating 
scales) ?  
 
Yes  
No 
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Appendix B: Checklist for reports of observational studies (STROBE statement) 
 
Title and abstract  a/Indicate the study design  
b/Provide an informative and balanced summary 
Introduction 
 
Background  
Objectives  
 
 
Explain scientific background and rationale 
State specific objective and prespecified hypothesis 
Methods 
 
Study design 
Settings  
Participants 
 
Variables 
 
Data 
source/measurements 
Bias 
Study size 
Quantitative variables 
  
Statistical methods  
  
Present key elements of the study  
 
 
Describe setting, location and relevant dates 
Give eligibility criteria and the source and method of data 
collection  
Define all outcomes, exposure, predictors and potential 
confounders as well as diagnostic criteria  
For each variable give sources of data and details of methods of 
assessment  
 
Describe any efforts to address potential bias  
Explain how the study size was arrived at 
Explain how quantitative variables were handled in the analysis 
a/Describe all statistical methods, including those used to control 
confounding  
b/Explain how missing data was addressed 
c/Describe methods used to examine subgroups and interactions 
 
Results 
 
Participants  
 
 
Descriptive data 
 
 
Outcome data 
Main results  
Other analysis  
 
 
a/Report number of individuals at each stage of study 
b/give reasons for none participants  
c/Consider use of a flow diagram  
a/Give characteristics if the study participants  
b/Indicate number of participants with massing data for each 
variable  
Report numbers of outcomes events or summary measures  
Give unadjusted estimates and confounder adjusted estimates  
Report other analysis done  
Discussion 
 
Key results  
Limitations 
  
Interpretation 
 
  
Generalisability  
 
 
Summarise key results with reference to study objectives  
Discuss limitations of the study, taking into account sources of 
potential bias 
Give a cautious overall interpretation of results considering 
objectives, limitations, multiplicity if analysis and results form 
similar studies  
Discuss the generalisability(external validity)of the study 
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Appendix C: Patient information sheet on PNES. 
 
NON EPILEPTIC SEIZURES – patient information  
 
 
As we discussed at the clinic you know now that the results of the test show that 
your attacks are not epileptic. You have Non Epileptic Seizures (NES) or 
Pseudoseizures. 
 
Many of the people that we see in this clinic have been told that they suffer from 
an illness called epilepsy. Other people have never been given a clear answer 
at all. 
 
With this leaflet we are hoping to answer some of the questions that you may 
have about this condition. 
 
 
1-What are Non Epileptic Seizures? 
 
These are turns that look like epileptic attacks and in fact are often mistaken for 
epilepsy but, unlike epilepsy, the cause is not due to something being wrong 
with your brain waves. These attacks are caused by psychological problems  
(stress, emotional problems, worries). 
 
This is not an uncommon problem. We run a clinic especially for people with 
these kind of attacks and we can see up to three new patients a week. 
 
In fact about two out of ten people who are thought to have untreatable epilepsy 
suffer from non epileptic seizures. 
 
 
2-What do you mean by a psychological or emotional cause? 
 
You may find it very difficult to understand how these attacks are caused by 
stress or to think of any causes for your turns. 
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The relationship between your emotional upset or stress and the attack is not 
always straightforward 
 
Our body can show stress or distress in a very physical way. For example some 
people can be physically sick because of worry. The person is being sick but the 
cause is not due to a stomach problem but to stress. 
 
Stress and worries can build up, sometime without a person being aware of it. 
But it may build up to a point that the pressure is too much and you have an 
attack to let go off the pressure . 
We can think of these turns as a way of coping, like a pressure release valve or 
“time out”. 
 
 
3-Does that means that I am putting them on? 
 
NO 
 
These attacks are a very real problem but the root of the problem is emotional, 
not physical. 
 
The fact that there is not a physical cause for your attacks does not mean that 
you are “mad” or pretending. What it may mean is that your are more upset or 
stressed than you realise. 
 
Having these attacks can be very unpleasant and upsetting as well as making 
you day-to-day life very difficult. 
 
 
4-What makes me have these attacks? 
 
For some people the problem is related to an unpleasant or traumatic 
experience from the past. For others it can be due to a number of different 
problems.  
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In some people it takes some time before we find the underlying problems. 
5-What about the result of the test ? 
 
Recording an attack during a Video EEG test is the best test we have for the 
diagnosis of NES. Is very accurate and we can trust the results  
  
With this test we are able to monitor your brain waves and take a video at the 
same time  
 
Your brain waves change depending if you are awake, asleep or even drowsy. 
By looking at you brain waves during an attack we can tell if you are 
unconscious or there is something affecting the way your brain works. 
 
The test has shown that your brain waves did not change or become epileptic 
before during or after the attacks we recorded. This confirms the diagnosis of 
Non Epileptic Seizures. 
 
6-How come I was told that I had epilepsy?  
(by doctors, nurses and paramedics) 
 
The diagnosis of your type of attacks can be difficult. Because the attacks can 
look so much like epilepsy, they are often confused and treated as epilepsy. 
 
However we now know that NES is not a rare condition. A psychological cause 
has to be considered when patients present with attacks that seem difficult to 
control with medication. 
Better tests are also available nowadays to help us with the diagnosis. 
 
7-Can Non Epileptic Seizures be treated? 
 
This kind of attack can often be successfully treated. There are a number of 
things we can do to make sure you have a good result. 
 
Some people improve just by having a clear answer and explanation for the 
attacks. Knowing what’s wrong with you is helpful in itself . 
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We think that being looked after by the same people is important for a 
successful recovery. We will support you through the recovery process and will 
not pass you on to any other doctors.  
 
You will also be able to see one of the two psychologists on our team. They are 
experienced at helping people with your kind of attacks. 
The psychologist will help you to find the cause (s) for your attacks and will also 
help you to have control over the attacks.  
 
 
9-What can this clinic do for me? 
 
• Give you a clear answer about the cause of you attacks  
• Help you to gain control over the attacks  
• Give you support 
• Give you advice on practical matters such as driving and work 
 
 
 
 
 
 
IF YOU HAVE ANY FURTHER QUESTIONS PLEASE CONTACT DR MARIA 
OTO AT:                                      
 
                        PHONE:  
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Appendix D: Drug withdrawal protocol.  
 
Drug withdrawal protocol  
 
Withdrawal programme agreed and discussed with patient 
Patients and primary care physicians given written withdrawal programme 
Patients, relatives and primary care physicians instructed to report any new 
event type to the clinic 
Contact phone number supplied 
Clinical follow up at 3 monthly intervals 
Psychology treatment programme of 2-6 visits during study period 
 
Drug withdrawal schedules 
 
Phenytoin 
100mg/week till dose is 100mg/day, then 25mg per week 
Carbamazepine 
200mg/week till dose is 1000mg/day, then 100mg/week 
Sodium valproate 
500mg/week till dose is 500mg, then 200mg/week 
Vigabatrin 
500mg every 2 weeks until dose is 500mg, then 500mg alternated days for 2 
weeks 
Lamotrigine 
100mg/week till dose is 300mg, 50mg/week till dose is 50mg, then 25mg/week 
Gabapentin 
800mg/week till dose is 1200mg, then 400mg/week 
Topiramate 
100mg/week till dose is 200mg, 50mg/week till dose is 50mg, then 25mg/week 
Levetiracetam 
500mg/week till dose is 1000mg, then 250mg/week  
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Appendix F: CONSORT Checklist of items to include when reporting a 
randomized trial      
 
PAPER SECTION 
And topic 
Item Description Reporte
d on 
Page # 
TITLE & 
ABSTRACT 
1 How participants were allocated to interventions (e.g., 
"random allocation", "randomized", or "randomly 
assigned"). 
 
INTRODUCTION 
Background 
2 Scientific background and explanation of rationale.  
METHODS 
Participants 
3 Eligibility criteria for participants and the settings and 
locations where the data were collected. 
 
Interventions 4 Precise details of the interventions intended for each 
group and how and when they were actually 
administered. 
 
Objectives 5 Specific objectives and hypotheses.  
Outcomes 6 Clearly defined primary and secondary outcome 
measures and, when applicable, any methods used to 
enhance the quality of measurements (e.g., multiple 
observations, training of assessors). 
 
Sample size 7 How sample size was determined and, when 
applicable, explanation of any interim analyses and 
stopping rules. 
 
Randomization -- 
Sequence 
generation 
8 Method used to generate the random allocation 
sequence, including details of any restrictions (e.g., 
blocking, stratification) 
 
Randomization -- 
Allocation 
concealment 
9 Method used to implement the random allocation 
sequence (e.g., numbered containers or central 
telephone), clarifying whether the sequence was 
concealed until interventions were assigned. 
 
Randomization -- 
Implementation 
10 Who generated the allocation sequence, who enrolled 
participants, and who assigned participants to their 
groups. 
 
Blinding (masking) 11 Whether or not participants, those administering the 
interventions, and those assessing the outcomes were 
blinded to group assignment. When relevant, how the 
success of blinding was evaluated. 
 
Statistical 
methods 
12 Statistical methods used to compare groups for 
primary outcome(s); Methods for additional analyses, 
such as subgroup analyses and adjusted analyses. 
 
RESULTS 
Participant flow 
 
13 Flow of participants through each stage (a diagram is 
strongly recommended). Specifically, for each group 
report the numbers of participants randomly assigned, 
receiving intended treatment, completing the study 
protocol, and analyzed for the primary outcome. 
Describe protocol deviations from study as planned, 
together with reasons. 
 
Recruitment 14 Dates defining the periods of recruitment and follow-
up. 
 
Baseline data 15 Baseline demographic and clinical characteristics of 
each group. 
 
Numbers 
analyzed 
16 Number of participants (denominator) in each group 
included in each analysis and whether the analysis 
was by "intention-to-treat".   State the results in 
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Appendix G: Diagnostic criteria and diagnostic process for PNES. 
 
The diagnostic process considered not only the diagnosis of nonepileptic 
seizures (NES) but also the diagnosis of possible coexisting epilepsy. 
 
An initial “provisional” clinical diagnosis of NES was made following an 
assessment by an epilepsy specialist, based on witness descriptions of all 
attacks and the patient account. The definite diagnose of NES was established 
following the recording of a typical attack during video EEG monitoring. 
 
The epilepsy specialist also assessed the patient for any evidence of current or 
past epilepsy (one of the exclusion criteria for the study) by reviewing clinical 
records and the reports of previous EEG and the descriptions of past attacks.     
 
To ensure the accuracy of the diagnosis the following criteria which were 
agreed by the team of senior epileptiologists was applied.  
 
 
Diagnostic criteria for Epilepsy.  
 
•Reports of attacks before the age of 12 years. 
•Description of past or present attacks (by patient, eyewitness or reported in the 
notes) compatible with epileptic seizures. 
•Interictal epileptiform abnormalities in past or current EEG (as agreed by a 
neurophysiologist and an epilepsy specialist) 
•Video EEG recording of any attack with associated EEG epileptic discharges. 
 
Any EEG reported as abnormal in the past this will be reviewed and reported by 
a nerophysiologyst. 
 
Diagnostic criteria for NES 
 
•Attack descriptions compatible with known clinical presentation of 
pseudoseizures (e.g. alternating movements, pelvic thrusting, and emotional 
content). 
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•Video recording of attack semiology was available and compatible with 
eyewitness account.  
 
•EEG record of attack showed no modification or associated EEG abnormalities.  
 
•ECG recording showed no arrhythmia during the attack (tachycardia 
acceptable if all other features compatible with pseudoseizure). 
 
Diagnostic accuracy and diagnostic process  
 
To minimize the risk of diagnosis error at least three clinicians (two epilepsy 
specialists and a neurophysiologist) were involved in the diagnostic process and 
each clinician assessed each case independently. 
 
The definitive diagnosis depended on video EEG confirmation of the provisional 
clinical diagnosis. Until we had been able to record all types of typical events on 
video EEG, the diagnosis of NES was not given to the patients. 
 
Before presenting the diagnosis to the patients, all cases were routinely 
discussed at the “epilepsy team clinical meeting” (attended by all epilepsy 
specialist and neurophysiologists). Video recordings and EEG’s were reviewed 
at that point. 
 
In some cases if there are doubts about diagnosis or there are conflicting 
opinions from the physicians involved, patients were discussed separately at the 
NES clinical meeting. Were a more formal presentation of the case including the 
results of all past and present investigations were reviewed and a decision was 
reached by consensus of all the physicians involved...    
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Appendix H: RCT protocol. 
 
An exploratory randomised controlled trial of withdrawal of antiepileptic drugs 
(AED) in patients with PNES. 
PROTOCOL 
 
Referral process 
 
All new referrals will be sent an appointment to attend the PNES clinic.  
Subjects will see the research assistant for administration of psychological 
measures followed by their 1st appointment with the research fellow.   
 
The appointment letter will contain a diary for the patient to prospectively record 
attack frequency prior to the PNES clinic appointment.   
 
Patient will be seen within 8 weeks of referral.   
 
The research assistant will call all those referred (with available telephone 
numbers) at the time of appointment allocation to collect 2-month retrospective 
information (historic attack frequency and healthcare utilisation) 
 
Screening: Pre-trial visit 
 
Psychology assistant: 
 
Administer psychological rating scales   
-NART 
-SEALS 
-HADS 
-ILLNESS PERCEPTION QUESTIONNAIRE  
  
Collect information regarding healthcare utilisation over the previous 6 months:   
-Out of hours and emergency health contacts for PNES or other and use of 
rescue drugs for NES 
   
First Visit (immediately after pre-trial visit) 
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Patient seen by the Research Fellow who will review medical records and 
gather routine clinical information, in order to establish a provisional clinical 
diagnosis. The provisional clinical diagnosis will be one of the following: 
Epilepsy or PNES or Epilepsy and PNES 
 
Group A:  Patients that at the time of referral had the diagnosis of PNES 
confirmed by Video EEG 
 
-Patient counselled and information about the trial given. 
-Patient consent ascertained. 
-Randomised to immediate or delayed withdrawal of AED: randomization will be 
by the EEG secretary using a random number list. 
-Phased withdrawal begins in immediate withdrawal group (see attached drug 
withdrawal protocol). 
-Phased withdrawal in delayed group will commence 9 months later 
-Anti-epileptic drug levels checked in both groups to monitor compliance. 
-To send a standard letter informing GP about the trial (see attached letter). 
 
Group B: Patients that following the screening visit have a provisional clinical 
diagnosis of PNES without video EEG confirmation 
 
All these patients will be referred for video EEG monitoring. Once the diagnosis 
is confirmed the same procedure as outlined for Group A takes place. 
 
TRIAL VISITS SCHEDULE 
Immediate withdrawal arm: 
 
0 months (trial visit 1) - RANDOMISATION VISIT.  Commence withdrawal of 
AED. 
 
3 months (trial visit 2) - Monitor withdrawal and collect data on seizure 
frequency and health care utilisation. 
 
6 months (trial visit 3) - Monitor withdrawal and collect data on seizure 
frequency and health care utilisation. 
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9 months (trial visit 4) - Collect data on seizure frequency and health care 
utilisation.  Psychological rating scales re-administered and check blood drug 
levels. 
 
12 months (trial visit 5) - Control visit.  Collect data on seizure frequency and 
health care utilisation. 
 
15 months (trial visit 6) - Control visit.  Collect data on seizure frequency and 
health care utilisation 
 
18 months (trial visit 7) - FINAL VISIT.  Collect data on seizure frequency, 
health care utilisation and social functioning.   Psychological rating scales re-
administered. 
 
Delayed withdrawal arm:  
 
0 months (trial visit 1)- RANDOMIZATION VISIT. 
 
3 months (trial visit 2) - Control visit. Collect data on seizure frequency and 
health care utilisation. 
 
6 months (trial visit 3) - Control visit. Collect data on seizure frequency and 
health care utilisation. 
 
9 months (trial visit 4) - Commence withdrawal of AED.  Collect data on seizure 
frequency and health care utilisation.  Psychological Rating Scales re-
administered and check drug blood levels.   
 
12 month (trial visit 5) - Monitor withdrawal and collect data on seizure 
frequency and health care utilisation. 
 
15 months (trial visit 6)-  Monitor withdrawal and collect data on seizure 
frequency and health care utilisation. 
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18 months (trial visit 7) - FINAL VISIT.  Collect data on seizure frequency, 
health care utilisation and social functioning. Psychological rating scales re-
administered and check drug blood levels.   
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 155 
Appendix I: Patient consent form for RCT.  
CONSENT FORM 
 
 
 
I have read the information sheet attached for the anti-epileptic drug 
withdrawal study. 
 
I know that I do not have to take part in this study.  I am aware that if I choose 
not to take part my treatment will not be affected in any way. 
 
By signing this form I am agreeing to take part in the study.  However, I can 
withdraw from the study at any time by letting my doctor know. 
 
 
 
 
Signed_________________________________   Date__________________ 
 
 
Witness signature 
 
 
 
Signed_________________________________   Date__________________ 
 
 
CONSENT FORM 
 
 
 
I have read the information sheet attached for the anti-epileptic drug 
withdrawal study. 
 
I know that I do not have to take part in this study.  I am aware that if I choose 
not to take part my treatment will not be affected in any way. 
 
By signing this form I am agreeing to take part in the study.  However, I can 
withdraw from the study at any time by letting my doctor know. 
 
 
 
 
Signed_________________________________   Date__________________ 
 
 
Witness signature 
 
 
 
Signed_________________________________   Date__________________ 
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Appendix J: Scripts for study visits.  
 
Presenting the diagnosis of NES: The same for all subjects  
 
Step 1  
Review the results of video EEG to confirm that the attacks recorded are typical 
and that all have been recorded. 
 
Step 2 
The good news:“this attacks are not epilepsy “ 
Explanation of the EEG results and emphasise the accuracy of our diagnosis  
 
Step 3  
Explain the nature of attacks: Attacks that resemble and are often confused by 
epilepsy however the cause is not an abnormal discharge of electricity in the 
brain but a result of psychological difficulties  
 
Normalise and instil hope –It is a common condition and we see and help many 
patients with this disorder 
Explanation of underlying mechanism using the model of predisposing, 
precipitating and perpetuating factors. 
 
Step 4 
Answer questions referring to our information leaflet created following  
 
Step 5 
Discuss management and research project and give written information. The 
patients information for the DW group will not have the question answer of 
medication. 
 
SCRIPT FOR VISITS:  3 and 6 months 
 
AED delayed withdrawal group: 
 
1-“How are you feeling at the moment?,(asked to rate using an interval scale 
from 1-10) 
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2- Have you had any turns since last appointment? Can I see you diary?” 
-If there has been a reduction of attacks: “this is very encouraging there is 
already improvement in only twelve weeks, you are doing very well” 
-If there has been no improvement, (try not to put too much emphasis on 
number of attacks):”At this stage we often don’t see a difference on the 
numbers of attacks, is OK, these can take time” 
3-“Have you been taken to hospital, called an ambulance or been given 
emergency medication because of the turns since the last appointment?” 
-If the answer is no, positive reinforcement particularly to the carer” That is 
really good, this shows that things are getting better. Its very important that you 
keep away from emergency ambulances and casualty departments “ 
-If the answer is yes, go over again with patient and carer (assertive way)” It’s 
very important that you keep away from ambulances and casualty departments. 
As we discussed you will not come to any harm through the attacks and the 
best way to deal with it is to leave the person alone, you will come round in your 
own time any contact with emergency services will complicate matters and 
potentially make you worse it’s important that everyone understands that this is 
not epilepsy”  
4-How do you feel now about the diagnosis? Depending on the degree of 
resistance to the diagnosis at this point go over a number or all the points made 
at the initial consultation about diagnosis and cause of PNES. 
5-Have you any new problems since I last saw you? Are you on any new drugs? 
(if new physical complaint ,record but do not show too much interest) 6-Have 
you got any questions for me? 
7-I will see you in X months time, but get in touch before if there is a problem. 
Make sure that you keep your diary up to date. 
 
AED immediate withdrawal group: 
 
1-Hour are you, feeling? ,(asked to rate using an interval scale from 1-10) 
2-How are you getting on with the reduction of the medication, any problems? 
Find out current medication and give written instructions of further reduction. 
3-Have you had any turns since the last appointment? Can I see your diary?” 
-If there has been a reduction of attacks:” this is very encouraging there is 
already an improvement in only twelve weeks, you are doing very well” 
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-If there has been no improvement, (try not to put too much emphasis on 
number of attacks):”At this stage we often don’t see a difference on the 
numbers of attacks, is OK, these can take time” 
4-Have you been taken to hospital, called an ambulance or been given 
emergency medication because of the turns since the last appointment?” 
-If the answer is no, positive reinforcement particularly to the carer” That is 
really good, this shows that things are getting better. Is very important that you 
keep away from emergency ambulances and casualty departments “ 
-If the answer is yes, go over again with patient and carer (assertive way)” Its 
very important that you keep away from emergency ambulances and casualty 
departments. As we discussed you will not come to any harm through the 
attacks and the best way to deal with it is to leave the person alone, you will 
come round in your own time Any contact with emergency services will 
complicate matters and potentially make you worse Its important that everyone 
understands that this is not epilepsy”  
5-How do you feel about the diagnosis now?  Depending on the degree of 
resistance to the diagnosis at this point go over a number of all the points made 
at  the first consultation about diagnosis and cause of NES . 
6-Have you any new problems since I last saw you? Are you on any new 
medication? (if any new physical complaint ,record but do not show too much 
interest) 
7-Have you any other questions? 
8-I will see you in X months time, but get in touch before if there is a problem. 
Make sure that you keep you diary up to date. 
 
SCRIPT FOR VISIT: 9 months 
 
Delayed withdrawal group 
1-How are you feeling? ,(asked to rate using an interval scale from 1-10) 
2-As we discussed this visit will be longer since we would like  you to complete 
the questionnaires again .At this important stage of you treatment we need to 
assess your progress by collecting all this information again and compare it with 
your previous results .We will also repeat the blood tests . 
3-I will also ask you to start withdrawing the tablets from now on. We will take 
you off one medicine at a time gradually following this protocol. I will give you 
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written instructions on how to reduce the tablets. Do you have any worries about 
coming off medication at this point (if yes answer questions and reassure) 
4-Have you had any turns since last appointment? Can I see you diary?” 
If there has been a reduction of attacks:”this is very encouraging there is 
already an improvement in only four weeks, you are doing very well” 
If there has been no improvement, (try not to put too much emphasis on number 
of attacks):”At this stage we often don’t see a difference on the numbers of 
attacks, is OK, this can take time” 
5-Have you been taken to hospital, called an ambulance or been given 
emergency medication because the turns since last appointment?” 
If the answer is no, positive reinforcement particularly to the carer” That is really 
good this shows that things are getting better. Is very important that you keep 
away from emergency ambulances and casualty departments “ 
If the answer is yes, go over again with patient and carer (assertive way)” Is 
very important that you keep away from emergency ambulances and casualty 
departments. As we discussed you will not come of any harm through the 
attacks and the best way to deal with it is to leave the person alone, you will 
come round in your own time any contact with emergency services will 
complicate matters and potentially make you worse Is important that everyone 
understands that this is not epilepsy”  
6-How do you feel now about the diagnosis? Depending on the degree of 
resistance to the diagnosis at this point go over a number or all the points made 
at the first consultation about diagnosis and cause of PNES . 
7-Have you had any new problems/symptoms since I last saw you? Are on any 
new medication?  
8-Have you got any other questions? 
9-I will see you in X month’s time, but get in touch before if a new problem 
arises. Make sure that you keep you diary up to date. 
 
Immediate withdrawal group 
 
1-How are you feeling? ,(asked to rate using an interval scale from 1-10) 
2-As we discussed this visit will be longer since we would like  you to complete 
the questionnaires again .At this important stage of you treatment we need to 
assess your progress by collecting all this information again and compare it with 
your previous results .We will also repeat the blood tests . 
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3-You have now been of the tablets for sometime, any problems? 
4-Have you had any turns since last appointment? Can I see you diary?” 
If there has been a reduction of attacks:”this is very encouraging there is 
already an improvement in only four weeks, you are doing very well” 
If there has been no improvement, (try not to put too much emphasis on number 
of attacks):”At this stage we often don’t see a difference on the numbers of 
attacks, is OK, this things take time” 
5-Have you been taken to hospital, called an ambulance or seen you GP 
because the turns since last appointment?” 
If the answer is no, positive reinforcement particularly to the carer” That is really 
good this shows that things are getting better. Is very important that you keep 
away from emergency ambulances and casualty departments “ 
If the answer is yes, go over again with patient and carer (assertive way)” Is 
very important that you keep away from emergency ambulances and casualty 
departments. As we discussed you will not come of any harm through the 
attacks and the best way to deal with it is to leave the person alone, you will 
come round in your own time Any contact with emergency services will 
complicate matters and potentially make you worse Is important that everyone 
understands that this is not epilepsy”  
6-How do you feel now about the diagnosis? Depending on the degree of 
resistance to the diagnosis at this point go over a number or all the points made 
at the first consultation about diagnosis and cause of NES. 
7-Have you had any new problems since I last saw you? Are on any new 
medication? (if new physical complaint ,record but do not show too much 
interest) 
8-Have you any other questions? 
9-I will see you in X month’s time, but get in touch before if there is a problem. 
Make sure that you keep you diary up to date. 
 
VISITS AT 12 AND 15 MONTHS FROM DIAGNOSIS 
Repeat the same script of visits at 3 and 6 months. 
 
FINAL VISIT at 18 months  
 
Same format as visit at 9 months also discuss discharge or need for further 
follow up. 
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Appendix K: Patient information sheet about RCT. 
 
  
Information Sheet 
 
The tests that you have had show that your attacks are not due to epilepsy.  
They also show that your brain is working normally during the attacks, which 
means that the attacks have an emotional cause. 
 
This kind of attack can often be treated successfully, and there are a number of 
things we do to make sure that you have a good result.   
 
We think it is sensible to withdraw your anti-epileptic medication, but we do not 
know whether this in itself is beneficial to your type of attacks.   
 
We are carrying out a study to measure the effects of this, and would like you to 
participate. 
 
We divide our patients into: 
 
1. Those who come off medication straight away and 
2. Those who stay on their medication for 9 months, and then come off of it.   
 
If you agree to take part you will go into one or other group.   
 
The group you go into will be chosen by chance.   
 
Your treatment programme will otherwise be exactly the same. 
 
 
 
You should be clear that you are entirely free not to take part in this study, and if 
you do not then your treatment will not be affected in any way.  The same 
applies if you find you want to withdraw from the study part way through it: all 
you have to do is let your doctor know. 
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Appendix L: Hospital Anxiety and Depression Scale (HADS) 
 
H A D Scale 
Read each item and place a tick in the box opposite the reply which comes closest to how you 
have been feeling in the past week. 
Don’t take too long over your replies:  your immediate reaction to each item will probably be 
more accurate than a long thought-out response. 
Tick only one box in each section 
 
2.  I still enjoy the things I used to enjoy 
Definitely as much. . . . . . . . . . . . .   
Not quite as much. . . . . . . . . . . . .  
Only a little. . . . . . . . . . . . . . . . . .  
Hardly at all . . . . . . . . . . . . . . . . .  
 
3.  I get a sort of frightened feeling as if 
     something awful is about to happen 
Very definitely and quite badly . . .  
Yes, but not too badly  . . . . . . . . .   
Time to Time, Occasionally  . . . . .  
Not at all  . . . . . . . . . . . . . . . . . . .  
 
4.  I can laugh and see the funny side of 
     things 
As much as I always could  . . . . . .  
Not quite so much now . . . . . . . . .  
Definitely not so much now  . . . . .   
Not at all  . . . . . . . . . . . . . . . . . . .  
 
5.  Worrying thoughts go through my mind 
A great deal of the time  . . . . . . . .  
A lot of the time . . . . . . . . . . . . . .  
From time to time but not too often  
Only occasionally . . . . . . . . . . . . .  
 
6.  I feel cheerful 
Not at all  . . . . . . . . . . . . . . . . . . .   
Not often . . . . . . . . . . . . . . . . . . .  
Sometimes . . . . . . . . . . . . . . . . . .  
Most of the time  . . . . . . . . . . . . .   
 
7.  I can sit at ease and feel relaxed 
Definitely . . . . . . . . . . . . . . . . . . .  
Usually . . . . . . . . . . . . . . . . . . . . .   
Not Often . . . . . . . . . . . . . . . . . . .  
Not at all  . . . . . . . . . . . . . . . . . . .  
 
1.  I feel tense or “wound up” 
Most of the time . . . . . . . . . . . . . .  
A lot of the time . . . . . . . . . . . . . .  
Time to Time, Occasionally . . . . .  
Not at all . . . . . . . . . . . . . . . . . . .  
8.  I feel as if I am slowed down 
Nearly all the time . . . . . . . . . . . . . .   
Very often  . . . . . . . . . . . . . . . . . . .  
Sometimes  . . . . . . . . . . . . . . . . . . .  
Not at all   . . . . . . . . . . . . . . . . . . . .  
 
9.  I get a sort of frightened feeling like      
     butterflies in the stomach 
Not at all  . . . . . . . . . . . . . . . . . . . .  
Occasionally . . . . . . . . . . . . . . . . . .  
Quite often . . . . . . . . . . . . . . . . . . .  
Very often  . . . . . . . . . . . . . . . . . . .  
 
10.  I have lost interest in my appearance 
Definitely   . . . . . . . . . . . . . . . . . . .  
I don’t take so much care as I should  
I may not take quite as much care . .   
I take just as much care as ever . . . .  
 
11.  I feel restless as if I have to be on the 
       move 
Very much indeed . . . . . . . . . . . . .   
Quite a lot. . . . . . . . . . . . . . . . . . .  
Not very much. . . . . . . . . . . . . . . .   
Not at all   . . . . . . . . . . . . . . . . . . .  
 
12.  I look forward with enjoyment to 
       things 
As much as ever I did . . . . . . . . . .   
Rather less than I used to . . . . . . .  
Definitely less than I used to . . . . .  
Hardly at all  . . . . . . . . . . . . . . . . .   
 
13.  I get sudden feeling of panic 
Very often indeed . . . . . . . . . . . . .   
Quite often . . . . . . . . . . . . . . . . . .  
Not very often  . . . . . . . . . . . . . . .   
Not at all  . . . . . . . . . . . . . . . . . . .  
 
14.  I can enjoy a good book or radio or 
      TV programme 
Often   . . . . . . . . . . . . . . . . . . . . .  
Sometimes . . . . . . . . . . . . . . . . . .  
Not Often. . . . . . . . . . . . . . . . . . .  
Very seldom . . . . . . . . . . . . . . . . .   
 
For Office use only: 
Total odd = Ax _______      Total even = De _______ 
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Appendix M: SEALS questionnaire. 
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Appendix N: IPQ 
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Appendix O: Attack diary 
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